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Resumen 
La integridad de la superficie ocular, en otras palabras, su capacidad para responder 
adecuadamente a los desafíos ambientales, depende de la integración adecuada de la 
información desde la superficie ocular, la transmisión de la señal creada hacia el cerebro y la 
generación de una respuesta, que modulará la función secretora así como la inmunidad local 
de la superficie ocular. Es fácilmente comprensible que cualquier alteración de uno de los tres 
pasos de este ciclo cerrado pueda desencadenar una respuesta inapropiada y desequilibrar 
aún más los mecanismos compensatorios que tienen lugar en la superficie ocular. 
La unidad funcional de la lágrima se puede definir como un conjunto de estructuras 
anatómicas cuyo funcionamiento armonioso mantiene la osmolaridad lagrimal dentro de 
límites estrechos. Está compuesto por la córnea y la conjuntiva, ambas protegidas por los 
párpados superior e inferior. Las estructuras mencionadas anteriormente comparten la misma 
ruta principal de inervación aferente representada por el quinto nervio craneal (es decir, el 
nervio trigémino) y sus ramas terminales que permiten que la córnea y la conjuntiva tomen 
información relacionada con los cambios ambientales y la transmitan al tronco cerebral. Los 
nervios corneales proporcionan un rango de modalidades de entrada aferentes tales como el 
dolor (nociceptor), estímulos mecánicos (mecanorreceptores) y temperatura 
(termorreceptor). Las glándulas lagrimales y el parpadeo representan la parte efectora de la 
unidad funcional de la lágrima. La secreción de las glándulas lagrimales es activada en 
respuesta a la estimulación de las vías aferentes de la superficie ocular y permiten una 
secreción adecuada de lágrima ortogando valores adecuados de osmolaridad en condiciones 
fisiológicas. Este lazo eferente es impulsado por una inervación secretora parasimpática que 
transmite la señal de respuesta desde el tronco cerebral hacia las glándulas lagrimales 
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(principales, palpebrales y accesorias), las células caliciformes de la conjunctiva, las glándulas 
de Meibomio, y adapta la secreción y composición de la lágrima a los desafíos ambientales. El 
drenaje apropiado de la lágrima también está involucrado en este ciclo reflejo ya que la 
película lagrimal se evapora en parte en la superficie ocular, pero también necesita ser 
evacuada dado que la secreción lagrimal es un proceso continuo.  
Según la definición incluida en el informe del TFOS DEWS II, "El síndrome de ojo seco es una 
enfermedad multifactorial de la superficie ocular que se caracteriza por una pérdida de 
homeostasis de la película lagrimal y que va acompañada de síntomas oculares, en la que la 
inestabilidad e hiperosmolaridad de la película lagrimal, la inflamación y daño de la superficie 
ocular y las anomalías neurosensoriales desempeñan papeles etiológicos”. El término 
multifactorial es apropiado ya que se han identificado numerosos factores desencadenantes: 
edad, sexo, hormonas, ambiente, cirugía ocular, particularmente cirugía de cataratas, 
enfermedades autoinmunes, uso de lentes de contacto, medicamentos sistémicos y 
conservantes en colirios entre otros. Todos estos factores pueden ser potencial 
desencadenantes de uno o ambos subtipos de la enfermedad. 
La hiperosmolaridad de la lágrima, junto con la pérdida de estabilidad de la película lagrimal, 
es la piedra angular de la cascada de inflamación. Ambas condiciones conducen al estrés 
celular y a los procesos inflamatorios (tanto agudos como crónicos), que inducen a la 
autoalimentación y promueven el círculo vicioso del síndrome de ojo seco. A medida que la 
enfermedad progresa, se aumenta gradualmente el daño a nivel de la superficie ocular que se 
caracteriza por la pérdida celular. Otro hallazgo clave son las anomalías neurosensoriales. De 
hecho, las vías aferentes alteradas que involucran mecanismos que se explicarán con más 
detalles en este trabajo, previenen una recepción adecuada de la información en la superficie 
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ocular fomentando aún más la autopromoción de la enfermedad. Una amplia gama de 
patologías y trastornos, cambios relacionados con la edad, condiciones ambientales e 
intervenciones quirúrgicas pueden desencadenar cascadas inflamatorias que conducen a la 
sequedad o empeorar los procesos inflamatorios en curso en la superficie ocular. A pesar de 
esta multitud de puertas de entrada, todas las etiologías del síndrome de ojo seco comparten 
una vía inflamatoria común que conduce al daño de la superficie ocular: muerte celular, 
aumento de la tasa de descamación y renovación de las células epiteliales y, sobre todo, 
alteraciones de las vías aferentes que conducen a la autoperpetuación del círculo vicioso de 
la enfermedad. 
La importancia científica de los estudios epidemiológicos se basa en una definición y 
clasificación precisa de la enfermedad, que hasta hace poco representaba el principal desafío 
ya que no se había adoptado un consenso sobre los criterios diagnósticos objetivos y 
subjetivos. Además, la ausencia de pruebas “gold estándar” para diagnosticar la patología, 
que va de la mano con una heterogeneidad reconocida entre signos y síntomas, hace que la 
interpretación y comparación de diferentes estudios epidemiológicos sea más difícil de 
evaluar. 
Sin embargo, aún considerando el síndrome de ojo seco como una enfermedad cuyo 
diagnóstico está basado principalmente en la sintomatología, los estudios epidemiológicos 
que se centran solo en los signos clínicos son fuente de una variación considerable en los 
valores de prevalencia. La estandarización de los criterios de diagnóstico y las pruebas clínicas 
son el gran objetivo a alcanzar. La situación actual podría explicar las dificultades a las que se 
enfrentan los investigadores cuando se trata de criterios de diagnóstico; las pruebas clínicas 
de ojo seco que evalúan el mismo parámetro no tienen la misma sensibilidad y especificidad 
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en el diagnóstico de la enfermedad, las pruebas utilizadas a menudo solo evalúan un aspecto 
de la patología, no se han elegido “gold estándares” o una combinación de pruebas para 
evaluar las características clínicas. A estos factores, se le deben añadir una gran cantidad de 
signos de la patología, todos ellos con distinta gravedad, una sensibilidad al dolor específico 
de cada individuo, la presencia de patologías de la superficie ocular y cambios en la unidad 
funcional de la lágrima relacionados con la edad y/o condiciones sistémicas con impacto 
ocular. Con todo ello, hace que un diagnóstico adecuado basado en signos y síntomas sea 
realmente un desafío. 
El primer informe de TFOS estableció que la hiperosmolaridad y la inestabilidad de la película 
lagrimal son los factores clave de la enfermedad. A partir de esa afirmación, se pueden definir 
dos subtipos de la enfermedad: el ojo seco acuo-deficiente, donde la hiperosmolaridad se 
debe a una disminución del contenido acuoso disponible en la superficie ocular (secundaria a 
la secreción lagrimal reducida) en presencia de una tasa de evaporación normal. El ojo seco 
evaporativo es el otro subtipo de la enfermedad, y en este caso, la hiperosmolaridad sigue a 
una tasa excesiva de evaporación en presencia de una función lagrimal normal. 
Según el Informe de Epidemiología de TFOS, la prevalencia de la enfermedad basada en los 
síntomas y en los signos clínicos muestra un cambio gradual desde los 50 años. Parece muy 
probable que se produzcan cambios importantes relacionados con la edad en la unidad 
funcional de la lagrima en este período de la vida (que podrían deberse a una combinación de 
envejecimiento del ojo y cambios sistémicos), posiblemente desequilibrando los complejos 
mecanismos de homeostasis de la superficie ocular y desencadenando o excacerbando signos 
y síntomas de sequedad. De hecho, cuando se trata de factores de riesgo para la enfermedad, 
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el envejecimiento, de nuevo dependiendo de los criterios de diagnóstico y la variabilidad de 
la definición del ojo seco, parece ser el factor más consistente asociado con la enfermedad. 
Cada parte del cuerpo humano está sujeta al envejecimiento y la unidad funcional de la 
lágrima no es una excepción: la glándula lagrimal, el borde palpebral, las glándulas de 
Meibomio y la conjuntiva se ven afectadas en su estructura y función a lo largo de la vida. 
Varios cambios histopatológicos relacionados con la edad ocurren en la glándula lagrimal. En 
primer lugar, se produce un grado bajo de dacrioadenitis junto con atrofia acinar. La fibrosis 
periacinar y la pérdida paraductal de vasos sanguíneos tienden a aparecer en adultos jóvenes, 
pero su incidencia aumenta con la edad. Curiosamente, los conductos secretores que siguen 
a los acinos se dilatan a lo largo de la vida y muestran una mayor tortuosidad, lo que sugiere 
la presencia de una obstrucción de los conductos. La infiltración linfocítica de las glándulas 
lagrimales está directamente relacionada con el envejecimiento, ya que se encontró que su 
incidencia era mayor en sujetos de edades superiores a los 40 años. Se concentra 
principalmente alrededor de los conductos secretores y acinos que conducen a su destrucción 
gradual. Además, se cree que el envejecimiento de la glándula lagrimal se acompaña de una 
infiltración de grasa y disminución de la masa de la misma glándula, lo que finalmente conduce 
a: la disfunción de la glándula lagrimal, a la reducción de la secreción refleja y del tiempo de 
ruptura de la película lagrimal. Sin embargo, se cree que la disminución reportada en la 
literatura de los valores reflejos de Schirmer a lo largo de la vida podría deberse a una variedad 
de factores como: una reducción del número de neurotransmisores secretores, a la pérdida 
de la funcionalidad de la glándula lagrimal y más importante, a la pérdida de sensibilidad de 
la vía aferente que se origina en la superficie ocular. De hecho, las vías corneales aferentes 
terminales que toman información relativa a los estímulos mecánicos y químicos en la 
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superficie ocular, pierden sensibilidad con la edad, lo que reduce el impulso sensorial hacia la 
glándula lagrimal.  
Además de los cambios mencionados anteriormente que tienen lugar en la unidad funcional 
de la lágrima, se producen dos procesos adicionales de deterioro visual relacionados con la 
edad a nivel del cristalino que conducen a la presbicia y cataractogénesis respectivamente, 
destacando la necesidad de una corrección óptica. El presente manuscrito describirá estos dos 
cambios relacionados con la edad y el impacto potencial de las soluciones refractivas 
existentes para corregirlos y su impacto sobre diferentes parámetros de la superficie corneal 
y la lágrima que podrían desencadenar signos y síntomas relacionados con el síndrome de ojo 
seco. 
Desde un punto de vista visual, posiblemente la presbicia (pérdida progresiva de la capacidad 
de acomodación) sea la característica principal del envejecimiento ocular. La acomodación es 
el proceso por el cual el ojo, más precisamente el cristalino, cambia su forma para permitir el 
enfoque sobre objetos cercanos. Este fenómeno óptico se basa en la contracción del músculo 
ciliar, que a su vez ablanda las fibras ciliares unidas al cristalino y permite que la lente adopte 
una forma más curva, lo que aumenta su poder de refracción y reduce la distancia focal al 
objetivo de interés. La presbicia, es uno de los defectos de refracción más comunes ya que 
toda la población desarrollará eventualmente presbicia, siendo el factor de riesgo mayor la 
edad avanzada, aunque otros elementos pueden influir en su inicio y progresión (enfermedad, 
medicamentos, trauma,…).  
Según la OMS, la catarata es la principal causa de ceguera y se espera que la pérdida de visión 
útil afecte a 16 millones de personas en todo el mundo. La cataractogénesis es multifactorial 
y puede desarrollarse a partir de una amplia variedad de causas; la radiación ultravioleta, en 
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particular ultravioleta B, (Involucrada en los cambios de cataratas corticales), factores 
genéticos, fármacos sistémicos, enfermedades infecciosas, pero el envejecimiento es, con 
mucho, el principal factor de riesgo para su aparición. Induce un amplio espectro de cambios 
con respecto a los procesos bioquímicos que tienen lugar en el cristalino que conducen a la 
alteración del equilibrio hídrico, de las proteínas, de las vitaminas y las enzimas, y es 
responsable de la pérdida progresiva de la transparencia de la lente. La catarata relacionada 
con la edad parece ser el resultado de un proceso prolongado y gradual de desnaturalización 
de proteínas que constituyen el cristalino, que puede ocurrir principalmente de tres maneras 
diferentes: condiciones ambientales mantenidos (principalmente radiación ultravioleta), 
reducción de la estabilidad intrínseca de las proteínas del cristalino o perdida progressiva de 
la homeostasis celular del cristallino. 
El síndrome de ojo seco, se ha convertido en un problema de salud pública en todo el mundo, 
ya que su impacto en los sistemas de salud está creciendo constantemente. Además del costo 
económico, el impacto social de la enfermedad se afianzó y se relaciona con una calidad de 
vida reducida debido al impacto de la enfermedad en la función visual y comfort del paciente. 
Todo ello deriva en una mayor frecuencia de visitas médicas, aumento en las tasas de 
depresión y una productividad laboral reducida. Numerosos estudios han analizado la 
influencia del envejecimiento sobre los signos y síntomas del síndrome de ojo seco y, según 
ellos, la edad es un factor de riesgo significativo para la enfermedad ya que las personas 
mayores de 50 años presentan una prevalencia del síndrome de ojo seco que aumenta 
significativamente, siendo las mujeres el sexo más afectado.  
Existen diversos métodos para corregir la presbicia que se podrían dividir en no quirúrgicos y 
quirúrgicos. En el primer grupo se incluirían desde gafas (incluyendo simples lentes de lectura, 
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bifocales, trifocales y multifocales) hasta lentes de contacto con diferentes geometrías 
(monovisión, bifocales, visión simultánea,…). Es necesario indicar que la primera opción es un 
método no invasivo mientras que la segunda, al adaptar la lente de contacto, ésta se asienta 
en la película lagrimal, alterando su estructura normal e interactuando con la superficie ocular, 
posiblemente empeorando un entorno ya desequilibrado. Por otro lado, la cirugía refractiva 
es otra opción disponible [cirugía de cataratas con implantación de lentes intraoculares de 
geometría diferente (monofocal, bifocal, trifocal), cirugía refractiva corneal] pero su caracter 
invasivo, aún habiendo realizado grandes avances en los últimos tiempos, podría perturbar la 
superficie ocular y empeorar o inducir signos y síntomas de sequedad ocular. 
El objetivo de este proyecto es evaluar los cambios en las métricas de película lagrimal y los 
signos oculares inducidos por diferentes tipos de corrección refractiva (implantación de lente 
intraocular y lentes de contacto) centrándose en la población de mayor edad, ya que la 
prevalencia de la enfermedad de ojo seco aumenta con la edad, y debido a la presbicia, la 
mayoría de las personas mayores de 40 años necesitan corrección refractiva para distancia 
lejana, visión intermedia o cercana, o para las tres. 
En el Capítulo 1, se realiza una introducción general, exponiendo diversos aspectos 
relacionados con la patofisiologia del síndrome de ojo seco, las manifestaciones clínicas del 
envejecimiento al nivel ocular describiendo la presbicia y la catarata. Además, se exponen las 
opciones terapéuticas tanto ópticas como quirúrgicas para ambas condiciones. 
En el Capítulo 2, se justifica la importancia del estudio del impacto de las ayudas ópticas para 
corregir la presbicia sobre los signos y síntomas de sequedad ocular y se plantean la hipótesis 
y los objetivos de la Tesis Doctoral. 
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En el Capítulo 3, se describe la metodología general que se va a seguir en los estudios clínicos 
que componen esta Tesis Doctoral. Se exponen las características de las muestras de sujeto 
estudiadas, los criterios de inclusión y además se describen los instrumentos de medida 
utilizados para obtener los resultados de los estudios presentados en posteriores capítulos. 
Además, se describen los procedimientos estadísticos utilizados para analizar los resultados y 
sacar, a partir de ellos, conclusiones. 
En el Capítulo 4, el objetivo fue evaluar el rendimiento de un nuevo material de lente de 
contacto desechable diaria en la superficie ocular de una población présbita. Se adaptó un 
material de lente de contacto diario con gradiente de agua (delefilcon A) en una población 
présbita y se evaluó durante el primer día de desgaste del material. Para lograr ese objetivo, 
se investigaron los parámetros de la película lagrimal y superficie ocular a lo largo de un 
tiempo de porte de 8 horas. Las medidas se realizaron al inicio del estudio, veinte minutos 
después de la inserción del lente de contacto y a las 8 horas de uso. Se comenzó por las 
pruebas menos realizando posteriormente las más invasivas: agudeza visual, refracción 
monocular y binocular, biomicroscopía de lámpara de hendidura del segmento anterior, 
osmolaridad, área del menisco lagrimal inferior, examen topográfico y evaluación del tiempo 
de ruptura de la película lagrimal usando fluoresceína. Los participantes fueron reclutados 
entre los empleados de la Universidad de Valencia y no presentaron ninguna patología de 
segmento anterior o cirugía corneal previa. La edad promedio de los participantes fue de 50,0 
± 4,4 años, con edades comprendidas entre 41 y 60 años. El error de refracción equivalente 
esférico medio fue + 1,11 ± 0,35 D y varió de -4,25 a +2,50 D. De los 40 ojos incluidos, 18 fueron 
miopes (error esférico medio equivalente -2,80 ± 0,72D) y 22 hipermétropes (+ 0,90 ± 0,24D). 
Se encontraron cambios significativos en los valores de osmolaridad entre los valores basales 
(306,93 ± 2,32 mOsm / L) y 20 minutos (312,43 ± 2,42 mOsm / L) (p <0,05). Los valores del 
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área del menisco lagrimal disminuyeron a lo largo del día (de 0,020 ± 0,003 mm2 a 0,017 ± 0,03 
mm2) (P = 0,061), pero no fueron estadísticamente significativos. El estudio de las 
aberraciones de la superficie ocular de orden superior mostró un incremento 
estadísticamente significativo entre el valor inicial (0,38 ± 0,21 μm) y 20 minutos (0,61 ± 0,44 
μm) (P≤0,001), y entre el inicio y las 8 horas (0,64 ± 0,41 μm) (P≤0,001). El tiempo de ruptura 
de la película lagrimal empeoró al final del día de 10,4 ± 0,4 segundos en los valores iniciales 
a 9.0 ± 0.3 segundos después de 8 horas de desgaste del lente de contacto (P <0,05). No se 
encontraron diferencias estadísticamente significativas entre las mediciones al inicio del 
estudio y después de 8 horas de porte de lente de contacto con respecto a la tinción corneal 
con fluoresceína (P = 0,727) y la tinción conjuntival (P = 0,092). De acuerdo con nuestros 
resultados, no se encontraron cambios significativos con respecto a la tinción de la córnea o 
la conjuntiva al final del día, lo que significa que incluso si la osmolaridad estaba por encima 
de los valores de corte, no fue clínicamente significativa ya que no hubo daño celular. Los 
valores de osmolaridad no cambiaron durante el tiempo de uso, lo que puede implicar que las 
propiedades de la superficie de la lente de contacto permanecieron estables durante las 8 
horas de porte proporcionando suficiente lubricación y transmisión de oxígeno a la superficie 
ocular para no inducir ninguna tinción adicional. Sin embargo, si los cambios de osmolaridad 
se produjeran en un patrón similar durante un tiempo prolongado, la integridad corneal 
podria verse comprometida. Además, se especuló que los aumentos en la osmolaridad a los 
20 minutos también podrían deberse en parte a la respuesta de la superficie ocular a la 
inserción de la lente de contacto, y a una interacción de la lágrima con el material, pudiendo 
ser diferente para cada paciente. 
También se sabe que el síndrome de ojo seco, de acuerdo con su gravedad, induce un aumento 
significativo de las aberraciones, lo que implica que, en el caso del desgaste de la lente de 
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contacto, la calidad de la superficie de la película lagrimal previa a la lente se vería afectada. 
El hecho de que las aberraciones de alto orden de la superficie ocular permanezcan bastante 
estable durante el período de uso puede implicar que la calidad de superficie de la película 
lagrimal y la dinámica de la película lagrimal prelente se vieron mínimamente afectados a lo 
largo del día. Concluimos que la inserción de la lente de contacto desechable diaria induce una 
disminución inicial de la estabilidad de la película lagrimal observada por valores de 
osmolaridad que aumentan después de 20 minutos de uso, pero no afectó las mediciones del 
menisco lagrimal y pareció transitoria, ya que al final se produjo una disminución aunque sin 
alcanzar valores iniciales del período de uso. Las aberraciones de la superficie ocular 
permanecieron estables a partir de la inserción del lente de contacto, lo que demuestra una 
distribución uniforme de la película lagrimal sobre la superficie del lente de contacto. 
En el Capítulo 5, el objetivo fue evaluar el efecto de la modalidad de uso de lentes de contacto 
en la fisiología de la superficie ocular durante un mes en una población présbita. Un total de 
40 ojos de 40 sujetos, empleados de la Universidad de Valencia, no portadores de lentes de 
contacto, con edades comprendidas entre 41 y 60 años, se incluyeron en este estudio. Se 
utilizaron dos materiales con diferentes modalidades de porte: una lente de contacto 
desechable diaria (Delefilcon A) y una lente de contacto de porte mensual (Lotrafilcon B). Se 
evaluaron los siguientes parámetros durante el mes de uso para cada material: cuestionario 
OSDI, cuestionario CLDEQ-8, agudeza visual y refracción, biomicroscopía con lámpara de 
hendidura, examen topográfico, medida del espesor corneal central usando un tomógrafo de 
coherencia óptica y un biómetro, medidas de osmolaridad, del tiempo de ruptura de la 
película lagrimal usando fluoresceína y área del menisco lagrimal inferior. Los parámetros 
previamente descritos se midieron en: condiciones basales (t0), después de 20 min (t1) y a las 
8 horas después de la inserción (t2), por la mañana (t3) y por la tarde (t4) del día 30 excepto 
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para OSDI / CLDEQ -8, que se evaluaron al final del período de uso para cada material de lente 
de contacto. El porte de la lente de contacto se interrumpió durante cuatro días entre cada 
período de un mes como medida de lavado. Las puntuaciones OSDI obtenidas en (t0) y (t4) 
para las lentes de uso diario y extendido fueron 8,5 (t0), 13,2 8 (t4) y 24,4 (t4) puntos 
respectivamente, y mostraron diferencias significativas solo con respecto a la lente de 
contacto de uso mensual (p = 0,042). Los puntajes del CLDEQ-8 obtenidos en (t0) y (t4) para 
los materiales de uso diario y mensual fueron de 6,2 ± 3,8 (t0) puntos, 10,6 ± 8,5 (t4) puntos y 
18,1 ± 9,8 (t4) puntos respectivamente, y mostraron diferencias significativas con el lotrafilcon 
B dando las puntuaciones más altas (P = 0,012). 
Para ambas lentes, el área del mensico lagrimal inferior disminuyó con el tiempo (p <0,001) y 
(p <0,002) respectivamente. El análisis post-hoc reveló solo diferencias significativas para la 
lente diaria entre las mediciones tomadas al inicio (t0) / (t2), (t0) / (t3), (t0) / (t4), así como 
también entre (t1) / (t2) y (t1) / (t4) (p <0.05). Para la lente de contacto mensual, se 
encontraron diferencias significativas entre (t0) / (t1) (p = 0,016), (t0) / (t3) (p = 0,009), (t0) / 
(t4) (p = 0,001) y (t1) / (t4) (p = 0,017). 
No se encontraron diferencias estadísticamente significativas en la osmolaridad a lo largo del 
día y al final del mes para cada lente. Al comparar ambas lentes, existen diferencias 
significativas en (t1) (p = 0,006) y en (t2) (p = 0,002), con valores mayores para Delefilcon A. 
Para ambas lentes, las aberraciones de orden superior de la superficie ocular mostraron 
diferencias significativas con el tiempo mientras que la prueba de Wilcoxon encontró 
diferencias significativas entre (t0) / (t1), (t0) / (t2), (t0) / (t3) y (t0) / (t4) (p <0,001) para cada 
lente, respectivamente. No se encontraron diferencias entre lentes a lo largo del mes de uso. 
Con respecto al grosor central total, al comparar ambas lentes, se encontraron diferencias 
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significativas entre todas las comparaciones pareadas (p <0,001) con valores de espesor más 
altos para la lente desechable diaria.  
La sintomatología evaluada a través de dos cuestionarios puso en evidencia diferencias al nivel 
de la comodidad de uso entre ambos materiales mostrando un incremento de la 
sintomatología par el lotrafilcon B mucho mas importante que para el material de uso diario. 
Delefilcon A presenta un módulo superficial muy bajo de 0.025 MPa (núcleo de 0,76 MPa) 
mientras que el material Lotrafilcon B tiene un módulo general de 1,2 MPa haciéndolo más 
rígido. Esto podría inducir una mayor incomodidad durante el período de estudio en 
comparación con el material de lente de contacto diario (ya que el diseño de la lente afecta la 
comodidad de la lente) y en parte explicar los puntajes de sintomatología más altos obtenidos 
para el material de lente de contacto de uso mensual. 
Dado que cada participante del estudio no presentó signos y/o síntomas de síndrome de ojo 
seco, parece razonable suponer que la reducción en los valores del área del menisco lagrimal 
inferior encontrados en el presente estudio podría deberse a la desestabilización de la película 
lagrimal por el material de la lente de contacto, independientemente del tipo de lente, y 
también a la gran variabilidad de este parámetro a lo largo del día. 
Con respecto a los valores de osmolaridad, el ligero aumento puntual en la osmolaridad 
encontrado para el material de lente de contacto diario no fue clínicamente significativo ya 
que volvió a los niveles basales a lo largo del mes de uso y no produjo cambios significativos 
en las tinciones vitales. El material de lente de contacto de porte mensual también mostró 
valores constantes de osmolaridad entre cada visita, lo que nos permite plantear la hipótesis 
de que ambos materiales proporcionan una alta compatibilidad y una mínima perturbación 
con la superficie ocular de los portadores neófitos presbitas de lente de contacto. 
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Los materiales de lente de contacto utilizados en este estudio son diferentes ya que aunque 
ambos son lentes de hidrogel de silicona, su contenido en agua y estructura central difieren. 
Sobre la base de esta observación, se esperaban diferencias significativas durante un mes de 
uso con respecto a la calidad de la película lagrimal pre lente y las aberraciones de alto orden 
de la superficie ocular resultantes. Sin embargo, no se encontraron disparidades al comparar 
lentes, excepto por los valores al final del día [(t2) / (t4)] que sugieren que la película lagrimal 
pre lente podría haber mostrado variaciones locales a las 8 horas de porte con el uso de 
lotrafilcon B. La calidad de la superficie de la película lagrimal y su dinámica fueron 
mínimamente impactados durante un mes de porte de lentes de contacto. Ambos materiales 
valorados en este estudio proporcionaron un comportamiento visual satisfactorio y similar en 
el ojo, y se mantuvieron bastante estables a lo largo del período experimental. Sin embargo, 
los resultados de la sintomatología valorados en los test subjetivos mostraron un mejor 
comportamiento para la lente de uso diario.  
En el Capítulo 6, el objetivo del estudio fue evaluar y comparar el efecto de lentes corneo-
esclerales y esclerales en los parámetros de la película lagrimal y el grosor corneal en sujetos 
présbitas sanos. Treinta ojos de 30 sujetos présbitas (54 ± 4 años; rango: 46-63 años) 
completaron el estudio. Los sujetos usaron dos lentes de contacto, asignadas aleatoriamente, 
con potencia neutra y diferentes diámetros [12,7 mm (lente corneo-escleral), 18 mm (lente 
escleral)]. Como parte de la exploración del estudio, cada uno de los participantes fue valorado 
en términos de agudeza visual, refracción, biomicroscopía con lámpara de hendidura, examen 
topográfico, medición del espesor corneal central con tomografía de coherencia óptica. Al 
inicio del estudio, después de 20 min (t1) y al cabo de 8 horas después de la inserción (t2), se 
evaluó el área del menisco lagrimal mediante la tomografía de coherencia óptica, el espesor 
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corneal central así como la osmolaridad lagrimal. Se pautó 4 días de lavado entre los dos 
portes.  
En cuanto al área del menisco lagrimal, los valores medianos con la lente corneo-escleral, para 
las medidas basales, a los 20 min y a las 8 horas fueron 0,0213, 0,0216 y 0,0152 mm2, 
respectivamente, mientras que con la lente escleral se obtuvo 0,0213, 0,0205 y 0,0137 mm2, 
respectivamente. Para ambas lentes, las diferencias fueron significativas con el tiempo (p 
<0,001), mientras que el análisis post-hoc reveló solo diferencias significativas entre las 
mediciones tomadas a las 8 horas y los otros dos períodos anteriores (p <0,001).  
En términos de espesor corneal central, con la lente corneo-escleral se midieron 549, 555 y 
563 μm, y con la lente escleral 549, 556, 577 μm, para los diferentes estadios. Para ambas 
lentes, la prueba de Friedman fue estadísticamente significativa entre visitas (p <0,001), 
mientras que el análisis post-hoc reveló diferencias estadísticamente significativas para todas 
las comparaciones pareadas (p <0,001).  
La osmolaridad medida fue 296, 298 y 305 mOsm / L y 296, 299 y 306 mOsm / L para la lente 
corneo-escleral y lentes escleral, respectivamente, en cada estadio. Para ambas lentes, se 
encontraron diferencias estadísticamente significativas entre las visitas (p <0,001), mientras 
que el análisis post-hoc reveló diferencias estadísticamente significativas entre todos los 
períodos comparados (p ≤0,002).  
El envejecimiento de la población aumenta la probabilidad de desarrollar síndrome de ojo seco 
ya que el aumento de la edad se asocia con una mayor prevalencia de trastornos sistémicos y 
oculares que pueden alterar la homeostasis del segmento anterior. Las lentes esclerales 
presentan una doble ventaja para esta población ya que pueden ser una buena plataforma 
óptica para corregir la presbicia a través de la multifocalidad y proteger la superficie ocular 
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mediante la bóveda de la córnea. Se necesitan más estudios para identificar mejor los 
beneficios que los lentes esclerales podrían aportar a una población de mayor edad con 
patologías del segmento anterior y para comprender mejor el papel potencial de esas lentes 
en la restauración / mantenimiento de la homeostasis de la superficie ocular durante períodos 
más largos. 
En el Capítulo 7, el objetivo del estudio piloto fue evaluar el impacto de la cirugía de catarata 
sobre la métrica de la película lagrimal, la superficie ocular y la función de las glándulas de 
Meibomio. Se incluyeron 11 pacientes diagnósticado de catarata (62,1 ± 10,7 años; rango: 40-
75 años). Los pacientes fueron visitados dos veces: 7 días antes de la cirugía de catarata, y 7 
días después del procedimiento quirúrgico. En cada visita, se valoró la sintomatología de 
acuerdo con el informe de metodología diagnóstica TFOS DEWS II utilizando los tests 
subjetivos OSDI y DEQ-5. El dispositivo I-Pen (I-MED Pharma Inc.) se usó para evaluar la 
osmolaridad del tejido ocular al nivel de la membrana conjuntival palpebral inferior. Después 
de medir el tiempo de ruptura de la película lagrimal usando fluoresceína, la tinción de la 
córnea y la conjuntiva se evaluaron según la escala de clasificación de Efron para la tinción de 
la superficie ocular. La altura del menisco lagrimal inferior se evaluó usando lámpara de 
hendidura, la expresividad del meibum se valoró mediante la aplicación de presión digital al 
tercio central del tarso superior usando la escala Arita et al. El valor de corte del meiboscore 
como criterio para el diagnóstico de disfunción de las glándulas de Meibomio fue ≥3. 
El sistema de meibografía estaba compuesto por una lámpara de hendidura equipada con un 
filtro transmisor de infrarrojos junto con una cámara digital que permite capturar imágenes 
fijas de infrarrojos o videos de grabación de la morfología de las glándulas de Meibomio. Las 
áreas donde no se pudo visualizar el tejido glandular se consideraron áreas de pérdida de las 
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glándulas de Meibomio. Los puntajes de meibografía, que cuantifican la obstrucción de las 
glándulas de Meibomio, se obtuvieron utilizando grados de la escala de Arita et al. El puntaje 
total de meibografía fue la suma de las puntuaciones de los párpados superior e inferior y 
toma valores entre 0 a 6. La media del puntaje DEQ-5 fue de 9,82 (rango de SD 1,9 de 1 a 18) 
antes de la cirugía, de los cuales el 63% (n = 7) tuvieron una puntuación basal mayor a 6 
(indicativos de síntomas de síndrome de ojo seco leves o mayores). Después de la cirugía, la 
puntuación media de DEQ-5 fue de 14 (SD 1,9 rango de 3 a 20), de los cuales el 82% (n = 9) 
tuvieron una puntuación mayor a 6. Se encontró un aumento significativo en la puntuación de 
DEQ-5 después de la cirugía (prueba de Wilcoxon p = 0.017). La puntuación promedio de OSDI 
al inicio del estudio fue de 36 (SD 4,8 rango 4 a 62) de los cuales el 91% estaban por encima 
del puntaje de corte para síndrome de ojo seco. La puntuación OSDI media después de la 
cirugía fue de 42,4 (rango SD 8 a 67), de los cuales 91% estaban por encima del puntaje de 
corte para síndrome de ojo seco. Se encontró un aumento significativo en la puntuación OSDI 
después de la cirugía (prueba t de muestras pareadas p = 0.03). La correlación entre estos dos 
cuestionarios fue moderada (Pearson's r= 0.60, Spearman's ρ= 0.57 p= 0.05). Los valores 
medios del tiempo de ruptura del menisco lagrimal fueron de 8.6 s (SD 0.5 rango de 6 a 11 s) 
antes de la cirugía y 8.4 s (SD 0.6 rango de 6 a 11 s). No se encontraron diferencias significativas 
entre los valores previos y posteriores a la cirugía (p = 0,608). Las puntuaciones medias de 
tinción fueron de 0,3 (SD 0,5 rango o a 1) y 1,3 (SD 0,5 rango 1 a 2) antes y después de la 
cirugía, respectivamente.  
La tinción vital aumentó significativamente a través de la cirugía (p = 0,004). Los valores 
medios de la altura del menisco lagrimal inferior fueron 0.26 mm (SD 0,03 rango 0,10 a 0,40 
mm) y 0,27 mm (SD 0,03 rango 0,15 a 0,40 mm) antes y después de la cirugía respectivamente. 
No se pudieron evidenciar diferencias entre las citas. La media de los valores de osmolaridad 
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eran 299,2 mOsm / L (SD 4,6 desde 282 a 333 mOsm / L) y 294 mOsm / L (SD 2,3 desde 275 
hasta 303 mOsm / L) antes y después de la cirugía, respectivamente. Los valores de 
osmolaridad no mostraron cambios significativos durante el estudio (p = 0,66). Las 
puntuaciones medias de expresividad de las glándulas de Meibomio fueron de 1,0 (SD 0.3 
rango 0 a 2) y de 1,7 (intervalo SD 0,3 rango 0 a 3) antes y después de la cirugía, 
respectivamente. De los 11 pacientes incluidos en este estudio, 6 presentaron un meiboscore 
antes de la cirugía ≥3 que los clasificó como pacientes con disfunción de las glándulas de 
Meibomio. La expresión de las glándulas de Meibomio fue significativamente más difícil de 
realizar después de la cirugía (p = 0,011). En cuanto a las imágenes de infra-rojo de las 
glándulas de Meibomio, los promedios fueron de 2.5 (SD 0.4 rango de 1 a 4) para pre- y post-
cirugía, respectivamente. No se detectaron diferencias estadísticas entre las citas para este 
parámetro. A partir de los resultados obtenidos en este estudio piloto, planteamos la hipótesis 
de que la cirugía de cataratas promueve la obstrucción de las glándulas de Meibomio a corto 
plazo, ya que solo se pudieron evidenciar cambios funcionales (reducción de la expresividad 
glándulas de Meibomio) y la meibografía infra-roja no mostró ninguna alteración estructural 
significativa. Tal como ya han propuesto algunos autores, es más probable que los cambios 
estructurales que afectan las glándulas de Meibomio, que no se encontraron en el presente 
estudio, sean más el resultado de una disfunción crónica que una parte de los resultados de 
la cirugía de catarata a corto plazo. El presente estudio no pudo dilucidar los mecanismos 
exactos por los cuales ocurren cambios funcionales a corto plazo en las glándulas de Meibomio 
después de la cirugía; sin embargo, es muy probable que incluso sin signos significativos de 
daño de la estructura de las glándulas de Meibomio, la cirugía de cataratas parece afectar su 
función. La literatura previa sugiere que la inflamación inducida por la cirugía, la infección 
bacteriana de la superficie ocular alterada, los medicamentos post-operatorios que contienen 
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conservantes o la combinación de los anteriores juegan un papel impotrtante en el desarrollo 
del síndrome de ojo seco después de la cirugía de catarata incluso en diferentes extensiones. 
Sin embargo, sería interesante para el seguimiento de los cambios que tienen lugar en la 
conjunción muco-cutánea y línea de Marx tanto superiores como inferiores, dado que el 
ensanchamiento y desplazamiento anterior de la línea de Marx son un buen indicador del 
estado funcional de las glándulas de Meibomio.  
Este estudio tiene algunas limitaciones. En primer lugar, se realizó en un número 
relativamente pequeño de sujetos y no tenía un grupo control que no se hubiera sometido a 
cirugía de cataratas. En segundo lugar, no se estudió el estado de higiene del párpado y no se 
evaluó la línea de Marx y la conjunción muco-cutánea, lo que podría haber proporcionado 
información valiosa sobre el impacto de la cirugía en estos parámetros; de hecho, un estudio 
previo mostró cambios significativos en la vasculación del margen del párpado y el 
desplazamiento de la junción muco-cutanea irreversible a través de la cirugía. En tercer lugar, 
la expresividad del meibum no se midió objetivamente utilizando un dispositivo que 
proporcionara presión estandarizada en el margen palpebral. Nuevas terapias están surgiendo 
con el fin de tratar la disfunción de glándulas de Meibomio, tales como los sistemas de luz 
pulsada intensa que se usan para tratar la enfermedad. Se encontró información valiosa con 
respecto a la función de las glándulas de Meibomio, pero se necesita más investigación para 
evaluar el impacto de esta terapia en pacientes con disfunción de las glándulas de Meibomio 
en los resultados de la cirugía. 
Como conclusión general de esta tesis doctoral, cabe señalar que el ojo, así como todo el 
cuerpo humano, está sujeto al proceso de envejecimiento, cuyas manifestaciones más 
notables son la presbicia y opacificación del cristalino, pero también todas las estructuras del 
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segmento anterior se someten a cambios funcionales y morfológicos relacionados con la edad, 
desde las glándulas lagrimales (glándula lagrimal principal, glándulas de Meibomio, células 
caliciformes) hasta los párpados y la conjuntiva. Estos cambios reducen tanto la cantidad como 
la calidad de la secreción lagrimal, evitan una repartición óptima de la película lagrimal en la 
superficie ocular que puede potencialmente inducir / empeorar los signos y síntomas de 
sequedad ocular.  
La prevalencia del síndrome de ojo seco aumenta con la edad, debido a los procesos de 
envejecimiento antes mencionados que van de la mano de una mayor prevalencia de 
enfermedades sistémicas (y su medicación asociada) con efectos secundarios oculares. En ese 
sentido, compensar la presbicia requiere una anamnesis exhaustiva previa, así como una 
evaluación de la unidad funcional de la lagrima en busca de procesos patológicos / 
inflamatorios en curso.  
Se pueden considerar múltiples enfoques al corregir la presbicia y la catarata, el objetivo 
común es restaurar la visión y brindar un confort sostenible al paciente. La gran mayoría de 
las opciones de refracción disponibles, a excepción de las lentes oftálmicas, se consideran 
invasivas y podrían perturbar la homeostasis de la superficie ocular. La corrección de la 
presbicia mediante lente de contacto (desde lente de contacto corneal hidrofílica o rígida 
permeable al gas hasta diseños esclerales y semiesclerales con diferentes geometrías) puede 
alterar la estructura normal de la película lagrimal interactuando con la superficie ocular, 
posiblemente empeorando un entorno ya desequilibrado. La cirugía refractiva es otra opción 
disponible [cirugía de cataratas con implantación de lentes intraoculares de geometría 
diferente (monofocal, bifocal, trifocal), cirugía refractiva corneal] pero su invasividad, incluso 
si se han realizado grandes pasos hacia adelante, perturba también la superficie ocular y 
 
 
xliv 
 
puede empeorar o inducir signos y síntomas de sequedad. Es obligatorio realizar una 
evaluación exhaustiva de la sintomatología y del estado general de salud del segmento 
anterior al corregir la presbicia con opciones refractivas invasivas. Con ello, además de 
permitir una identificación precisa de las estructuras debilitadas de la unidad funcional de la 
lágrima, tambien ofrece la posibilidad de elaborar una estrategia adecuada para optimizar los 
resultados a corto y largo plazo en funión de la opción de refracción elegida.  
La identificación adecuada de los cambios que tienen lugar en la unidad funcional de la lágrima 
es una condición sine qua non para introducir medidas de profilaxis en masa en los exámenes 
optométricos y oftalmológicos de rutina. El diagnóstico precoz de esta condición multifactorial 
es el mejor medio para prevenir, si no retrasar, su aparición y las complicaciones posiblemente 
inducidas por diferentes tipos de correcciones refractivas. Se necesita más investigación para 
identificar mejor los síntomas relacionados con la enfermedad, así como los primeros signos 
de la enfermedad en la superficie ocular con el fin de dar soluciones a una población que 
envejece y está dispuesta a ser independiente de la corrección con lentes oftálmicas. El 
conocimiento global sobre la sensibilidad ocular, el daño y sus vías asociadas se ha 
incrementado significativamente; sin embargo, los mecanismos exhaustivos a través de los 
cuales síndrome de ojo seco se desarolla y afecta aún más la homeostasis de la superficie 
ocular no se comprenden completamente debido a su alta complejidad y a los numerosos 
mecanismos implicados. Se necesitan investigaciones adicionales sobre la neuropatogénesis 
de la alteración de la sensación ocular en el síndrome de ojo seco para profundizar en los 
conocimientos relacionados con los mecanismos de homeostasis, la respuesta ocular al daño 
nervioso y su papel en la aparición y perpetuación del síndrome de ojo seco en una población 
que se enfrenta a nuevos desafíos debido al envejecimiento, pero también a la aparición de 
nuevas técnicas de cirugía refractiva. 
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Thesis Summary 
Ocular surface integrity, in other words, its ability to respond adequately to environmental 
challenges, depends on a proper information intake at the ocular surface, the transmission of 
the created signal to the brain and the generation of a response, that will modulate secretory 
function and local immunity. It is easily understandable that any disturbance of one of the 
three steps of this closed loop could trigger an inappropriate response and further unbalance 
the compensatory mechanisms taking place at the ocular surface. 
The LFU can be defined as a set of anatomical structures whose harmonious functioning 
maintains tear osmolarity within narrow limits. It is composed of the cornea and the 
conjunctiva, both protected by the upper and lower lids. All of the structures named above 
share the same main afferent innervation path represented by the fifth craneal nerve (i.e. 
trigeminal nerve) and its terminal branches, which allow the cornea and the conjunctiva to 
take information related to environmental changes and transmit it to the brainstem. Corneal 
nerves provide a range of afferent inputs modalities such as pain (nociceptor), 
mechanoreception and temperature (thermoreceptor). Lacrymal glands and blink response 
are the effectory part of this LFU. LGs are stimulated in response to ocular surface afferent 
inputs and allow appropriate tear secretion and proper osmolarity values in physiological 
conditions. This efferent loop is driven by a parasympathetic, secretory innervation which 
transmits the response signal to the LGs (main, palpebral and accessory), the conjunctival 
goblet cells, the MGs and adapts tear secretion and composition to environmental challenges. 
Proper drainage of tears is also involved in this reflex loop as tear secretion is in part 
evaporated at the ocular surface but also needs to be evacuated since lacrimal secretion is a 
continuous process. 
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According to TFOS DEWS II, “Dry eye is a multifactorial disease of the ocular surface 
characterized by a loss of homeostasis of the tear film, accompanied by ocular symptoms, in 
which tear film instability and hyperosmolarity, ocular surface inflammation and damage, and 
neurosensory abnormalities play etiological roles”. 
The term multifactorial is appropriate since numerous factors have been identified as triggers: 
age, gender, hormones, environment, ocular surgery and more particularly cataract surgery, 
auto immune diseases, CL wear, systemic medications, preservatives in eyedrops between 
others, all of the former potentially conducting to one or both subtypes of the disease. 
Tear hyperosmolarity, next to a loss of tear film stability, are keystone of the inflammation 
cascade, both leading to cellular stress and the inflammatory processes, as acute as chronic, 
inducing auto alimentation and promoting the vicious circle of dry eye disease. As the disease 
progresses, ocular surface is gradually jeopardized and is characterized by cellular loss. Other 
key findings are the neurosensory abnormalities; indeed, impaired afferent pathways 
involving mechanisms that will be explain in further details, prevent a normal information 
intake at the ocular surface further fostering the auto-promotion of the disease. 
A wide range of pathologies and disorders, age-related changes, environmental conditions 
and surgical interventions can trigger inflammatory cascades leading to dryness or worsen 
ongoing inflammatory processes at the ocular surface. Despite this multitude of entry doors, 
all of the etiologies of dry eye share a common inflammatory pathway leading to ocular 
surface damage: cellular death, increased epithelial cells shedding and turnover and above all, 
impaired afferent pathways leading to self-perpetuation of the vicious circle of the disease. 
The scientific significance of epidemiological studies relies on a precise definition and 
classification of the disease, which, until recently, represented the main challenge for DED as 
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no consensus was adopted regarding dry eye objective and subjective diagnostic criteria. 
Furthermore, the absence of gold standard tests to diagnose the pathology, which goes hand 
to hand with an acknowledged heterogeneity between signs and symptoms, make the 
interpretation and comparison of different epidemiological studies more difficult to assess. 
However, even if DED is considered a symptoms-driven disease, epidemiological studies 
focusing only on clinical signs are source of a considerable variation in prevalence values. 
Standardization of diagnostic criteria and clinical tests are the great goal to achieve. The actual 
situation could explain the difficulties searchers are facing when it comes to diagnosis criteria; 
dry eye clinical tests evaluating the same parameter don’t have the same sensibility and 
specificity in diagnosing the disease, tests used often only assess one aspect of the pathology, 
no gold standard or combination of tests have been chosen to evaluate clinical features; 
adding to the previous statements a great extent of DED signs, all of them with distinct 
severity, sensitivity to pain specific to each individual, age-related/ongoing ocular surface 
pathologies and systemic conditions with ocular impact or age-related changes taking place in 
the LFU, make a proper diagnosis based on both signs and symptoms challenging. 
The first TFOS report stated that hyperosmolarity and tear film instability are the key drivers 
of DED. From that statement, two subtypes of the disease could be defined: ADDE where tear 
hyperosmolarity is due to a decrease of the aqueous content available on ocular surface 
(secondary to reduced tear secretion) in presence of a normal tear evaporation rate.  EDE is 
the other subtype of the disease, and in this case, hyperosmolarity follows an excessive tear 
evaporation rate in the presence of normal lacrimal function. 
According to the TFOS Epidemiology Report, prevalence of the disease based on symptoms 
and on clinical signs both show a gradual shift from aged 50. It seems very likely that important 
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age-related changes take place in the LFU at this period of life (that could be due to a 
combination of aging eye and systemic changes), unbalancing the complex homeostasis 
mechanisms and leading to onset or excacerbation of signs and symptoms of dryness. Indeed, 
when it comes to risk factors for the disease, increased age, again depending on diagnostic 
criteria and variability of the definition of DED, appears to be the most consistent factor 
associated with dry eye. 
Every part of the human body is subject to aging and LFU is no exception: LG, the eyelid area, 
MGs and conjunctiva are affected in their structure and function over the life span. Various 
histopathologic age-related changes occur in LGs. In the first place, a low grade of 
dacryoadenitis occurs along with acinar atrophy, periacinar fibrosis and paraductal blood 
vessel loss tend to appear in young adults but increases with age. Interestingly, the secretory 
ducts following the acini dilate over the life span and show an increased tortuosity suggesting 
the presence of an obstruction of the ducts. LG lymphocytic infiltration is directly related to 
aging as its incidence was found to be higher in subject aged 40 and older. It is mainly 
concentrated around the secretory ducts and acini leading to their gradual destruction. 
Besides, it is believed that LG aging comes with fatty infiltration and decrease in LG mass, the 
former eventually leading to LG dysfunction, reduced reflex tear secretion and breakup time. 
However, it is thought that the reported decrease in reflex Schirmer values over the life span 
could be due to a variety of factors such as reduced availability of secretory neurotransmitters, 
loss of functionality of the gland itself as explained earlier and more important, loss of sensory 
drive originating from ocular surface. Indeed, terminal afferent corneal pathways taking 
information relative to mechanical and chemical stimuli at ocular surface, loose sensitivity 
with age, which is expected to reduce sensory drive to the lacrimal gland. 
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Over and above to the age-related changes aforementioned taking place in the LFU, two 
additional, visual impairing processes take place within the eye and more precisely within the 
crystalline lens leading to presbyopia and cataractogenesis respectively, highlighting the need 
for an optical correction. The present manuscript will describe these two age-related changes 
and the potential impact of existing refractive approaches to correct them on the onset/ 
worsening of dry eye signs and symptoms. 
Accommodation is the process by which the eye, more precisely the crystalline lens, changes 
its shape in order to focus on near objects. This optical phenomenon relies on the contraction 
of the ciliary muscle, which in turn loosens the ciliary fibers attached to the crystalline lens. It 
allows the lens to take a more curved shape, which increases its refractive power and reduces 
the focal length to the target of interest. With age, the lens progressively looses its ability to 
change shape, it is called presbyopia. Presbyopia refers to the age-related progressive loss of 
accommodation of the crystalline lens that result in an inability to focus on near objects. It is 
one of the most common refractive defects as everyone eventually develops presbyopia, 
increased age being the major risk factor even if other elements may influence its onset and 
progression (disease, medications, trauma). Presbyopia directly affects quality of life over all 
in high-income countries where the main near distance activities involve writing and reading.  
According to the WHO, cataract is the leading cause of blindness and the loss of useful vision 
is expected to affect 16 million people worldwide. Cataractogenesis is multifactorial, and can 
develop from a wide variety of causes ; UV radiation ( in particular UV B) are involved in 
cortical  cataract changes, genetic factors systemic drugs, infectious diseases, but aging is by 
far the major risk factor for its onset. It induces a broad spectrum of changes regarding 
biochemical processes taking place in the lens leading to alteration in water balance, proteins, 
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vitamins and enzymes, being responsible for progressive loss of lens transparency. Age-
related cataract seems to be the result of a prolonged and gradual process of crystalline 
proteins denaturation, which can occur principally in three different ways: repeated 
environmental insults (mainly UV radiation), reduction in intrinsic stability of crystalline 
proteins, or decline of lens cell homeostasis. 
DED has become a public health issue worldwide as its impact on healthcare systems is 
growing steadily. In addition to the economic cost, the social impact of the disease gained a 
foothold and showed reduced quality of life due to the major impact of the disease on 
patient’s visual function with more frequent visits to the physician, higher frequency of 
depression and reduced workplace productivity between other impairments. Numerous 
studies have looked into the influence of aging on dry eye signs and symptoms and according 
to them, age is a significant risk factor for the disease as people over 50 years old present a 
prevalence of dry eye increasing significantly with women being more affected. The burden 
to become for the society is thus undeniable. 
Various refractive means exist to correct presbyopia, from spectacles (including simple 
reading glasses, bifocal, trifocals and multifocal), to CLs with different geometries 
(monovision, bifocals, simultaneous vision). However, CLs, once upon eye, sit in the TF, 
disturbing its normal structure and interact with the ocular surface possibly worsening an 
already unbalanced environment. Refractive surgery is another option available (cataract 
surgery with implantation of different geometry IOLs (monofocal, bifocal, trifocal), corneal 
refractive surgery) but its invasiveness, even if great steps forwards have been made, could as 
well disturb the ocular surface and worsen or induce signs and symptoms of dryness. 
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The aim of this project is to evaluate changes in tear film metrics and ocular signs induced by 
different types of refractive correction (refractive surgery, IOL implantation and CL) focusing 
on the older population, since the prevalence of DED increases with age and due to presbyopia 
most people over 40 need refractive correction for distance, intermediate or near vision, or 
all three. 
In Chapter 1, a general introduction is made, exposing various aspects related to the 
pathophysiology of dry eye syndrome, the clinical manifestations of aging on the eye 
describing anterior segment changes as well as presbyopia and cataract onset, and 
therapeutic and optical treatment options for these conditions. 
In Chapter 2, the importance of studying the impact of optical aids to correct presbyopia on 
the signs and symptoms of ocular dryness is justified describing the actual situation using 
epidemiological data. The hypothesis and objectives of the Doctoral Thesis are presented. 
In Chapter 3, the general methodology and designs choosed in the clinical studies that 
compose this Doctoral Thesis are described. This chapter presents the characteristics of the 
parameters evaluated as well as the devices used to obtain the results of the studies presented 
in subsequent chapters. 
In Chapter 4, the purpose was to assess the performance of a new daily disposable CL material 
on the ocular surface of a presbyopic population.  A water gradient daily CL material 
(delefilcon A) was fitted in a presbyopic population and evaluated over their first day of CL 
wear. To achieve that goal, TF and ocular surface parameters were investigated across a 8 
hours’ time of CL wear. Tear film metrics were evaluated at baseline, twenty minutes after CL 
insertion and then at 8 hours of CL wear. Measurements were taken from the less to the most 
invasive test as follow: visual acuity, monocular and binocular refraction, anterior segment slit 
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lamp biomicroscopy, osmolarity, measurement of the inferior TMA, topographic examination 
and TBUT assessment using fluorescein. Participants were recluted among the employees of 
the University of Valencia and did not present any anterior segment pathology or previous 
corneal surgery. The average age of the participants was 50.0±4.4 years, ranging between 41 
and 60 years old. Mean spherical equivalent refractive error was +1.11±0.35 D and ranged 
from -4.25 to +2.50 D. From the 40 eyes included, 18 were myopic (mean spherical equivalent 
error -2.80±0.72D) and 22 hypermetropic (+0.90±0.24D).  Significant changes in osmolarity 
values were found between baseline (306.93±2.32 mOsm/L) and 20 minutes (312.43±2.42 
mOsm/L) (p < 0.05). TMA values diminished across the day (from 0.020±0.003 mm2 to 
0.017±0.03 mm2) (P=0.061), but were not statistically significant.  Ocular surface higher order 
RMS aberrations showed a statistically significant increase between baseline (0.38±0.21 µm) 
and 20 minutes (0.61±0.44 µm) (P≤0.001) and between baseline and 8 hours (0.64±0.41 µm) 
(P≤0.001). TBUT worsened by the end of the day from 10.4±0.4 seconds at baseline to 9.0±0.3 
seconds after 8 hours of CL wear (P<0.05). No statistically significant differences were found 
between the measurements at baseline, and after 8 hours of CL wear regarding fluorescein 
corneal (P=0.727) and conjunctival staining (P=0.092). According to our results, no significant 
changes were found regarding corneal or conjunctival staining by the end of the day, which 
means that even if osmolarity was above cut-off values, it was not clinically significant since 
there was no significant cellular damage. Osmolarity values did not change over the time of 
wear, which may imply that CL surface properties remain rather stable during the 8 hours of 
CL wear and provide enough oxygen transmission and lubrication to the ocular surface in order 
not to induce any additional staining. However, if the osmolarity changes occured in a similar 
pattern over longer-term wear, corneal integrity could well be compromised. Besides, we 
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speculated that increases in osmolarity at 20 minutes might also be partly due to both an 
ocular surface response to CL insertion, and an individual tear interaction with the CL material.     
DED, according to its severity, is also known to induce a significant rise in aberrations, which 
implies that in the case of CL wear, pre-lens tear film surface quality would be impacted.  The 
fact that ocular surface high order RMS remained rather stable during the wearing period may 
imply that the pre-lens TFSQ and dynamics were minimally impacted over the course of the 
day.   We conclude that CL insertion induces an initial decrease in TF stability observed by 
osmolarity values rising after 20 minutes of wear, but it did not impact tear meniscus metrics 
and seemed to be transitory, as a decrease, without reaching baseline values, occurred by the 
end of the wearing period. Ocular surface aberrations remained largely stable from CL 
insertion, demonstrating an even repartition of TF over the CL material surface.    
In Chapter 5, the purpose was to assess the effect of lens wearing modality on the ocular 
surface physiology across a month in a presbyopic population. A total of forty eyes of 40 
subjects, employees of the University of Valencia, no previous CL wearers, aged between 41 
and 60 years old, were included in this study. Two different wearing Schedule CL material were 
used: a daily disposable CL (delefilcon A) and a monthly CL (lotrafilcon B). The following 
parameters were evaluated across the month of wear for each CL material: OSDI 
questionnaire, CLDEQ-8 questionnaire, visual acuity and refraction, SL biomicroscopy, 
topographic examination, CCT measurements using OCT and a swept-source biometer, 
osmolarity measurements, TBUT and TMA. Previously described parameters were measured 
at: baseline (t0), 20 min margin (t1) and 8 hours margin after insertion (t2), in morning hours 
(t3) and in the afternoon (t4) of the 30th day excepted for OSDI/CLDEQ-8 that were assessed 
at the end of the wearing period for each CL material. CL wear was discontinued for four days 
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between each period of one month of wear in order for the eyes to fully recover. OSDI scores 
obtained at (t0) an (t4) for the daily and EW lenses were 8.5, 13.2 and 24.4 points respectively 
and showed significant differences over time only regarding the EW lens (p=0.042). CLDEQ-8 
scores obtained at (t0) and (t4) for the daily and extended wear EW material were 6.2 ± 3.8 
points (t0), 10.6 ± 8.5 points (t4) and 18.1 ± 9.8 points (t4) respectively and showed significant 
differences lotrafilcon B giving the higher scores (P=0.012). For both lenses, TMA decreased 
with time (p<0.001) and (p<0.002) respectively (Figure 2). The post-hoc analysis revealed only 
significant differences for the daily lens between the measurements taken at baseline 
(t0)/(t2), (t0)/(t3), (t0)/(t4), as well as between (t1)/(t2) and (t1)/(t4) (p<0.05). For the EW lens, 
significant differences were found between (t0)/(t1) (p=0.016), (t0)/(t3) (p=0.009), (t0)/(t4) 
(p=0.001) and (t1)/(t4) (p=0.017). No statistical significant differences in osmolarity were 
found across the day and at the end of the month for each lens (Figure 3). When comparing 
both lenses, significant differences exist at (t1)(p=0.006) and at (t2) (p=0.002) values being 
greater for Delefilcon A . For both lenses, higher order aberrations showed significant 
differences with time whereas Wilcoxon test found significant differences between (t0)/(t1), 
(t0)/(t2), (t0)/(t3) and (t0)/(t4) (p<0.001) for each lens respectively. No differences were found 
between lenses across the month of lens wear. Regarding overall central thickness, when 
comparing both lenses, significant differences were found between all paired comparisons 
(p<0.001) with higher thickness values for the daily CL material. The symptomatology 
evaluated through two questionnaires revealed differences at the level of comfort of use 
between both materials, showing an increase in symptomatology for lotrafilcon B much more 
important than for the daily material. Delefilcon A presents a very low surface modulus of 
0.025 MPa (core of 0.76 MPa) whereas Lotrafilcon B material has an overall modulus of 1.2 
MPa making it more rigid. This could induce increased discomfort across the period of study 
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compared to the daily CL material (as lens design affects lens comfort) and partly explain the 
higher symptomatology scores obtained for the EW CL material. 
Since every participant of the study did not present any signs and symptoms of DED, it seems 
reasonable to surmise that the reduction in TMA values found in the present study might be 
due to: the destabilization of TF by CL material regardless of lens type as well as to the large 
day to day variability of this parameter. 
Regarding osmolarity values, the slight punctual raise in osmolarity found for the daily CL 
material was not clinically significant since it came back to baseline levels across the month of 
wear and did not lead to any significant changes in vital stainings. The EW material showed as 
well constant values of osmolarity between each visit, which allow us to hypothesize that both 
materials provide high compatibility and minimum disturbance with the ocular surface of first 
time presbyopic CL wearers. 
CL materials used in this study are different and, even if both are silicone-hydrogel lenses, 
their water content and core structure do differ. On the basis of this observation, significant 
differences were expected to be found across a month of wear regarding PLTF quality and the 
resulting ocular surface high order aberrations. However, no disparity were found when 
comparing lenses, except for the end of the day values ((t2)/(t4)) which suggests that PLTF 
might have showed local end of the day variations regarding lotrafilcon B. Pre-lens TFSQ and 
dynamics were minimally impacted across a month of CL wear. Both CL materials fitted in this 
study provided satisfactory and similar objective on-eye behavior and remained rather stable 
along the experiment period. However, subjective symptoms showed a greater increase from 
baseline regarding the extended wear lens. Comfort seems to be impacted by CL material 
modulus, parameters of both CLs being otherwise very resembling. 
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In Chapter 6, the aim of the study was to assess and compare the effect of the C-ScL and ScLs 
on TF parameters and corneal thickness in healthy presbyopic subjects. Thirty eyes from thirty 
presbyopic subjects (average age from thirty presbyopic subjects (average age 54 ± 4 years, 
range: 46-63 years) completed the study. The subjects wore two contact lenses, randomly 
assigned, with neutral power and different diameters [12.7 mm (C-ScL), 18 mm (ScL)]. As part 
of the study screening, each of the participants underwent a comprehensive ophthalmic 
examination, which included, in the order as follow: visual acuity, refraction, slit lamp 
biomicroscopy, topographic examination, CCT measurement using OCT. At baseline, 20 min 
margin (t1) and 8 hours margin after insertion (t2), the area of the tear meniscus was 
evaluated with OCT as well as CCT and tear osmolarity. CL wear has been discontinued for four 
days between each measurement in order for the eyes to fully recover. For the C-ScL, median 
values for basal, 20 min, and 8 hours were 0.0213, 0.0216, and 0.0152 mm2, respectively. For 
the ScL, median values obtained for basal, 20 min, and 8 hours were 0.0213, 0.0205, and 
0.0137 mm2, respectively. For both lenses, significant differences with time (p<0.001), while 
the post-hoc analysis revealed only significant differences between the measurements taken 
at 8 hours and the other two earlier time periods (p<0.001). For the C-ScL, median values for 
basal, 20 min, and 8 hours were 549, 555, and 563 µm, respectively. For the ScL, median values 
obtained for basal, 20 min, and 8 hours were 549, 556, 577 µm, respectively. For both lenses, 
Friedman test was statistically significant between visits (p<0.001), while the post-hoc 
revealed statistically significant differences for all paired comparisons (p<0.001). For the C-
ScL, mean values for basal, 20 min, and 8 hours were 296, 298, and 305 mOsm/L, respectively. 
For the ScL, mean values for basal, 20 min, and 8 hours were 296, 299, and 306 mOsm/L, 
respectively. For both lenses, statistically significant differences between visits (p<0.001), 
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while the post-hoc revealed statistically significant differences between all paired time periods 
(p≤0.002). Ageing population is more prone to develop DED as increased aged is associated 
with higher prevalence of systemic and ocular disorders that may disturb anterior segment 
homeostasis. ScLs present a double advantage for this population as ScL can be a good optical 
platform for correcting presbyopia through multifocality as well as protecting the ocular 
surface by vaulting the cornea. Further studies are needed to better identify the benefits of 
the ScL could bring to an older population with anterior segment pathologies and to better 
understand ScL potential role in restoring/maintaining ocular surface homeostasis over longer 
periods of time. 
In Chapter 7, the goal of the pilot study was to assess the impact of cataract surgery on tear 
film metrics, ocular surface and meibomian gland function. Eleven patients with cataract 
(mean [±SD] age 62.10 [±10.7] years (range 40 – 75 years, median 63.5 years) were included. 
Patients were seen two times; seven days before cataract surgery, and 7 days after the surgical 
procedure. At each visit, the following tests were performed: 
Symptomatology was evaluated according to the TFOS DEWS II Diagnostic methodology 
report using the Ocular Surface Disease Index Questionnaire (OSDI) and the 5-Item Dry Eye 
Questionnaire (DEQ-5). The I-Pen device (I-MED Pharma Inc.) was used to assess the 
osmolarity of the ocular tissue on the inferior palpebral conjunctival membrane. As non-
invasive methods were not available, fluorescein tear film break-up time (TBUT) was 
evaluated by using blue illumination and a yellow filter (Wratten #12), and placing a single 
fluorescein strip (previously shaken) at the outer canthus of the inferior eyelid. After 
measuring TBUT, corneal and conjunctival staining were assessed by evaluating the extent of 
the staining of conjunctiva and cornea (central, superior, temporal, inferior, and nasal) was 
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graded from 0 (none) to 4 (severe), according to the Efron’s grading scale for ocular surface 
staining. Lower TMH was evaluated using a SL. Expressibility of the meibum was scored by the 
application of digital pressure to the central third of the upper tarsus using Arita et al. scale. 
The cutoff value of the meiboscore as a criterion for the diagnosis of MGD was found to be 
≥3. 
The meibography system was composed of a SL equipped with infra-red transmitting filter 
coupled with a digital camera allowing to capture infrared still images or recording videos of 
the morphology of meibomian glands. Areas where glandular tissue could not be visualized 
were considered areas of MGs dropout. 
Meibography scores, which quantify obstruction of meibomian glands, were obtained using 
grades from. The total meibography score was the sum of the scores of the upper and lower 
lids and was recorded as 0 to 6. The mean Five-item DEQ score was 9.82 (SD 1.9 range 1 to 18) 
before the surgery of which 63% (n=7) had a baseline score greater than 6 (indicative of mild 
or greater DED symptoms). Post-surgery, mean DEQ score was 14 (SD 1.9 range 3 to 20) of 
which 82% (n=9) had a score greater than 6. A significant increase in DEQ-5 score was found 
after surgery (Wilcoxon test p= 0.017). Mean OSDI score at baseline was 36 (SD 4.8 range 4 to 
62) of which 91% were above the cut-off score for DED. Post-surgery, mean OSDI score was 
42.4 (SD 5 range 8 to 67) of which 91% were above the cut-off score for DED. A significant 
increase in OSDI score was found after surgery (Paired sample t-test p=0.03). The correlation 
between these two questionnaires was moderate (Pearson’s r= 0.60, Spearman’s ρ= 0.57 
p=0.05). Mean TBUT values were 8.6 s (SD 0.5 range 6 to 11 s) before surgery and 8.4s (SD 0.6 
range 6 to 11 s). No significant differences were found between pre- and post-surgery values 
(p= 0.608). Mean staining scores were 0.3 (SD 0.5 range o to 1) and 1.3 (SD 0.5 range 1 to 2) 
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pre- and post-surgery respectively. Vital staining significantly increased through the surgery 
(p=0.004). Mean TMH values were 0.26 mm (SD 0.03 range 0.10 to 0.40 mm) and 0.27mm (SD 
0.03 range 0.15 to 0.40mm) pre- and post-surgery respectively. No differences could be 
evidenced between the appointments. Mean osmolarity values were 299.2 mOsm/L (SD 4.6 
range 282 to 333 mOsm/L) and 294 mOsm/L (SD 2.3 range 275 to 303 mOsm/L) pre- and post-
surgery respectively. Osmolarity values did not show significant changes during the study (p= 
0.66).  Mean MGs expressibility scores were 1.0 (SD 0.3 range 0 to 2) and 1.7 (SD 0.3 range 0 
to 3) pre-and post-surgery respectively. From the 11 patients included in this study, 6 
presented a pre-surgery meiboscore ≥3 which classified them as having MGD. MG expression 
was significantly more difficult to perform after the surgery (p= 0.011). Regarding IR imaging 
of MGs, mean grades were 2.5 (SD 0.4 range 1 to 4) for pre- and post-surgery respectively. No 
statistical differences were detected between appointments for this parameter. From the 
results obtained in this study, we hypothesize that cataract surgery further promotes short-
term MG obstruction, as only functional changes (reduction in MG expressibility) could be 
evidenced and IR meibography did not show any significant structural alteration. As proposed 
by Han et al., it is more likely that structural changes impacting MGs, which were not found in 
the present study, are more the result of a chronic dysfunction than a part of the short-term 
cataract surgery outcomes. The present study could not elucidate the exact mechanisms by 
which functional short-term changes occur in MGs following the surgery; however, it is very 
likely that even without significant signs of MG structure damage, cataract surgery seems to 
impact MG function. Previous literature suggests that surgery-induced inflammation, bacterial 
infection from breached ocular surface, preservative-containing postoperative medications or 
combination of the former, are thought to play a role, even if in different extents. However, it 
would be interesting to follow-up changes taking place in both upper and lower MCJ and 
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Marx’s line, as widening and anterior displacement of Marx’s line is a good indicator of 
meibomian glands orífices status. This study has some drawbacks. First, it was conducted in a 
relatively small number of subjects and did not have a control group that had not undergone 
cataract surgery. Second, the lid hygiene status was not studied and Marx’s line and MCJ not 
evaluated which could have given valuable information on the impact of the surgery on these 
parameters; indeed, a previous study showed significant changes in lid margin vasculature and 
irreversible MCJ displacement through the surgery. Third, meibum expressibility was not 
objectively measured using a device that delivers standardized pressure on the lid. Promizing 
therapies are emerging in order to treat MGD, such as IPL systems used to treat the disease, 
which gave valuable information regarding MG function, further investigation is needed to 
assess the impact of this therapy in MGD patients on surgery outcomes. 
As a general conclusion of this doctoral thesis, it should be noted that the eye, as well as the 
entire human body, is subject to the process of aging, the most remarkable manifestations of 
which are the presbyopia and opacification of the lens, in other words, cataract.  Almost every 
anterior segment structure undergoes age-related functionnal and morphological changes, 
from LGs (main lacrymal gland, MGs, goblet cells) to eyelids and conjunctiva. These changes 
reduce both quantity and quality of tear secretion, prevent an optimal repartition of the TF on 
the ocular surface potentially leading to/ worsening signs and symptoms of dryness. DED 
prevalence increases with age, because of the aforementionned aging processes that go hand 
to hand with an increased prevalence of systemic diseases with ocular side-effects as well as 
its associated medications. In that sense, compensating presbyopia or getting rid of a clouded 
lens require a previous comprehensive anamnesis as well as assessment of the LFU looking for 
on-going pathological/ inflammatory processes. The great majority of refractive options 
available, apart from eyeglasses, are considered as invasive and could easily perturb the ocular 
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surface homeostasis. Multiple approaches can be considered when correcting presbyopia and 
cataract, the common goal being to restore vision and give sustainable comfort to the patient. 
Presbyopia correction can be achieved through eyeglasses (monofocal, bifocal, trifocal and 
multifocal lenses) and the former approaches are not expected to induce or worsen signs and 
symptoms of dryness. Presbyopia correction through CLs is another option (from corneal RGPs 
to semi-scleral and scleral designs with different geometries such as monofocal, bifocal, soft 
CLs). However, CLs, once upon eye, sit in the TF, disturbing its normal structure and interact 
with the ocular surface possibly worsening an already unbalanced environment. Refractive 
surgery is another option available (cataract surgery with implantation of different geometry 
intra ocular lenses (IOL) (monofocal, bifocal, trifocal), corneal refractive surgery) but its 
invasiveness, even if great steps forwards have been made, disturbs as well the ocular surface 
and can worsen or induce signs and symptoms of dryness. An exhaustive assessment of 
symptomatology and anterior segment general state of health is mandatory when correcting 
presbyopia with invasive refractive options. It allows for a precise identification of the 
weakened structures of the LFU and the elaboration of an appropriate strategy in order to 
optimize short and long-term outcomes for the refraction option that has been chosen for the 
patient. Proper identification of changes taking place in the LFU is is a condition sine qua none 
to introduce mass prophylaxis measures in routine optometric and ophtalmologic exams. 
Early diagnosis of this multifactorial condition is the best mean to prevent, if not delay, its 
onset and the complications possibly induced by different types of refractive corrections. 
Further research is needed in order to better identify disease-related symptoms as well as the 
early signs of the disease on the ocular surface in order to fulfill the requirement of an aging 
population willing to be spectacle independent. Global knowledge regarding ocular sensation, 
damage and its associated pathways have significantly increased; however, the thorough 
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mechanisms through which DED rises and further affects ocular surface homeostasis are not 
fully understood due to its high complexity and to the numerous mechanisms involved. 
Further research regarding the neuropathogenesis of impaired ocular sensation in DED is 
needed in order to deepen the knowledge regarding homeostasis mechanisms, ocular 
response to nerve damage and its role in DED onset and perpetuation in a population that 
faces new challenges due to aging but also to the emergence of new refractive techniques. 
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1.1 Tear Film  
The TF is a complex structure designed to cover and protect the anterior segment of the eye 
(anterior portion of the conjunctiva and the cornea) [Willcox et al. 2017]. TF is the first 
refractive surface of the eye and as such, is essential to keep the visual system healthy and 
functional [Craig et al. 2017]. Besides, it provides mechanical functions and a defensive 
environment to the ocular surface structures. TF mainly spreads over three compartments: 
the fornix (and its associated retrotarsal space), the preocular TF and tear menisci (from the 
lower and upper lids). Preocular TF presents a thickness around 2-5.5µm over the corneal area 
[King-Smith et al. 2004, King-Smith et al. 2000, Chen et al. 2010].  It is usually described as a 
trilaminar structure composed of an outermost lipid layer, an aqueous layer and an innermost 
mucin layer, each of which has a specific function in its formation and stability [Holly et Lemp 
1977 (1), Wolff 1946]. It is widely accepted that the aqueous and mucin layers form a 
mucoaqueous gel, this layer providing an increased gradient of mucins from the aqueous layer 
towards the epithelium [Dilly 1994, Cher 2008]. Tears, from their formation to their 
evacuation, involve three main components: secretory system, distribution system and 
excretory system [Holly 1980]. 
The secretory system consists of the lacrimal glands: main lacrimal gland, accessory lacrimal 
glands of Wolfring and Krause, goblet cells, ciliary glands of Moll and Zeis, and the MGs of the 
tarsal plate [Holly 1980, Mishima et al. 1966]. The main lacrimal gland and accessory glands of 
Krause and Wolfring [Ubels et al. 2012] secrete the aqueous phase of TF with a smaller portion 
secreted by the conjunctiva [Dartt 2002]. LGs secrete continuously the aqueous phase of the 
TF with the rate of 1.2µL/min [Mishima et al. 1966].  Meibomian, Zeis and Moll glands secrete 
lipids, which gives the lipid layer of TF [Korb 2002, Kunnen et al. 2016] and globet cells located 
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in the conjunctival epithelium produce mucins, which form the mucinous phase of TF [Gipson 
2007]. 
The distribution system is composed of the eyelids, whose main function is to distribute the 
tear and to mix all its components through the blinking and redistribute them on the exposed 
ocular surface [Stern et al. 1998]. This is a two-step process following the blink as described 
by Brown and Dervichian [Brown et Dervichian 1969], upper lids pulling tears over the cornea 
by capillary attraction (negative hydrostatic pressure originating from the forming tear 
meniscus) and lipid layer secondarily spreading upon the TF, dragging additional tears to 
thicken and stabilize it. During the blinking interval, TF thinning is mainly due to evaporation 
[Peng et al. 2014 a, Peng et al. 2014 b, Bron et al. 2004, King-Smith et al. 2009, Nichols et al. 
2005, Craig et Tomlinson 1997].  
The excretory system is composed of the upper and lower canaliculi, lacrimal points, sacs and 
ducts; its function is to favor lacrimal drainage towards the lacrimal fossa, since once TF is 
formed, it is spread by action of eyelids (blinking) and the remaining part of the TF (which is 
not evaporated) is then drained towards superior and inferior lacrimal canaliculi, the common 
canaliculus and the lacrimal sac, to the lacrimonasal canal [Doane 1981, Klein et al. 1998]. 
Tears help to protect the corneal surface while maintaining hydration of the corneal 
epithelium and reducing friction forces, whereas blinking favors the continuous moisturization 
of the ocular surface spreading TF all over the exposed area of the anterior segment of the 
eye [Durán-de-la-Colina et Arntz. 2004]. 
1.2 Tear film structure 
The classical TF model is described as a trilaminar structure [Holly 1977, Wolff et al. 1946] 
formed by an external lipid layer, an intermediate aqueous layer and an innermost mucin layer 
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[Durán-de-la-Colina et Arntz 2004, Craig et al.  2017, Pflugfelder et al. 1998, Stern et al. 2004, 
Stern et al. 1998, Holly 1980, Korb 2002]. It is now widely accepted that TF is a complex system, 
where the aqueous and mucous layers are mixed, forming an upper gelatinous layer and a 
high concentration of mucins in its innermost part (in contact with the epithelia) [Durán-de-
la-Colina et Arntz 2004, Craig et al. 2017, Pflugfelder et al. 1998, Stern et al. 2004, Stern et al. 
1998, Holly 1980, Korb 2002].  
1.2.1 Tear Film Lipid Layer 
TFLL is produced by MGs located in the upper tarsal conjunctiva (25-31 glands) and inferior 
tarsal conjunctiva (20-26 glands) [Bron et al. 1998a]. This is the thinnest layer of the tear film 
ranging from 0.015 to 0.160 μm with a mean thickness of approximately 40 nm [King-Smith et 
al. 2010]. Its main function is to stabilize TF by reducing surface tensions [Miller 1968)]. It also 
reduces and retards water evaporation [Pearlman, 2015], but does not prevent it [Millar et 
Schuett 2015, Georgiev et al. 2014], forming a structure that prevents the collapse of the tear 
film [Millar et Schuett 2015] and enables TF to form a thin layer. It secondarily avoids mixing 
(and further contamination) with skin lipids, which could, partly explain its antimicrobial 
properties [Mudgil 2014]. It is believed that TFLL, due to its complex composition, is organized 
according to a multi-layered model [Cwiklik 2016]. TFLL composition has been thoroughly 
analyzed [Millar et Schuett 2015] as various studies suggested that DED associated with a 
deficient TFLL could be due to changes in meibum composition [Brown et al. 2013, Butovich 
2009, Green-Church et al. 2011, Lam et al. 2011, Pucker et Nichols 2012]. Indeed, TFLL is 
formed by an anterior or external zone, which is in contact with the external environment, 
and is constituted by non-polar hydrophobic lipids: cholesterol esters, waxes and triglycerides 
[Bron et al. 2004a] responsible for the delayed evaporation of TF [Bron et Tiffany 2004b, King-
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Smith et al. 2010]. The posterior lipid layer is formed by polar lipids, phospholipids and free 
fatty acids, and is located at the interface with the aqueous layer [Bron et al. 2004a, King-
Smith et al.  2010]. Thus, high polarity lipids forming this phase (phospholipids, glycolipids and 
sphingolipids) ease the extension of the hydrophobic lipid layer, the outermost lipidic layer, 
on the hydrophilic aqueous layer of the tear [Bron et al. 2004a, King-Smith et al. 2013]. 
Mechanical effect of blinking induces Riolan’s muscle contraction, which allows lipid secretion 
from MGs, and increases TF thickness [Korb 2002]. 
1.2.2 Aqueous tear film layer 
Aqueous layer is produced by the acini of the lacrimal glands and by the soluble mucins 
secreted by goblet cells [Sullivan 2012a, Harriet et Kuonen 2004] providing an optically smooth 
surface [Montes-Micó et al. 2005]. Aqueous secretion originates from the main LG, located in 
the supero-temporal orbital cavity, and the accessory lacrimal glands of Krause (fornix) and 
Wolfring (between the peripheral edge of the tarsus and the fornix) [Craig 2002]. Aqueous 
layer is considered the main layer of TF [Holly 1980] representing more than 98% of its 
thickness (7μm) [Craig et al. 2017]. This layer is composed of electrolytes, proteins, enzymes 
and metabolites [Craig et al. 2017]. It contains antibacterial proteins (lysozyme and 
lactoferrin), albumin, lipocalin, FGF, NGF, Ig, mainly IgA, considered as one of the first line of 
defense of ocular surface; aqueous phase also contains glucose, glycogen and oxygen, used as 
nutrients by the avascular cornea [DEWS 2007, Craig 2002, Lemp 1995]. Lipocalin plays a key 
role in the posterior lipid transition zone (with the aqueous phase), as it binds to the polar 
lipids forming an interface increasing stability of TF [Korb 2002]. EGF and TGFβ, originating 
from the aqueous phase, respectively maintain homeostasis by promoting renewal of corneal 
surface epithelial cells [Tseng et Tsubota 1997] and play an immunomodulatory role. Lacrimal 
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gland also secretes several CKs such as IL-1 and TNFα, fundamental immunological markers 
that participate in maintaining the balance and protection of ocular surface [DEWS 2007, 
Conrady et al. 2016].  
1.2.3 Mucins tear film layer 
Mucin layer is composed of Igs, salts, urea, glucose, leukocytes and enzymes such as 
peroxidase and lysozyme [Nichols et al. 1985].  
Mucins play a major role in ocular surface homeostasis through its capacities to: lubricate the 
ocular surface, reduce friction forces (and hence mechanical stress); clear waste and debris, 
and prevent dessication of corneal and conjunctival epithelial cells providing an efficient 
barrier function [Stephens et McNamara 2015, Mantelli et Argüeso 2008]. Three main types 
of mucins have been identified at the ocular surface: gel forming, MAMs and soluble mucins. 
Each one of the former is expressed by different components of the LFU and participate in 
different extents to the homeostasis of the ocular surface. 
1.2.3.1 Gel-forming mucins 
This type of mucins is secreted by goblet cells. Goblet cells lye intercalated in the conjunctival 
epithelium with a greater density at the nasal side and fewer cells at the superior and inferior 
bulbar quadrants [Kessing 1968, Moore et al. 1987]. They extend through the entire thickness 
of the conjunctival epithelia, their basal side in contact with the basal membrane and their 
apex in contact with ocular surface [Gipson 2016]. They are filled with mucin granules 
containing a filamentous structure: a large secretory glycoprotein called MU5AC [Inatomi et 
al. 1996], which, once liberated at the ocular surface, binds to the components of the aqueous 
layer and forms a gel. The spread of this gel onto ocular surface allows to trap and remove 
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cellular debris but also acts as a scaffold for CKs and antimicrobial molecules as well as 
reducing shearing stress during blink [Mantelli et Argüeso 2008]. 
1.2.3.2 Membrane Associated Mucins 
This type of mucins, also called cell-surface associated mucins [Mantelli et Argüeso 2008], is 
mainly located at the apex of ocular mucosal epithelial cells [Mantelli et Argüeso 2008] 
[Govindarajan et Gipson 2010]. They markedly differ from the gel-forming mucins as they are 
composed of two main parts: an extra cellular domain, extending 200-500 nm into the muco-
aqueous phase [Mantelli et Argüeso 2008]; which possesses anti-adhesive properties that 
allow the muco-aqueous phase to move freely across the ocular surface and by that mean 
clear debris [Sumiyoshi et al. 2008] and prevent the adhesion of foreign bodies [Aristoteli et 
al. 2003]; and a cytoplasmic tail which is bound to cytoskeletal components and cell-cell 
junctions. Membrane associated mucins secrete glycocalyx, which prevent the penetration of 
dyes such as rose bengal used to assess epithelial damage and epithelial barrier integrity 
[Blalock et al. 2007]. The authors show that MUC16 abrogation (MUC16 is one of the MAMs) 
[Mantelli et Argüeso 2008, Govindarajan et Gipson 2010] in cultured human corneal epithelial 
cells results in loss of cell surface protection against dye penetrance and increased 
Staphylococcus. aureus adherence, suggesting that cell surface-associated mucins contribute 
to the formation of a protective barrier against injury and pathogens [Argüeso et al. 2006] and 
as such there are considered to provide a protective cell surface barrier function [Mantelli et 
Argüeso 2008]. They also play an important role in tear film stabilization [Govindarajan et 
Gipson 2010]. Among them, we can find MUC 1, MUC 16 and MUC 20 located across the entire 
corneal and conjunctival epithelia. MUC 4 is another subtype of MAMs, which expression is 
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mainly restricted to the conjunctiva, but can also be found in the limbus and lacrimal gland 
[Mantelli et Argüeso 2008, Govindarajan et Gipson 2010]. 
1.2.3.3 Soluble mucins  
Interestingly, soluble mucins are not found in the tears even if they are expressed by 
conjunctival cells and lacrimal glands [Jumblatt et al. 2003]. Little is known about their 
function within the ocular surface but they are thought to perform an antibacterial function 
[Bobek et Situ 2003]. 
1.3 THE LACRIMAL FUNCTIONAL UNIT 
 
1.3.1 Definition 
 
Ocular surface integrity, in other words, its ability to respond adequately to environmental 
challenges, depends on a proper information intake at the ocular surface, the transmission of 
the created signal to the brain and the generation of a response, that will modulate secretory 
function and local immunity. It is easily understandable that any disturbance of one of the 
three steps of this closed loop could trigger an inappropriate response and further unbalance 
the compensatory mechanisms taking place at the ocular surface. 
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Figure 1.1. The lacrymal functionnal unit as described by Stern et al. 2013. 
The LFU can be defined as a set of anatomical structures whose harmonious functioning 
maintains tear osmolarity within narrow limits [Sullivan et al. 2012]. The ocular surface is 
composed of the cornea and the conjunctiva, both protected by the upper and lower lids. All 
of the structures named above share the same main afferent innervation path represented by 
the fifth craneal nerve (i.e trigeminal nerve) and its terminal branches, which allow the cornea 
and the conjunctiva to take information related to environmental changes and transmit it to 
the brainstem. Corneal nerves provide a range of afferent inputs modalities such as pain 
(nociceptor), mechanoreception and temperature (thermoreceptor) [Bron et al. 2017]. 
Lacrymal glands and blink response are the effectory part of this LFU. Lacrymal glands are 
stimulated in response to ocular surface afferent inputs and allow appropriate tear secretion 
and proper osmolarity values in physiological conditions. This efferent loop is driven by a 
parasympathetic, secretory innervation which transmits the response signal to the lacrimal 
glands (main, palpebral and accessory), the conjunctival goblet cells, the MGs [Bron et al. 
2017] and adapts tear secretion and composition to environmental challenges. 
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Proper drainage of tears is also involved in this reflex loop [Paulsen 2003] as tear secretion is 
in part evaporated at the ocular surface but also needs to be evacuated since lacrimal 
secretion is a continuous process. 
1.4 DRY EYE DISEASE 
1.4.1 Definition 
According to TFOS DEWS II, “Dry eye is a multifactorial disease of the ocular surface 
characterized by a loss of homeostasis of the tear film, accompanied by ocular symptoms, in 
which tear film instability and hyperosmolarity, ocular surface inflammation and damage, and 
neurosensory abnormalities play etiological roles” [Craig et al. 2017]. 
The term multifactorial is appropriate since numerous factors have been identified as triggers: 
age gender, hormones, environment, ocular surgery and more particularly cataract surgery, 
auto immune diseases, contact lens wear, systemic medications, preservatives in eyedrops 
between others, all of the former potentially conducting to one or both subtypes of the 
disease [Baudouin et al. 2017]. 
Tear hyperosmolarity, next to a loss of tear film stability, are keystone of the inflammation 
cascade, both leading to cellular stress and the inflammatory processes, as acute as chronic, 
inducing auto alimentation and promoting the vicious circle of dry eye disease. As the disease 
progresses, ocular surface is gradually jeopardized and is characterized by cellular loss. Other 
key findings are the neurosensory abnormalities; indeed, impaired afferent pathways 
involving mechanisms that will be explain in further details through the next paragraph, 
prevent a normal information intake at ocular surface further fostering the auto-promotion 
of the disease. 
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1.5 PATHOPHYSIOLOGY OF DRY EYE DISEASE 
In order to properly understand the signs and symptoms of DED and the complex relationships 
that unite them, it is important to get a precise picture of the mechanisms involved in the 
pathophysiology of the disease. As defined earlier, a wide range of pathologies and disorders, 
environmental conditions and surgical interventions can trigger inflammatory cascades 
leading to dryness or worsen ongoing inflammatory processes at the ocular surface. Despite 
this multitude of entry doors, all of the etiologies of dry eye share a common inflammatory 
pathway leading to ocular surface damage: cellular death, increased epithelial cells shedding 
and turnover and above all, impaired afferent pathways leading to self-perpetuation of the 
vicious circle that will be described later on. 
The first TFOS report stated that hyperosmolarity and tear film instability are the key drivers 
of DED [DEWS 2007]. From that statement, two subtypes of the disease could be defined: 
ADDE where tear hyperosmolarity is due to a decrease of the aqueous content available on 
ocular surface (secondary to reduced tear secretion) in presence of a normal tear evaporation 
rate. EDE is the other subtype of the disease, and in this case, hyperosmolarity follows an 
excessive tear evaporation rate in the presence of normal lacrimal function [Bron et al. 2017]. 
Different etiologies of both subtypes of the diseases are summarized Table 1 and Table 2.
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  Aqueous Deficient Dry Eye 
(ADDE)  
   
Sjögren Syndrome Dry Eye 
(SSDE) 
Associated systemic diseases: 
-Rheumatoid arthritis 
-Polyarteritis nodosa 
-Systemic lupus 
erythematosis 
-Wegener granulomatosis 
-Systemic sclerosis 
-Mixed connective tissue 
disease 
Non-Sjögren Syndrome 
Dry Eye (NSDE) 
-Intrinsic Lacrimal 
Gland Deficiency 
-Lacrimal gland 
ablation 
-Congenital alacrima 
Age-related dry eye 
-Inflammatory and other 
lacrimal gland infiltration 
-Sarcoidosis 
-Lymphoma 
-Viral infection 
-Radiation injury 
Lacrimal Gland 
Obstruction 
-Cicatricial 
conjunctivitis 
-Graft Versus 
Host Disease 
-Stevens-
Johnson 
Syndrome 
-Cicatricial 
pemphigoid 
-Trachoma 
-Chemical 
injury  
Hyposecretory 
States-Failure of the 
Lacrimal Functional 
Unit 
Reflex Afferent 
Block 
-Topical anesthesia 
-Trigeminal nerve 
injury 
-Refractive Surgery 
-Neurotrophic 
keratitis 
Secretomotor 
Block: 
-Parasympathetic 
damage 
-Pharmacological 
inhibition 
 
Other Disorders 
-Meige Syndrome 
-Diabetes Mellitus 
-Pseudoexfoliation 
Table 1. Causes of Aqueous Deficiente Dry Eye.Taken from (Bron et al. 2017)
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                                                          Evaporative Dry Eye (EDE) 
 
Meibomian Glands Diseases: 
Meibomian Gland Dysfunction (MGD) 
Primary: 
-Meibomian Seborrhea 
-Obstructive MGD (Cicatricial / non-cicatricial) 
Secondary to Local Disease: 
-Anterior blepharitis 
-Ocular surface inflammation 
-Contact lens wear 
 
 
Secondary to systemic Dermatoses: 
-Rosacea 
-Seborrheic dermatitis 
-Atopic dermatitis 
-Ichtyosis 
-Psoriasis 
 
Secondary to chemical Exposure 
Disorders of Lid Aperture, Congruity, Dynamics 
-Blink-Related 
 
Ocular Surface-Related Evaporative Dry Eye 
-Allergic Eye Disease 
-Vitamin A Deficiency 
-Short Breakup Time Dry Eye 
-Iatrogenic Disease 
Table 2. Causes of Evaporative Dry Eye.Taken from (Bron et al. 2017) 
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Actually, both subtypes of DED could be considered as evaporative forms since, indeed, 
increased evaporation eventually occurs in both subtypes and is responsible for high 
osmolarity values at the ocular surface. Furthermore, hybrid forms of DED are not uncommon 
as explained by Bron et al.:“It was recognised that these subtypes of DED may coexist and this 
is the case in Sjögren syndrome where lacrimal deficiency frequently coexists with MGD” 
[Shimazaki et al. 1998, Krenzer et al. 2000, Bron et al. 2017] making the diagnosis sometimes 
difficult. 
When the disease evolves in ADDE, TF thickness reduction affects TFLL spreading and could 
possibly lead to a functional EDE [Bron et al. 2017]. Conversely, a severe form of EDE could 
(through the afferent corneal nerve impairment), reduce the information intake at the ocular 
surface and lead to a secondary ADDE [Bron et al. 2017]. This why it is important to emphasize 
the recommendations made by Bron et al. that ADDE/EDE are only classifications for the initial 
states of DED, since, as DED evolves, regardless of its subtype, tear break up eventually occurs 
within the blink interval adding an extra evaporating component to the disease [Bron et al. 
2017]. 
Ocular surface integrity, in physiological conditions, is ensured by both resident immune cells 
and the epithelial barrier. It is important to understand that ocular surface is subject to 
constant solicitation originating from the outside world: mechanical trauma, temperatures 
variations [Belmonte 2013], wind speed, foreign bodies, allergens and antigen adherence to 
ocular surface [Baudouin et al. 2017, Baudouin et al. 2013, McDermott et al. 2005, Stern et al. 
2013]. Any of the risk factors named above can easily jeopardize ocular surface homeostasis 
and initiate an acute inflammatory cascade.  
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 The role of the LFU is to respond as far as possible to these threats, controlling actively the 
local immune system by initiating an inflammatory response only when homeostasis is at 
stake, maintaining at the same time tolerance to commensal flora and auto-antigens 
[Schaumburg et al. 2011]. In that sense, corneal tissue can be considered as an immune 
privileged site which goal is to maintain its transparency and thus preserve vision [Streilein 
2003]. Among the main resident immune cells we can find resident T lymphocytes (CD8+ ɣ𝛿/ 
Natural Killer (NK) (which response damages target tissue but also facilitate dendritic cells 
maturation through INF-ɣ) [Coursey et al. 2014, Zhang et al. 2012, Chen et al. 2011a, 
Bonaccorsi et al. 2015] and regulatory CD4+ that permanently interact with anti-inflammatory 
factors such as IL-1, IL-1RA, matrix protease inhibitors such as TIMP-1 [Gupta et al. 1996, 
Sobrin et al. 2000, Solomon et al. 2001, Barabino et Dana 2007, Stern et al. 2013], and an 
immunosupressor and anti-inflammatory cytokine : TGF- β2 [Baudouin et al. 2017, Baudouin 
et al. 2013]. Furthermore, a number of proteins presenting antimicrobial properties are 
present in the tears: defensins (subtypes α and β), lysozyme, lactoferrin and lipocalin between 
others [Vinding et al. 1987, Zhou et al. 2004].  
The role of physical barrier at the ocular surface is played by a set of structures (derived from 
the epithelia or the epithelia itself) that work together in order to maintain ocular surface 
homeostasis. Gels mucins (produced by goblet cells), glycocalyx [Spurr-Michaud et al. 2007], 
ensure ocular surface lubrication, prevent adherence of foreign bodies and form an interface 
with ocular surface epithelia providing stability of the tear film. Corneal epithelium 
microvillosities serve as anchor points on which MAMs can bind and further interact with the 
mucin gel secreted by goblet cells and mix to the aqueous layer of the tear film [Argüeso et al. 
2013]. The most important part of this physical barrier is represented by the epithelia (cornea 
and conjunctiva) considered as the “gate keepers” of the ocular surface [Ueta 2008, Bron et 
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al. 2017]. Intercellular junctions of the corneal and conjunctival epithelia contribute in a major 
way to the integrity of this barrier [Argüeso et al. 2013]. Corneal epithelium provides 4 types 
of intercellular junctions from the outermost apical layer to the innermost basal layer: TJ being 
the principal guarantor of an effective sealing [Sugrue et Zieske 1997, Tsukita et al. 2001], 
adherens junctions (zonula adherens throughout the different layers), desmosomes (macula 
adherens located in the wing cell layer) and gap junctions (basal cell layer) [Argüeso et al. 
2013]. The most superficial epithelial layer contains TJs, located between two adjacent cells 
in its apical part, which role is to serve as a barrier to the diffusion of molecules (such as vital 
stainings) in the paracellular space by sealing the intercellular space [Argüeso et al. 2013]. 
Tight Junctions are composed of several precursors (claudins, occludin, junctional adhesion 
molecule-A) that are the target of some pro-inflammatory cytokines (MMP-3, MMP-9 [Luo et 
al. 2004, Huet et al. 2011, Pflugfelder et al. 2005] and TNF-α) [Bron et al. 2017, Tanaka et al. 
2013] liberated during the acute and chronic phase of the inflammation and responsible for 
epithelial cells apoptosis that is clinically observed as an increased uptake of vital staining. The 
other junctions’ types (desmosomes, hemi-desmosomes, and adherens junctions) play a 
structural and anchoring role [Suzuki et al. 2003] between neighbor cells and corneal layers, 
whereas gap junctions facilitate cellular communication and differentiation [Argüeso et al. 
2013].  
Accelerated evaporation increases the solute concentration (mainly glucose, sodium, 
potassium, and chloride) of the tear at the ocular surface giving rise to hyperosmolarity. 
Following surface dessication (and subsequent cooling at the ocular surface) trigger 
thermoreceptors responsible for the initiation of compensatory mechanisms involving: 
increased lacrimal secretion and blink rate [Nakamori et al. 1997, Wu et al. 2014, Belmonte et 
al. 2017] the former inducing discomfort. Besides, ocular surface dryness induces mechanical 
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issues such as increased friction forces between the lid wiper of both upper and lower lid and 
ocular surface possibly initiating inflammatory events [DEWS 2007, Bron et al. 2017]. 
Increased osmolarity, through the induced cellular damage, leads to exposure of nerve 
endings and to an increased stimulation [Dastjerdi et Dana 2009, Stevenson et al. 2012]. Nerve 
endings exposure initially induces a higher blinking rate and lacrimal secretion liberating 
neuropeptides (Neuropeptide Y, Substance P, calcitonine) leading to neurogenic 
inflammation, and NGF liberation (by nerve endings) [Baudouin et al. 2017] that will promote 
nerve regeneration at the ocular surface. However, too much and prolonged stimulation over 
time causes reduction in corneal sensitivity and can modify tear composition by inflaming 
lacrimal glands, creating toxic tears, where pro-inflammatory factors will be released on ocular 
surface and further promote the innate inflammation process [Rolando et al. 2005, DEWS 
2007, Mantelli et al. 2010, Lambiase et al. 2012]. Besides, hyperosmolarity directly affects 
ocular surface epithelial cells (cornea and conjunctiva) inducing cellular stress to which the 
cells will respond through innate acute immunity processes and by initiating a programmed 
death called apoptosis.  
Indeed, cellular stress can by-pass the epithelium barrier by the induction of an intra cellular 
cascade involving MAPK [Li et al. 2004; Luo et al. 2004, 2005, Stevenson et al. 2012, Stern et 
al. 2013], a protein with enzymatic activity located in the cytoplasm that, once activated, 
translocates to the nucleus of the cell and regulates the expression of a transcription factor 
called NF-ĸB. According to Schulze-Osthoff et al., [Schulze-Osthoffet al. 1997] NF-ĸB “has an 
established role in the regulation of numerous genes involved in cellular defense mechanisms 
in response to immune and inflammatory processes”. Among the targeted genes of this 
transcription factor, we can find the pro-inflammatory CKs IL-1 and TNF-α and IL-6 [Yoon et al. 
2007, Tishler et al. 1998, Lam et al. 2009], whose main activity is “pro- inflammatory”, in other 
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words, to spread the inflammation signal to neighbour cells and allow recruitment of other 
immunity cells involved in the transition between the acute, innate response to a chronic, 
adaptive, antigen-specific, blood-mediated immunity. Other target genes of NFĸB are the one 
coding for chemokines. By the same intra cellular mechanism explained earlier, CKs liberated 
in the tears by the epithelial cell will bind to its specific receptor located at the surface of 
another epithelial cell (all corneal and conjunctival cells possess receptors to various types of 
CKs). The principal consequence of this cascade of activation is the liberation of more pro-
inflammatory CKs on ocular surface, but also the up-regulation of MMP-9 by corneal epithelial 
cells inducing, as explained earlier, the disruption of the epithelial corneal barrier [Li et al. 
2006, Chotikavanich et al. 2009]. Besides, these inflammatory mediators also allow the 
maturation of immature APCs, which are DCs mainly located along the basal membrane of the 
corneal epithelium and stroma [Brissette-Storkus et al. 2002, Hamrah et al. 2003, Sosnova et 
al. 2005, Chinnery et al. 2008]. DCs are present in physiological conditions in corneal and 
conjunctival tissue and their main function is to continuously sample antigen from their 
environment [Saban et al. 2014]. These DCs are more densely represented in corneal 
periphery and their number decreases centripetally [Knickelbein et al. 2009]. However, in 
response to repeated inflammatory insults, their number is known to increase [Schaumburg 
et al. 2011]. DCs play a key role in the transition of the immune response (from acute to 
chronic) thanks to their ability to stimulate T cell activation in the lymph node [Khandelwal et 
al. 2013, Schlereth et al. 2012, Schaumburg et al. 2011, Chen et al. 2013, Stern et al. 2013, 
Pflugfelder et al. 2009, Saban et al. 2013]. Indeed, DCs located in the affected tissue (i.e the 
cornea/conjunctiva) present the ability to recognize pathogens (that can be auto-antigens) 
and detect inflammatory signals. The recognized Ag is then internalized through different 
mechanisms and disrupted so as it can be presented through MHC at the cell surface [Saban 
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et al. 2014, Bron et al. 2017]. DCs can also detect inflammatory signals mainly represented by 
ILs liberated secondary to cellular hyperosmotic stress. Both mechanisms induce the 
maturation of the DC, which will give the DC the ability to present the Ag at its surface to other 
immune cells and more importantly, migratory abilities, an essential stage in the transition 
from acute to chronic inflammation. Naïve T cell stimulation in the LN relies on the migration 
of the DCs from the cornea/conjunctiva to LN paracortex, and this is made possible by the C-
C chemokine receptor type 7 CCR7 [Saban et al. 2013, Forster et al. 1999, Scandella et al. 2002, 
Saeki et al. 1999, Ohl et al. 2004, Forster et al. 2008, Yanagihara et al. 1998]. Chemokines are 
chemotactic cytokines, upregulated in inflammation processes that control patterns of 
migration and the positioning of immune cells and influence every aspect of the immune 
system [Comerford et Mccoll 2011]. In the case of DED, DCs maturation is induced by 
recognition of the Ag, but the triggering of the adaptative immune response requires the 
activation of T cells in the LN. This requires gaining access to the lymphoid vessels at the limbo, 
then migrate to the LN parenchyma and get access to the naive T cells [Saban 2014]. During 
its maturation, DCs upregulate the expression of CCR7 [Saban et al. 2013, Saban 2014]. The 
propagation of the inflammation signal allows an upregulation of CCR7 ligands at the surface 
of endothelial cells located inside lymphoid vessels and the creation of a chimiotactic gradient 
that goes from the lymphatic vessel to the LN [Forster et al. 1999, Ohl et al. 2004, Martin-
Fontecha et al. 2003]. Once in the LN, DCs locate in the paracortex where they will meet naive 
helper T cells (Th) and initiate the differentiation of LT CD4+ in two main lineages; Th 1 mediated 
immunity or Th 17 cell subsets. [El Annan et al. 2009, De Paiva et al. 2009 a, Niederkorn et al. 
2006]. In the LN, Th 1 subset LT acquires the ability to secrete INF-ɣ at the ocular surface 
whereas Th17 lineage secretes IL-17. The homing of these activated inflammatory cells is blood 
mediated and requires the expression of endothelial adhesion molecules to guide them back 
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to the inflammation site [Comerford et Mccoll 2011]. ICAM-1 is an adhesion molecule 
expressed by conjunctival, corneal epithelium and by blood vessel endothelium in DED [Bron 
et al. 2017; Pisella et al. 2000]. ICAM-1 interacts with a type of receptor expressed by activated 
T cells (Th1 and Th17) called leucocyte factor antigen 1 (LFA-1) and induces: rolling, 
transmigration and activation both in LN and at the site of inflammation [Perez et al. 2016]. In 
the case the inflammation site is located onto the cornea (knowing that cornea, in 
physiological conditions, is devoid of blood/lymphatic vessels) [Stevenson et al. 2012], the 
homing of Th1 and Th17 cells is facilitated by the production of prolymphangiogenic molecules 
such as vascular VEGF D and VEGF C. The arrival of Th 1 and Th17 cells on the inflammation site 
exerts their pathologic effect as Th1-secreted INF-ɣ and Th17-secreted IL-17 promote the 
liberation of proinflammatory CKs, MMPs (MMP-3 and MMP-9), chemokines [De Paiva et al. 
2009b,  Coursey et al. 2013 , Dohlman et al. 2013]  leading to disruption of epithelial barrier 
corneal and decrease in goblet cells density  [Stevenson et al. 2012,  De Paiva et al. 2009b,  
Chauhan et al. 2011; Chauhan et al. 2009]. The liberation of pro-inflammatory factors on 
ocular surface is expected to reach every structure within the LFU. 
1.6 AGING, AGING EYE AND DED 
The National Institute on Aging of the National Institutes of Health (USA) gave a 
comprehensive definition of aging: “Aging is a complex natural process involving every 
molecule, cell, and organ in the body. In its broadest sense, aging merely refers to changes 
that occur during the lifespan.” [Dollemore 2008]. As proposed by Rocha et al. [Rocha et 
al.2008] a set of two main theories could explain the process of aging, from programmed 
mechanisms inducing senescence to error signals leading to aging, but no consensus on the 
origin of age-related changes can fully explain the processes undergone by the human body 
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through the years [Gatza et al. 2008, Jarrard et al. 1999, Makrantonaki et al. 2006, Sarkisian 
et al. 2007, Abdel-Rahman et Cowen 1994, Ishimaru et al. 1997 ,Ishimaru et al. 2000, Meites 
1990, Sander et al. 2006, Tanaka 1990 , Kikuchi et al. 2007, Lim 2006, Schwarze et al. 2005, 
Sharma et al. 2005, Artandi et al. 2002, Inoue et al. 2003, Alves et al. 2005, Shamanin et 
Androphy 2004, Wiktor-Brown et al. 2006].  
1.6.1 Age-related changes taking place in the LFU 
Every part of the human body is subject to aging and LFU is no exception: LG, the eyelid area, 
MGs and conjunctiva are affected in their structure and function over the life span. Various 
histopathologic age-related changes occur in LG. In the first place, a low grade of 
dacryoadenitis occurs along with acinar atrophy, periacinar fibrosis and paraductal blood 
vessel loss tend to appear in young adults but increases with age [Damato et al. 1984, Nasu et 
al. 1984, Obata et al. 1995]. Interestingly, the secretory ducts following the acini dilate over 
the life span and show an increased tortuosity suggesting the presence of an obstruction of 
the ducts [Rocha et al. 2008]. Obata et al. suggest that since acini and ducts are anatomically 
closely related, the obstruction of the ducts could influence the atrophic changes taking place 
in the acini [Obata et al. 1995]. LG lymphocytic infiltration is directly related to aging as its 
incidence was found to be higher in subject aged 40 and older [Nasu et al. 1984]. It is mainly 
concentrated around the secretory ducts and acini leading to their gradual destruction; 
Damato et al and Nasu et al. [Damato et al. 1984, Nasu et al. 1984] proposed that the 
lymphocytic infiltration generates fibrosis, a secondary response to chronic inflammation. 
Besides, it is believed that LG aging comes with fatty infiltration and decrease in LG mass, the 
former eventually leading to LG dysfunction, [Bukhari et al. 2014, El-Fadaly et al. 2014, Nasu 
et al. 1984] reduced reflex tear secretion and breakup time [Patel et Farrell 1989]. However, 
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Rocha et al. [Rocha et al. 2008] emphasize the fact that the reported decrease in reflex 
Schirmer values over the life span [Van Haeringen 1997, Seal 1985] could be due to a variety 
of factors such as reduced availability of secretory neurotransmitters, loss of functionality of 
the gland itself as explained earlier and more important, loss of sensory drive originating from 
ocular surface [Rocha et al. 2008]. Indeed, terminal afferent corneal pathways taking 
information relative to mechanical and chemical stimuli at ocular surface, loose sensitivity 
with age, which is expected to reduce sensory drive to the lacrimal gland [Bourcier et al. 2005, 
Millodot 1977, Acosta et al. 2006]. Another argument in favor of the diminution of LG function 
with age lies in the analysis of the lacrimal-derived proteins (peroxidase, lyzozyme, lactoferrin) 
which amount decreases with age [McGill et al. 1984, Seal 1985, Pietsch et Pearlman 1973, 
Bonavida et Sapse 1968, Mathers et al. 1996]. 
Alterations of the eyelid include lid laxity [Chhadva et al. 2016] MG atrophy [Alghamdi et al. 
2016] and gland loss/dropout [Den et al. 2006, Norn 1987] the former increasing with age as 
seen using noninvasive meibography [Arita et al. 2008]. Furthermore, Arita et al. and Ban et 
al. used noncontact infrared meibography to emphasize decreased mean duct length and 
percent acini area in older when compared to younger, asymptomatics subjects [Arita et al. 
2008, Ban et al. 2013]. Decreased hormonal levels, particularier androgen levels, shown to 
decline in older adult male, are associated with changes occuring in the function of MGs. 
[Sullivan et al. 2002]. Bron et al. proposed an interesting theory regarding Marx’s line, a vital 
dye staining pattern [Knop et al. 2011a, Knop et al. 2010, Donald et al. 2003, Norn 1985], 
located behind the MCJ [Knop et al. 2011b], in lifespan keratinization of terminal meibomian 
ducts possibly leading to MGD. MCJ is a shifting zone of the epithelia properties, changing 
from keratinized epithelium of the lid margin skin, which is hydrophobic, to a hydrophilic 
parakeratinized conjunctival epithelium [Knop et al. 2011b]. Marx’s line is a staining pattern 
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that extends from lacrimal puncta to outer canthi of both upper and lower lids, it is very 
limited in width in younger subjects (few cells wide) [Donald et al. 2003], but tends to broaden 
and loose regularity with age along with the neighbour MCJ [Bron et al. 2017]. The staining of 
this particular zone is believed to be the result of permanent increased osmolarity at this site 
(secondary to a local high evaporation rate), increasing epithelial cell and glycocalyx secreting 
cells turnover eventually leading to insufficient cell maturation and to the corresponding vital 
staining [Bron et al. 2011a, Bron et al. 2011b]. Furthermore, local maintained hyperosmolarity 
leads to an increased epithelium permeability and could be used as a route for pro-
inflammatory CKs released in response to osmotic stress (IL-1β, INF-ɣ, MMPs, TNFα) and reach 
the nearby meibomian gland terminal ducts. As specified by [Li et al.2010 ], liberation during 
a lifespan of IL-1 β and INF- ɣ locally, through their ability to favor the expression of cornified 
precursor proteins, could participate to hyperkeratinisation of meibomian terminal ducts, a 
prerequisite to MGD onset. Conjunctiva seems to be rather resistant to age-induced damage 
[Giebel et al. 2005, Zhu et al. 2010, Labbe et al. 2005, Abdel-Khalek et al. 1978]. 
Over and above to the age-related changes aforementioned taking place in the LFU, two 
additional, visual impairing processes take place within the eye and more precisely within the 
crystalline lens leading to presbyopia and cataractogenesis respectively, highlighting the need 
for an optical correction. The next paragraphes will describe these two age-related changes 
and the potential impact of existing refractive approaches to correct them on the onset/ 
worsening of dry eye signs and symptoms. 
1.6.2 Age-related changes to the crystalline lens: presbyopia onset 
Accommodation is the process by which the eye, more precisely the crystalline lens, changes 
its shape in order to focus on near objects. This optical phenomenon relies on the contraction 
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of the ciliary muscle, which in turn loosens the ciliary fibers attached to the crystalline lens. It 
allows the lens to take a more curved shape, which increases its refractive power and reduces 
the focal length to the target of interest. With age, the lens progressively looses its ability to 
change shape, it is called presbyopia. Presbyopia refers to the age-related progressive loss of 
accommodation of the crystalline lens that result in an inability to focus on near objects. It is 
one of the most common refractive defects as everyone eventually develops presbyopia, 
increased age being the major risk factor even if other elements may influence its onset and 
progression (disease, medications, trauma) [American Optometric Association 2010]. 
Presbyopia directly affects quality of life over all in high-income countries where the main near 
distance activities involve writing and reading [McDonnell et al. 2003, Patel et West 2007]. It 
affected 1.3 billion people worlwide in 2011 [Frick et al. 2015], and up to 2 billion people in 
2012 [Charman 2013].  
This trend is expected to keep on increasing as fertility rates have fallen to very low levels in 
most world regions and people tend to live longer [He 2015]. Various theories exist to explain 
the presbyopia onset process like for instance changes in tissue elasticity and ciliary body 
[Glasser et al. 2001, Heys et al. 2004, Strenk et al. 2005, McGinty et Truscott 2006], but 
increased stiffness of the lens with age is the main accepted theory [Weeber et al. 2007]. With 
advancing age, oxidative processes within the protein constituting crystalline fibers lead to a 
progressive diminution of lens elasticity/flexibility and hence to a loss of accommodation 
[Hanson et al. 2000, Lou 2003]. Crystalline lens growth is characterized by an increase in the 
inelastic mass that is responsible for lens shape changes allowing for lens power variation and 
thus lead to a diminution in near distance focusing abilities [Goertz et al. 2014]. A great variety 
of symptoms occurs during presbyopia onset such as eyestrain and headaches as well as 
blurred vision after or when performing maintained near tasks. 
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1.6.3 Age-related changes to the crystalline lens: cataract genesis 
According to the WHO, cataract is the leading cause of blindness [Thylefors et al. 1995, WHO 
Global initiative for the eliminitation of avoidable blindness 2000] and the loss of useful vision 
is expected to affect 16 million people worldwide [Asbell et al. 2005]. Cataractogenesis is 
multifactorial, and can develop from a wide variety of causes ; ultraviolet (UV) radiation (in 
particular UV B) are involved in cortical  cataract changes [West et Valmadrid 1995, McCarty 
et Taylor 2002, Hollows et Moran 1981], genetic factors [Hammond et al. 2000, Hammond et 
al. 2001] systemic drugs, infectious diseases [Shichi 2004] but aging is by far the major risk 
factor for its onset [Thylefors et al. 1995, WHO Global initiative for the elimination of avoidable 
blindness 2000, Asbell et al. 2005]. It induces a broad spectrum of changes regarding 
biochemical processes taking place in the lens leading to alteration in water balance, proteins, 
vitamins and enzymes, being responsible for progressive loss of lens transparency 
[Pescosolido et al. 2016]. Age-related cataract seems to be the result of a prolonged and 
gradual process of crystalline proteins denaturation, which can occur principally in three 
different ways: repeated environmental insults (mainly UV radiation), reduction in intrinsic 
stability of crystalline proteins, or decline of lens cell homeostasis [Hejtmancik et Kantorow 
2004, Truscott 2005]. According to Halsbeck et al. [Haslbeck et al. 2015], a protein with a 
chaperone-like activity called α-Crystallins seems to delay this aging-process mainly by its 
ability to bind, even partially, to denatured proteins (i.e βγ-crystallins) [Horwitz 2003, Datiles 
2008]. However, Shiels et Hejtmancik found that the level of this unbound protein decreased 
sixfold in individuals with a clear lens [Shiels et Hejtmancik 2017]. Binding properties of this 
protein get saturated as age increases and complexes formed, aggregate to the point that they 
are large enough to generate opacities, and thus, to scatter light [Shiels et Hejtmancik 2017]. 
Based on the location of the opacities, three main types of age-related cataract exist: cortical, 
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nuclear posterior subcapsular; mixed forms are not unusual. Cataract onset is usually bilateral 
but typically asymmetrical. 
 
1.6.4 Existing refractive means to correct presbyopia and their potential impact on dry eye 
signs and symptoms 
Various refractive means exist to correct presbyopia, from spectacles (including simple 
reading glasses, bifocal, trifocals and multifocal), to CLs with different geometries 
(monovision, bifocals, simultaneous vision). However, CLs, once upon eye, sit in the TF, 
disturbing its normal structure and interact with the ocular surface possibly worsening an 
already unbalanced environment. Refractive surgery is another option available (cataract 
surgery with implantation of different geometry IOLs (monofocal, bifocal, trifocal), corneal 
refractive surgery) but its invasiveness, even if great steps forwards have been made, could as 
well disturb the ocular surface and worsen or induce signs and symptoms of dryness. 
 
1.6.4.1 Spectacle Correction 
Correction of presbyopia using spectacle is achieved with either single vision or multifocal 
lenses [Jalie 2008]. Single vision spectacles also known as reading spectacles, are monofocal 
lenses intended only to correct near vision; if patients require correction for distance vision, 
he will have to use separate glasses depending on the target he wants to look at. Multifocal 
lenses include bifocal, trifocal and progressive lenses, which require a change of gaze in order 
to look through the zone of appropriate correction. Bifocal and trifocal lenses present the 
main advantage of providing a full lateral field of vision which is not the case with progressive 
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lenses, that despite great improvements made to enhance the periphery of the lens, eye 
direction when glasses are on are limited because peripheral vision is subject to distortions 
due to the unwanted astigmatism surrounding the narrow corridor of progression. While 
progressive lenses provide a smooth transition between far- and near-vision through a narrow 
corridor of intermediate vision, bifocal and trifocal lenses present a drawback lying in the 
image jump occurring at the top edge of the transition between lenses responsible for the 
formation of ghost images possibly disturbing vision. Despite the few drawbacks of different 
spectacle approaches to correct presbyopia, it is considered as a reliable option opted by a 
great majority of the presbyopic population. However, spectacle dependence has been proven 
to impact quality of life for this age-based population [Luo et al. 2008]. 
Spectacles are not expected to induce dry eye. However, environmental stress (low relative 
humidity or high air velocity) [Koh et al. 2012] might be responsible for higher and faster 
evaporation rate leading to dry eye symptoms and to the consequences on the ocular surface 
already described earlier [Wolkoff et al. 2005, Wyon et Wyon 1987]. The influence of 
temperature and humidity has already been assessed in a previous study using controlled-
environment chambers [Maruyama et al. 2004]. Koh et al. compared normal and dry eye 
subjects before and after airflow exposure evaluating TMA, TMH using OCT and TBUT [Koh  et 
al 2012]. They found significant decrease in TMH and TMA values for the dry eye group 
(P=0.027) whereas the normal group only presented an increased TMA. It seems that having 
a preexisting dry eye (evaporative dry eye in this case) influences the response of the ocular 
surface to adverse environment exposure. Indeed, Koh et al. found a significant increased 
blinking rate in the dry eye patients (up to 59 % P=0.039) whereas no change occured in the 
normal eyes sample (P=0.917) after exposure to airflow [Koh et al. 2012]. 
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Besides, it could be hypothesized that spectacles frames and optical lenses, depending on its 
shape and on the surface covered, might present some degree of protection regarding airflow 
exposure. Waduthantri et al. evaluated the impact of a commercially available retention 
spectacles for evaporative dry eye patients evaluating TBUT and symptoms at baseline and 3 
months after treatment [Waduthantri et al. 2015]. A close-fitting wrap around frames seems 
to play an important role in decreasing signs and symptoms of dry eye by increasing peri-
ocular humidity [Tsubota et al 1994, Savar et al 1979]. Waduthantri et al. found a significant 
amelioration of signs, symptoms, corneal fluorescein staining (P<0.05) for all the parameters 
previously cited with retention spectacles [Waduthantri et al. 2015]. 
1.6.4.2 CLs 
Varieties of options for CL correction are available on the market: single vision (combination 
CL and reading glasses), monovision, bifocal designs and at last but not least, multifocal 
designs [Bennett 2008, Llorente-Guillemot et al. 2012]. According to a survey conducted by 
Morgan et al., only 16% of all CL wearers are patients with presbyopia, which shows that this 
interesting market remains untapped [Morgan et al. 2011]. Besides, less than a third of those 
over the age of 45 years (hence presumably presbyopic) were prescribed multifocal (CL): the 
majority of presbyopes (63 per cent) were fitted with non-presbyopic corrections (distance 
prescription and additional reading spectacles for near) and only a 29 per cent with multifocal 
lenses [Morgan et al. 2011]. The low rate of prescribing multifocal CLs designs appears to 
pertain to several factors:  inadequate fitting skills and reluctance of the practitioner that 
perceives this type of fitting as being technically complex and time-consuming [Morgan et al. 
2011]. 
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CL can correct presbyopia through: movement – ‘alternating images’ which only works with 
RGPs and needs tight lids and careful fitting; or through ‘simultaneous’ images in which both 
distance and near optics are placed in front of the pupil to split the incoming light [Pérez-
Prados et al. 2016]. The optic zone of the CL (corresponding to the pupil area) is composed of 
several powers from near to far vision, which allows both distance and near targets to be 
imaged on the retina at the same time. The brain suppresses the most blurred image which 
otherwise may alter the quality of the best image selected for a given task. This optical concept 
is based on blur interpretation and/or blur tolerance of superimposed multiple images on the 
retina formed by the miscellaneous powers of the lens [Bennett 2008]. Superimposition of 
images produces an increase in depth of focus for high-contrast targets, but also can cause 
glare and loss of contrast sensitivity; the latter is exacerbated when the contrast of the target 
and the lighting condition are low, especially in near vision conditions [Plakitsi et Charman 
1995, Montés-Micó et Alió 2003, Montés-Micó et al. 2004].  
Not every CL wearer is able to achieve acceptable comfort during the time they wear the CLs 
and this can eventually lead to discontinuation and dropout. Despite the fact that many 
studies have looked into the subject, precise estimates of CL dropout remain unclear [Weed 
et al. 1993, Pritchard et al. 1999, Harknett et al. 2001, Jutai et al. 2003, Richdale et al. 2007, 
Rumpakis 2010, Dumbleton et al. 2013b, Sulley et al. 2017]: between 12%-43% of CL wearers 
drop out the CL permanently; CLD (24%) and dryness (20%) being the primary reasons of 
discontinuation [Pritchard et al. 1999, Richdale et al. 2007, Dumbleton et al. 2013b,  Young et 
al. 2002, Sulley et al. 2017]. According to Dumbleton et al., “discomfort” is the most frequently 
cited reason for discontinuing CL wear (up to 51% of lapsed CL wearers) [Dumbleton et al. 
2013b], but its precise meaning to individuals is more complex to assess. CLD has been defined 
as the “condition characterized by episodic or persistent adverse ocular sensations related to 
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lens wear, either with or without visual disturbance, resulting from reduced compatibility 
between the contact lens and the ocular environment, which can lead to decreased wearing 
time and discontinuation of contact lens wear” [Dumbleton et al. 2013b]. Indeed, the terms 
dry eye and CLD closely interlace, since a patient that presents signs and symptoms of dry eye 
has more propensity to have CLD [Begley et al. 2001]. Furthermore, CLD can be associated 
with the following visual signs: conjunctival hyperhemia, corneal staining, meibomian glands 
dropout, lid wiper epitheliopathy [Dogan et al. 2018] that can be found as well in CL associated 
dry eye. However, it may not be associated with any of the former signs, which makes the 
diagnosis more difficult. Little progress has been made regarding solutions to 
alleviate/eliminate CLD despite great advances in technology [Efron 2017], and the resulting 
CL discontinuation is a real issue for the industry as recent estimates evaluate the annual loss 
to reach several hundreds of millions of dollars [Nichols et al. 2013]. When a CL is fitted on a 
patient’s eye, TF is separated in a pre- and postlens TF. In addition to the changes in 
composition of the two created TFs, prelens TF stability is reduced due to the thinning of the 
lipid layer; tear volume on the anterior surface of the CL is also diminished, both events leading 
to increased evaporation rate and dewetting compared to the normal TF [Dumbleton et al. 
2013b]. Changes observed in tear lipid composition of prelens TF are associated events but up 
to now, it is not clear if those changes are induced by CL itself or if they were already present 
before CL wear [Dumbleton et al. 2013a, Dumbleton et al. 2013b]. It has been hypothesized 
that CL wear might impact the function of MGs as reduced MGs function has been associated 
with CL wear [Pritchard et al. 1999, Richdale et al. 2007,  Young et al. 2002, Dumbleton et al. 
2013a]. DED in CL wearers is associated with reduction in wearing time [Pritchard et al. 1999], 
increased risk of dessication (and raised osmolarity) and thus higher rates of infection 
[Bruinsma et al. 2001]. It appears that a uniform prelens TF is considered a key factor in order 
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to achieve comfort, good vision, lubrication and prevent infections during wearing time 
[Pritchard et al. 1999, Richdale et al. 2007, Dumbleton et al. 2013b, Young et al. 2002, 
Dumbleton et al. 2013a, Begley et al. 2001, Dogan et al. 2018, Bruinsma et al. 2001]. Dry eye 
patients tend to present a thinner prelens TF than the patients without DED, which could lead 
to a shorter prelens thinning time and increased friction [Nichols et Sinnott 2006]. Besides, 
lipid layer thinning, evaporation and CL material dewetting are likely to be due to the 
electrostatic interaction of the polar heads of the TF with CL material leading to an alteration 
of the lipid layer, increased evaporation and eventually dewetting of CL surface [Nichols et 
Sinnott 2006]. Osmolarity also is an increased parameter in DED CL wearers since significant 
differences have been found between healthy and DED CL wearers [Nichols et Sinnott 2006]. 
This could mainly be explained by the fact that DED CL wearers present a thinner prelens TF 
and hence are more prone to evaporation, TF instability being one mechanism of increased 
osmolarity. According to Fonn et al., there is no existing relationship between lens 
dehydration, dryness and TF thinning time [Fonn et al. 1999]. However, it is thought that high 
water content CL attract polar heads components of the TF causing disruption of the prelens 
TF and thus evaporation and/or dewetting [Dumbleton et al. 2013, Fonn et al. 1999].  
The physiological changes of an advancing age on the ocular surface and TF might decrease 
the tolerance for CLs and increase the risks of complications [Dumbleton et al. 2013]. 
However, recent findings give new insights on the possible reasons for CLD and the 
mechanisms involved seem to share common pathways with DED: CL is considered as one of 
the main risk factors for ocular surface and corneal inflammation [Wagner et al. 2011, Thakur 
et Willcox 2000, Robertson 2013, Sweeney et al. 2003]. 
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 Indeed, CL wear, in addition to reduced TF stability and an increased ocular staining [Purslow 
et al. 2005, Muselier-Mathieu et al. 2013] can potentially lead to:  hypoxic stress to the corneal 
tissue and mechanical friction (shear stress) which in turn can jeopardize ocular surface 
epithelia and create an entry door for pathogens [Chao et al. 2016]. CL fitting, even if 
successful, can lead to typical signs of inflammation as previously described by Efron (i.e 
hyperhemia, pain, swelling, increased temperature and eventually loss of function, in this case 
CL discontinuation) and be translated by the wearer as discomfort [Efron 2016]. Upgrading 
the fit, changing CL material and wearing schedule or even prescribing eyedrops are the main 
solutions available to alleviate those signs, but we have to keep in mind that in some cases 
these changes are not sufficient as prolonged inflammation can lead to complications that 
require CL discontinuation. Chao et al. proposed a two steps mechanism [Chao et al. 2016] to 
explain dryness and discomfort sensations during CL wear as a result of a sub-clinical 
inflammation in the presence of a functionnal LFU [Belmonte et al. 2004, Rosenthal et Borsook 
2012]. When a CL is inserted on a patients’s eye, regardless of biocompatibility characteristics 
of the material or the quality of the fit, the human body will consider CL as a foreign body and 
as such, an immunological response is expected to occur [Thakur et Willcox 2000, Oppenheim 
et al. 1991].  
Considering the case that CL material is free of pathogen agents (which is expected to occur 
in the majority of cases), sub-clinical inflammation might be induced by friction of epithelial 
surfaces with CL material leading to cellular damage and to the classical inflammatory cascade. 
Redfern et al. described the role of an innate immune response receptor family, the toll-like 
receptors, (TLRs) that can be activated by endogenous cellular components liberated by 
apoptotic cells (either due to friction of CL material with ocular surface or to raised osmolarity 
as found in DED) and which activation has been proven in pathophysiology of DED [Chao et al. 
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2016, Redfern et Mcdermott 2010]. These endogenous ligands, such as snRNPs, activate the 
TLRs and the NFĸB pathway leading to the production and liberation of CKs and chemokines 
including: IL-α and β, Il-6, IL-8 and IL-17A, INF ɣ and TNFα [Pearlman et al. 2008]. The liberation 
of these CKs upregulates inflammation as it allows for the activation of APCs (i.e dendritic 
cells), the former playing a key role in spreading inflammation by promoting cellular 
communication as well as setting the vicious circle of DED. [Barabino et al. 2012, Baudouin et 
al. 2017]. TNFα is responsible for cell apoptosis through epithelial barrier disruption and 
promotes inflammation [Tanaka et al. 2013, Hu et al. 2013]; IL-1 is a very powerful CK that 
promotes further inflammation [Dinarello 2011]. IL-6 is a key CK, first due to its pleiotropism, 
and second because its levels in tears are highly correlated with DED severity [Chao et al. 2016, 
Gabay 2006], it has been found in CL wearers but not in non-lens wearers [Schultz et Kunert 
2000]. IL-17 and INFɣ complete the vicious circle of ocular inflammation, both of them 
inducing further epithelial cells apoptosis [Chao et al. 2016, de Paiva et al. 2009a]. 
These pro-inflammatory CKs play a key role in CLD as IL-6, TNFα and MMP-9 are increased in 
healthy CL wearers [Schultz et Kunert 2000, González-Pérez et al. 2012, González-Pérez et al. 
2012, Kallinikos et al. 2006]. CLD and DED seem to share similar inflammatory pathways which 
allow us to affirm that, even if the response is not always as strong as in DED (i.e sub-clinical 
inflammation), the same ligands resulting from ocular surface insult (either due to friction of 
CL material with ocular surface (low lubricity)/inadequate fit/ patient-related interaction with 
CL material leading to raised osmolarity as found in DED) trigger a common intracellular 
pathway leading to the liberation of  pro-inflammatory CKs eventually initiating the closed 
loop of inflammation vicious circle as described by [Baudouin et al. 2013].  
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To sum up, TF factors (stability and efficient turnover), CL parameters, wearing schedule and 
environmental conditions [Nichols et Sinnott 2006] interact from the moment CL is inserted 
and can impact in different extents TF structure and ocular surface integrity. Taking into 
account age-related changes taking place in the LFU, it is understandable that CL fit in an older 
population is expected to be more challenging and, in this regard, deserves further 
investigation. 
1.6.4.3 Surgical techniques 
1.6.4.3.1 Corneal innervation and physiological role 
The cornea contains the highest density of sensory nerves of the whole human body with 
about 44 nerve bundles entering the cornea around the limbus centripetally [Al-Aqaba et al. 
2010]. Corneal sensation is made possible by large nerve fibers originating from the long ciliary 
nerve of the ophthalmic division of the trigeminal nerve (fifth pair of cranial nerve). Large 
nerve fibers enter the cornea equally in all quadrants and spread to cover the entire corneal 
surface [Muller et al. 1997]. Nerve fibers enter the cornea in the middle third of the stroma 
and then climb to the superior layers forming a plexus in the sub-Bowman’s layer that densely 
innervates central cornea [Muller et al. 1996]. Corneal nerves finish their path in the wing cell 
layer of the epithelium after going through Bowman’s layer and losing their myelin’s sheath. 
Corneal nerves are the angular stone of ocular surface homeostasis constantly adapting ocular 
surface response to environmental challenges. Free nerve endings, more precisely the intra 
epithelial sensory terminals, are stimulated in response to different stimuli (temperature, 
mechanical and chemical inputs between others) giving rise to afferent impulses that will 
travel along the ophthalmic branch of the trigeminal nerve to the central nervous system 
(CNS) [Marfurt et al. 2010]. It allows for the detection of potentially damaging stimuli and the 
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induction of defensive reflexes [Chao et al. 2016] provided by the efferent pathways such as 
lacrimation, blinking and regulation of different lacrimal glands secretions. Furthermore, 
nerve bundles play an important trophic role for the corneal epithelium, modulate immune 
response as well as wound healing process [Belmonte et al. 2004]. The different surgical 
procedures that will be described later on, use the cornea as an entry door to perform the 
medical gesture. As such, it is expected that corneal integrity is somehow jeopardized leading 
to alterations of the closed loop of the LFU and to the main anterior segment adverse effect 
of ocular surgery: DED. 
1.6.4.3.2 Cataract surgery and dry eye 
It is the most commonly performed elective surgery with an estimated 19 million procedures 
being performed every year worldwide [Trikha et al. 2013, Donaldson et al. 2013]. The WHO 
is counting on a significant increase of this surgery by the year 2020 (estimated 32 million 
procedures a year) as number of people over 65 is expected to increase significantly [Brian et 
Taylor 2001]. 
Furthermore, IOL implantation is gaining popularity in presbyopic population mainly due to 
the necessity to be spectacle independent and to bypass the limitations of corneal surgery to 
correct high refractive defects [Charman 2014]. Thus, IOLs are used in cataract patients as well 
as in young presbyopic subjects. 
Multifocal IOLs, like for spectacles, present a wide ranges of correction modalities, from 
bifocal, trifocal to extended depth of focus geometries and within these designs, multifocality 
can be achieved based on two optical principles: refraction and diffraction.  
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Before any surgical treatment, biometric measurements are required in order to calculate the 
power of the  IOL to be implanted; the accuracy of these measurements mainly rely on TF 
quality and stability [Montés-Micó 2007]. In the case tear TF is jeopardized by one of the 
multifactorial causes of DED, accuracy of measurements is reduced and could lead to 
unconformity with post-surgical expected refractive outcomes. Pre-operative assessment of 
the patient is one mandatory requirement in order to obtain reliable measurements. 
Surgical treatment for cataract involves the removal of the clouded lens and its replacement 
with an IOL; the main goal of this surgical procedure being to regain visual acuity getting rid 
of the opacified and light scattering lens and correct adequally the refractive defect of the 
patient. However, in the case that a clear lens is replaced for refractive purposes, the term 
“refractive lens exchange” or “clear lens exchange” is used. The indication for surgery mainly 
relies on patient’s visual needs, the risks, benefits, as well as patient's expectations. 
Following topical anesthetics (eyedrops) instillation, small temporal clear corneal incision, 
around 2.8 mm in length, is made in order to access the anterior chamber [Lam et al. 2013]. 
In order to reach the opacified lens, a circular incision is made to open the anterior capsular 
bag, this is called capsulorrhexis. The lens, now accessible, is then disaggregated using 
ultrasounds (phacoemulsification) and the pieces that result from its disruption are sucked 
out of the eye [Lam et al. 2013]. Posterior capsular bag is conserved as it will be used as a 
support for the prosthesis to be implanted. An IOL is then inserted and placed properly in the 
capsular bag using the haptics. Newer technique, previously used for the creation of lamellar 
flaps in laser assisted  in situ keratomileusis (LASIK) (described later on in the present work), 
has been adapted to the cataract surgery [Gogate et al. 2005, Donaldson et al. 2013] from 
corneal incisions to capsulotomy and previous fragmentation of the lens before 
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phacoemulsification: FLACS is far more accurate than mechanical devices at the cutting edge 
of technology and better procedure safety and clinical outcomes are expected, [Nagy et al. 
2009] with reports demonstrating  higher capsulorrhexis precision and reduced ultrasound 
power during the phacoemulsification [Donaldson et al. 2013, Palanker et al. 2010]. One 
drawback of this technique is the pressure to which the peri-limbic conjunctiva is subjected 
by the suction ring, which has been proven to reduce goblet cells density and be identified as 
an important risk factor in the pathology of LASIK-induced DED [Friedman et al. 2011, 
Rodriguez et al. 2007]. 
Risk factors for dry eye following cataract surgery, regardless of the technique used are well 
known, but the mechanisms through which they induce dry eye are yet to be established. The 
following risk factors could be related to disruption of corneal nerves and harm to the epithelia 
through the surgical procedure : eyedrops containing active agents/preservatives affecting 
the epithelium pre, peri and post-surgery [Salomão et al. 2009, Walker 2004],  forced opening 
of the eyelid with the blepharostat prevents normal blinking thus an even repartition of the 
TF on ocular surface [Cho et Kim 2009], long microscopic light exposure times which leads to 
thermal damage [Salomão et al. 2009, Walker 2004, Cho et Kim 2009], repeated irrigation of 
the ocular surface may impact the goblet cells density and further impact TF stability [Salomão 
et al. 2009, Walker 2004,  Cho et Kim 2009, Nakamori et al. 1997)] and for sure incision location 
and accuracy that will be discussed later on. 
One of the main difficulties in assessing dry eye is the lack of gold standard test [Chao et al. 
2016], which eventually leads to a variable prevalence of the disease. Dry eye after cataract 
surgery is as such expected to give discordant values from one study to another mainly due to 
the different diagnostic tests used and their inherent specificity and sensitivity [Li et al. 2007, 
 
 
39 
 
Kasetsuwan et al. 2013]. However, the great majority of studies agree that the surgical 
procedure induces/worsens signs and symptoms of ocular dryness [Salomão et al. 2009, Cho 
et Kim 2009]. Furthermore, a recent report from TFOS [Chao et al. 2016], shares new insights 
regarding inflammation processes and dry eye signs onset that could highlight the 
mechanisms involved at the ocular surface. As said before, transection of corneal nerves 
interrupts the feedback loop of the LFU, and corneal/conjunctival damage induced by surgical 
procedure are expected to generate inflammation.  
According to Baudouin et al., damage or ongoing disease processes to any component of the 
LFU are expected to induce signs and symptoms of DED [Baudouin et al. 2013]. DED, as defined 
earlier, is a multifactorial disease and as such, it is expected that in cataract surgery induced 
DED, various factors act as triggers in its onset: neurogenic inflammation and epithelial 
(corneal and conjunctival) damage induced by surgical gesture being the more important 
[Kasetsuwan et al. 2013]. On one hand, epithelial damage during surgery is the root of the 
activation of stress-associated intra-cellular transduction cascades involving  MAP-kinase and 
NF- κB [Baudouin et al. 2013, Srinivasan et al. 2017, Li et al. 2004, Li et al. 2006, Luo et al. 2004, 
Luo et al. 2005], responsible for the liberation of pro-inflammatory CKs: IL-1β, IL-6,  TNFα, 
INFɣ, MMP-1,-3,-9,-13, being the main pro-inflammatory messengers involved in DED 
pathogenesis/vicious circle [Baudouin et al. 2013, Srinivasan et al. 2017, Li et al. 2004, Li et al. 
2006, Luo et al.  2004, Luo et al. 2005, Stevenson et al. 2014, Stern et al. 2013, Brignole-
Baudouin et al. 2017, Calonge et al. 2010, Redfern et al. 2015, DEWS 2007]. The spread of 
inflammation signaling molecules on ocular surface further upregulates expression of their 
receptors and adhesion factors that facilitate recruitment and migration of inflammatory 
mediators promoting inflammation process [Stern et al. 2013, Brignole-Baudouin et al. 2017]. 
Activation signals occurring after the union of the pro-inflammatory CKs on epithelial cells 
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surface either promotes liberation of other CKs or induces apoptosis responsible for the 
positive vital staining of cornea and conjunctiva. Dessicating stress induced by surgery and 
epithelial damage gives rise to an immediate « innate » ocular surface response, which is a 
broad-spectrum answer to the surgical damage [Baudouin et al. 2013]. On the other hand, 
surgery-induced corneal nerve damage induces corneal sensitivity impairment [Chao et al. 
2016]. 
This further affects negatively blink rate and reflex-induced lacrimal secretion [Calonge et al. 
2010] which eventually leads to TF instability and increase in osmolarity values [Calonge et al. 
2010]. According to the TFOS II definition and classification report, the new definition of DED 
places osmolarity increase (at the same level as ocular damage and TF instability) as key 
etiologies of DED onset [Craig et al. 2017]. Tear hyperosmolarity induces epithelial cell 
hyperosmolarity leading to the liberation of pro-inflammatory CKs inducing cellular apoptosis 
and the corresponding ocular surface staining. Previous studies have investigated the 
pathophysiology of dry eye after cataract surgery: Kasetsuwan et al. found a significant dry 
eye signs and symptoms in a healthy population after cataract surgery; the prevalence of dry 
eye diagnosed with OSDI was 9.8%, the incidence of dry eye diagnosed with different tests 
was 68.4% with TBUT, 11.9% with Schirmer test and 58.7% with the Oxford Schema Staining 
respectively 7 days following surgery [Kasetsuwan et al. 2013]. Cho et al evaluated 70 eyes 
from 35 patients with no signs or symptoms of dry eye before cataract surgery.  
All of the parameters evaluated in this study BUT, Schirmer test, TMH and subjective 
symptoms worsen after cataract surgery until the second month post-operatively [Cho et al. 
2009]. Li et al. used the ocular surface disease index questionnaire (OSDI), TBUT, Schirmer 
test, corneal and conjuntival staining as well as impression cytology before and after cataract 
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surgery and found DED in all patients after the surgical procedure [Li et al. 2007]. Khanal et al. 
and Kohlaas et al. found a decrease in central corneal sensitivity which was associated with a 
reduced tear production [Khanal et al. 2008, Kohlhaas et al. 1997]. Ram et al. [Ram et al. 2002] 
evidenced a slight decrease in TBUT test and Schirmer’s test. Oh et al. found a significant 
decrease in TBUT and conjunctival cell count at one day from surgery; however, full recovery 
of corneal sensation at one month was not achieved and dry eye symptoms were worse and 
did not return to normal levels even after 3 months [Oh et al. 2012]. 
 A former cataract surgery technique, called extracapsular cataract extraction requires a larger 
incision and thus is expected to induce more corneal sensitivity loss [Hoffman et al. 2005]. This 
is confirmed by Oh et al. and Khanal et al. as a 2.8 mm and 4.1 mm incisions respectively were 
performed in each study and lead to significant differences in corneal sensitivity recovery as 
the more reduced incisions led to complete recovery within 1-3 months and only to a focal 
diminution of corneal sensation whereas the larger incision lead to a longer time of complete 
recovery. Incision shape, depth and regularity clearly affect post-surgery healing [Khanal et al. 
2008, Oh et al. 2012]. Furthermore, micro incisional procedures such as phaco emulsification 
are expected to induce less hyopesthesia than more conventional techniques [Ram et al. 2002, 
Oh et al. 2012, Hoffman et al. 2002, and Kissner et al. 2007]. Corneal sensitivity is significantly 
reduced just after cataract surgery [Oh et al. 2012]. However, the healing process is already 
ongoing as new neurites rapidly emerge, and after 25 days NGFs are released to regenerate 
the subepithelial corneal axons [Marfurt et al. 2010, Park et al. 2016]. 
Goblet cells are located on the conjunctiva, they are responsible for mucin secretion and play 
a key role in TF stability [Kashima et al. 2014] and ocular defense against foreign bodies 
[Hodges et Dartt 2013], so it is easily understandable that any dysfunction in these cells could 
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lead to evaporative dry eye [Kashima et al. 2014, Hodges et Dartt 2013, Sutu et al. 2016]. 
Several studies report a decrease in goblet cell density after cataract surgery [Li et al. 2007] 
which can last up to three months after the surgical procedure [Oh et al. 2012]. However, the 
reason of this decrease is multifactorial: inflammation, and more precisely MMPs, IL-1 and 
TNF α induce goblet cell apoptosis [Park et al. 2016, Kashima et al. 2014, Sutu et al. 2016, and 
Pflugfelder et al. 2013] so it is not surprising that goblet cell loss occurs during the acute phase 
of inflammation. Besides, potential toxicity of antiseptic agents used during the surgical 
procedure as well as topical multi-dose eyedrops with preservatives seem to play a role in the 
onset of dry eye signs and symptoms: BAK, is one of the most commonly used preservatives 
in ocular topical drugs and is recognized to induce, apart from goblet cells apoptosis, 
conjunctival squamous metaplasia, disruption of the corneal epithelium barrier and tear film 
instability between other [Baudouin et al. 2010].
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Authors Sample Tests performed Results 
[Kasetsuwan et al. 
2013] 
92  OSDI 
Oxford Staining 
Schirmer I 
TBUT 
DED Prevalence 7 days postoperatively 
OSDI: 9.8% 
Oxford Staining: 58.7% 
Schirmer I: 11.9% 
TBUT: 68.4% 
[Li et al.2007] 
 
 
 
 
37 (50 eyes) NEI-VFQ25 
OSDI 
BUT 
Schirmer Test I 
Fluorescein staining (Oxford 
and van Bijsterveld 
Impression Cytology 
TMH with fluorescein 
 
NEI-VFQ25 
Improvement in functional indices and ocular pain aggravated before/after surgery 
OSDI did not show any changes 
BUT significantly worse (P<0.01) 
Fluorescein staining (Oxford and van Bijsterveld 
Increase of staining at one-month post-surgery. 
OSDI did not show difference before/after surgery 
Impression Cytology 
TMH disminshed significantly 70% >0.3mm pre-surgery and 70% post-surgery maintained 
at 1 month and 3 months after surgery 
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Authors Sample Tests performed Results 
[Ram et al. 2002] 
 
23 (25 eyes) Schirmer test with 
anesthesia 
TFBUT 
The mean preoperative Schirmer score was 4.80 mm ± 2.01 (SD) and the mean 
postoperative score, 3.80 ± 2.40 mm                                                                                                                                    
The mean preoperative TFBUT was 4.00 ± 1.87 seconds (range 0 to 9 seconds) and the 
mean score at the last follow-up, 3.40 ± 1.60 seconds 
[Cho et al. 2009] 49 (98 eyes) Dryness symptoms 
TMH (SL and graticule) 
Schirmer test without 
anesthesia 
Fluorescein TBUT 
Significant aggravation in dryness symptoms/TMH/Schirmer/FBUT at 2 months post-
operatively (p<0.05) 
 
[Kohlhaas et al. 
1997] 
26  Corneal sensitivity (Draeger 
aesthesiometer) 
Markedly reduced corneal sensitivity in central corneal and discretely hyposensitive in the 
6 o’clock position 
[Khanal et al. 2008] 18 Corneal sensitivity (Non-
Contact Corneal 
Aesthesiometer (NCCA) 
Osmolarity (freezing point 
depression) 
Tear Evaporation 
Turnover rate (TTR) 
(automated scanning 
fluorophotometer) 
 
 
A significant decrease was seen postoperatively in central corneal sensitivity at 3 days (p < 
0.001), 2 weeks (p < 0.001), 1 month (p = 0.003) and 3 months (p = 0.009)  
Osmolarity significantly rises 3 days after surgery but decreases across the 3 months post-
surgery (no statistical differences with pre-operative values) 
Significant increase in evaporation at 3 days and 2 weeks post-surgery. 
Significant reduction in TTR at 3 days until two weeks post-surgery 
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Authors Sample Tests performed Results 
[Oh et al. 2012] 30 (48 eyes) Own symptoms 
questionnaire                           
Corneal sensitivity (Cochet–
Bonnet esthesiometer)           
Schirmer Test 1                       
Fluorescein BUT 
Significant differences in overall symptomatology score in comparison with pre surgery 
(p<0.01) Decrease of goblet cells density at 1 day post-surgery (P<0.01) but not at 1 month 
or 3 months 
Significant decrease in mean corneal sensitivity at one day post-surgery (p<0.05) that comes 
back to normal values at one month  
Not significative differences for Schirmer test  
TBUT significantly decreased at day 1 post surgery. 
[Kissner et al. 2007] 26 (52 eyes) Corneal surface aberrations 
(corneal wavefront 
instrument): Trefoil and 
astigmatism  
Surgery increased Trefoil and astigmatism (p<0.05) 
[Park et al. 2016] 
 
 
 
 
 
 
34 (8 eyes) Ocular symptoms 
FTBUT 
Schirmer I Test 
Corneal fluorescein staining 
(NEI scale) 
Corneal sensitivity (Cochet-
Bonnet aesthesiometer 
Multiplex immunoassay kits 
Significant increase at 1 day, 1 month, 2 months post-surgery (p<0.05) for the dry eye group. 
Significant differences post-surgery between dry eye and non-dry eye groups (TBUT values 
being lower in the dry eye group P<0.01) 
Significant lower FTBUT in the dry eye group (p<0.01) 
Significant lower Schirmer I in the dry eye group (p<0.05) 
Significant corneal staining differences between groups (dry eye group presenting the higher 
staining score p<0.01) 
Corneal sensitivity showing a significant higher threshold in the dry eye group (p<0.05) 
Significant increase in CKs levels at 1 month and 2 months after suergery in comparison with 
day 1 post surgery. 
Table 3. Prevalence of Dry Eye after Cataract Surgery
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1.6.4.3.3 Corneal refractive surgery  
- PRK 
PRK procedure requires previous corneal anesthesia because corneal epithelium is removed 
manually before the application of an excimer laser in order to reshape the stroma and thus, 
modify corneal power. It is a surface technique anterior to Laser Epithelial Assisted 
Keratomileusis (LASEK) and LASIK procedures. Indeed, PRK is based on previous corneal 
epithelium removal using alcohol solution (corneal epithelium is discarded) [Helena et al. 
1997, Browning et al. 2003]; the underlying corneal tissue is then reshaped using the excimer 
laser. No flap is needed for this procedure. Recovery is longer than LASIK technique since it 
takes more time (around a week) for epithelial cells to grow [Browning et al. 2003]. Eye 
infection is more frequent with this technique due to corneal exposure [Helena et al. 1997, 
Browning et al. 2003]. PRK induces temporary decrease in sub basal corneal nerves density for 
up to a year, and complete recovery might take as long as two years [Erie 2003]. Other studies 
stand that recovering corneal sensitivity could only take three months [Shikawa et al. 1994, 
Campos et al. 1992]. However, Ozdamar et al. reported sensibly disminished BUT and Schirmer 
tests (up to 50%, 6 weeks after after the procedure in comparison with controls [Ozdamar et 
al. 1999]. Campos et al. [Campos et al. 1992] as well as Pérez Santonja et al. [Pérez-Santonja 
et al. 1999] found that up to 96% of the PRK patients completely recovered corneal sensitivity 
after three months post-surgery. On the other hand, Hong et al. [Hong et Kim 1997] found 
different results revealing that up to 73 % of patients complained of DED and about half of the 
cohort had significantly reduced BUT. This is in agreement with both Lee and al. [Lee et al. 
2000] and Nejima et al. [Nejima et al. 2005] in which studies significantly reduced tear 
secretion was found post-surgery after three months.
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Authors Sample Tests performed Results 
[Erie et al. 1997] 14 (24 eyes) eyes from 
14 patients 
Confocal microscopy 
(epithelial and central 
thickness/keratocyte 
density/corneal nerve 
density) 
Significant increase in epithelial thickness (21%) (p<0.001) at 12 months post-PRK and was 
maintained at 36 months. 
No change in stromal thickness from 1-36 months after surgery (p=0.35) 
Keratocyte population at the anterior stroma did not reach pre-operative values (p<0.01) 
Decrease up to 60% of subbasal nerve bundle density at 12 months post-surgery (p<0.001) 
before almost reaching pre-operative values (p=1.0) 
[Ishikawa et al. 1994] 17 eyes from myopic 
subjects 
Corneal sensitivity 
with two group of 
patients: 
Shallow photoablation 
(0 to 30 µm) 
Deep photoablation 
(31 to 70 µm) 
Superior corneal sensation loss in the deep ablation group with no recovery within one 
month of the surgery.  
Corneal fluctuations in sensations present up to 6 months post-surgery in this group 
[Ozdamar et al. 1999] 
 
 
 
 
 
 
32 (64 eyes)  -Schirmer test 
-FTBUT 
 
Significant decrease in Schirmer/FTBUT values post-surgery in comparison with the fellow 
eye (control) (p=0.0001) 6 weeks after the surgical procedure 
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Authors Sample Tests performed Results 
[Perez-Santonja et al. 
1999] 
18  Corneal sensitivity 
(Cochet-Bonnet 
aesthesiometer): 
Central zone and 2 mm 
from that central zone 
(nasal, inferior, 
temporal, and 
superior) 
Return to pre-operative values at 3 months for central cornea and 1 month for the other 
corneal areas evaluated (p>0.05) 
[Hong et Kim 1997] 220 eyes Schirmer test 
TBUT 
 
No significant changes in Schirmer test values were found at 6 months post-surgery 
47.8% of eyes showed a reduced TBUT of which 72.7% complained of dry eye symptoms. 
 
[Lee et al. 2000] 21 (36 eyes) eyes from 
21 patients 
Schirmer with 
anesthesia 
FTBUT 
 
Significant decrease in Schirmer values at 3 months (p=0.0011) which tend to come back 
to normal values at 6 months (p=0.3080) 
Same trend for FTBUT values at 3 months (p=0.0001) and 6 months (p=0.0678) 
Table 4. Prevalence of Dry Eye after PRK 
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- LASEK 
This surgical technique is based on PRK procedure. The main difference with PRK is that the 
peeled corneal epithelium called an epithelial flap (which is discarded in the PRK technique) is 
repositioned after photoablation as for the stromal flap in the LASIK procedure [Ambrósio et 
Wilson 2003]. Alcohol is used to weaken adhesions between stroma and epithelium [Shah et 
al. 1998]. Factors such as alcohol concentration (usually between 18-25%) and exposure time 
play a key role in post-operative healing [Kim et al. 2002]. The detached epithelium is then 
moved to the periphery for the stromal ablation to be performed [Kim et al. 2002]. After 
ablation, the epithelium is repositioned with a spatula and a therapeutic bandage CL fitted in 
order to protect the vulnerable corneal epithelium. This technique is considered as well as a 
surface technique because no stromal flap is needed to perform corneal reshaping. Autrata et 
al. compared 184 eyes of 92 patients between PRK and LASEK with a 2 years follow-up and no 
post-operative complications occurred, no signs or symptoms of dry eye were found in this 
sample [Autrata et al. 2003]. Herrmann et al. found that LASEK patients obtained higher OSDI 
scores up to 2 months post-surgery but that these values returned to baseline at 3 months 
[Herrman et al. 2005] whereas Dooley et al. and Horwath-Winter et al. did not find any 
difference between baseline, 3 months, 6 months and 12 months [Dooley et al. 2012, 
Horwath-Winter et al. 2004]. 
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Authors Sample Tests performed Results 
[Herrmann et al. 2005] 20 eyes from 10 
patients 
Schirmer test with 
anaesthesia                   
Schirmer test without 
anaesthesia                   
FTBUT                           
Fluorescein staining of 
the cornea                
Corneal 
aesthesiometry 
(Cochet-Bonnet)           
Symptomatology 
-Schirmer test with anesthesia was reduced at 3 months post-surgery (p<0.05) 
 Schirmer test without anesthesia was reduced at 2 and 3 months after surgery (p<0.05) 
FBUT was reduced at 1 week and 1 month after surgery (p<0.05) 
Corneal staining was increased at 3 days and one week after surgery (p<0.05) 
Symptomatology was increased after surgery (p<0.05) excepted at 3 months 
[Dooley et al. 2012] 35 eyes OSDI                              
Schirmer test with 
anaesthesic                   
Osmolarity (TearLab) 
OSDI values did not change during the follow-up period 
Schirmer values changed significantly at 12 months 
Osmolarity did not change across the follow-up period 
[Horwath-Winter et al. 
2004] 
37 eyes from 21 
patients 
Symptoms                       
Corneal sensitivity 
(Cochet-Bonnet)           
 FTBUT                           
 Schirmer I                   
Fluorescein staining of 
the cornea                 
No statistical difference in symptomatology was found. 
Corneal sensation reduced up to one month after the surgical procedure (p<0.05) 
FTBUT was significantly reduced at 1 week and 1 month (p<0.05 respectively) 
No changes in Schirmer results 
Significant increase in corneal staining at one week (p<0.05) 
No changes in lissamine green staining 
Table 5. Prevalence of Dry Eye after LASEK
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- LASIK 
LASIK is a surgical corneal option for treating refractive errors [Sutton et Kim 2010] including 
presbyopia. This surgery technique is enjoying a growing popularity [Duffey et Leaming 2005] 
and presents a high success rate [Solomon et al. 2002, Liu et al. 2008, Miller et al. 2001, 
Marinho et al. 1996] as more than 90% of patients achieve 20/25 or better without glasses 
[Danasoury et al. 1999, Knorz et al. 1998]. However, DED is one, if not the most common 
adverse effects of LASIK surgery [Shoja et Besharati 2007, Chao et al. 2014, Miller et al. 2001, 
Salomão et al. 2009, Quinto et al .2008, Ang et al. 2001] even for people that did not show any 
signs or symptoms of the disease before the surgical procedure [Hovanesian et al. 2001, Mian 
et al. 2009].  
LASIK is a surgical procedure in which a corneal flap (around 120-160 micrometers) is created 
by a blade called microkeratome/ or a femtosecond laser (the former inducing less DED signs 
and symptoms) [Salomão et al. 2009], and then reclined in order to proceed to the stromal 
ablation with an excimer laser (photoablation) which will reshape the cornea and modify the 
patient visual defect according to the amount of corneal tissue removed. LASIK-Induced 
neurotrophic epitheliopathy (LINE) [Wilson 2001, Ambrósio et al. 2008] refers to the 
neurotrophic component of this surgical procedure induced dry eye that mainly results from 
the nerve damage occurring during flap creation and stromal ablation. Indeed, the damage is 
so important that regrowth of subasal nerves takes up to five years to reach a density almost 
similar (but still inferior) to that before surgery [Erie et al. 2005]. Flap creation was initially 
performed using blades (microkeratome), but the emergence of newer technologies such as 
femtosecond lasers [Suga 2002] have allowed to reduce signs of dry eye. Indeed, flap creation 
is quite different in architecture: [Jagow et Kohnen 2009] based on the tool used to do it, the 
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peripheral shape will differ significantly:  the blades from the microkeratome only allow for a 
single mechanical continuous cut whereas the femtosecond laser uses repeated impacts to 
photodisrupt the tissue providing a more regular peripheral flap shape [Tran et al. 2005, Durrie 
et Kezirian 2005], less aberrations and better visual outcomes [Tran et al. 2005, Durrie et 
Kezirian 2005, Kezirian et Stonecipher 2004]. Stromal reinnervation after corneal injury is 
eased by precise apposition of wound edges at the flap margin [Patel 2010] which is thought 
to be explained by the realignment of proximal and distal Schwann cell channels [Chan-Ling 
et al. 1987, Tervo et al. 1985] as no reinnervation after penetrating keratoplasty has been 
evidenced when no Schwann cell channel could have been affixed [Patel et al 2007]. 
Once the flap is reclined, ablation is performed and destroys mid stromal nerves; knowing that 
stromal nerves are limited to the anterior 60% of the corneal stroma [Al-Aqaba et al. 2010] it 
is expected that most of them are destroyed across the ablation process (although nerves that 
run through the hinge are not expected to suffer any damage). Thus, LASIK surgical process 
induces double damage to the cornea; during the flap creation where the subbasal nerves are 
cut, and during the excimer laser stromal ablation where stromal nerve trunks are destroyed 
by the laser. It is estimated a 90% reduction of central nerve fibers density in the first month 
following surgery [Denoyer et al. 2015]. 
Various studies investigated dryness symptoms after LASIK surgery and found that ocular 
symptoms of dryness tend to reach a peak between one week and three months after surgery, 
regardless of preexistent dry eye condition [Autrata et Rehurek 2003, Dooley et al 2012, 
Vroman et al 2005, Mian et al 2007, Mian et al 2009, Wildon 2001, Ambrósio et al. 2008, Erie 
et al. 2005, Sugar 2002, Jagow et Kohnen 2009,  Tran et al. 2005, Durrie et Kezirin. 2005, 
Kezirian et Stonecipher 2004, Patel 2010, Chan-Ling et al. 1987, Tervo et al. 1985, Patel et al. 
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2007, Denoyer et al. 2015]. Hovasenian et al. obtained a 48% rate in self-reported DED at 6 
months after surgery using a questionnaire [Hovasenian et al. 2001]. Patel et al. found that 
around 50 % of patients undergoing LASIK surgery will complain of dryness up to 6 months 
after the procedure [Patel et al. 2007]. Shoja et al. obtained an incidence rate of 20% for DED 
that lasted for more than 6 months after surgery [Shoja et Beshariti 2007].  
Clinical signs post LASIK surgery are often highly variable [Feng et al. 2012]. When performed 
on DED patients, LASIK procedure worsens tear metrics and staining (reduced Schirmer test 
and BUT, increased rose Bengale and fluorescein staining) as reported by Toda et al. [Toda et 
al. 2001]. Tao et al found a decreased tear volume over time after LASIK surgery [Tao et al. 
2010]. Various authors reported increased osmolarity values up to 6 months after LASIK 
[Autrata et Rehurek 2003, Lee et al. 2000] whereas Chao et al. only reported a peak at one 
day and a return to basis level at 6 months [Chao et al. 2015]. Chao et al. reported corneal 
sensitivity to reach baseline values between 6-12 months after surgery [Chao et al. 2014]. This 
is in agreement with previous studies that show that recovery of NFD 6 months after LASIK 
was less than 25 % [Chao et al. 2014] and could take, as said earlier, up to 2-5 years to reach 
basis levels [Patel 2010, Moilanen et al. 2008].  
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Authors Sample Tests performed Results 
[Vroman et al. 2005] 94 eyes from 47 
patients 
Corneal sensitivity 
(Cochet-Bonnet)           
Schirmer with 
anaesthesic                   
TFBUT                            
Ocular surface staining 
(NEI scale)               
OSDI 
Significantly diminished at 1 week/1 month/ 3months/ 6 months (p<0.001) 
Schirmer values were significantly reduced only at 1 week post-surgery (p<0.05) 
TFBUT significantly reduced at 3 months post-surgery (p<0.01) 
No difference in ocular surface staining 
Significant increase in OSDI score at 1 week/1 month/ 3months/ 6 months (p<0.01) 
[Mian et al. 2007] 66 eyes of 33 patients Corneal sensitivity 
(Cochet-Bonnet)           
Schirmer test with 
anaesthesia                   
FBUT                              
Corneal fluorescein 
staining                           
Lissamine green 
staining with Oxford 
scale                               
OSDI 
Significant reduction in corneal sensitivity at 1 week/1 month /3 months/ 6months/ 12 
months (p<0.0001) 
Increase in Corneal fluorescein at 1 week post-surgery (p=0.01) 
FBUT/Schirmer test and conjunctival staining did not show significant changes after 
surgery. 
Increase in OSDI score at 1 week and one month (p<0.0001) respectively that stabilized at 
3 months 
[Shoja et Besharati 
2007] 
 190 eyes FBUT                              
Schirmer I                      
Corneal fluorescein 
staining                           
Central corneal 
sensitivity                      
Symptomatology 
Significant decrease of Schirmer and TBUT at 1 month/ 3 months/ 6 months (p<0.05) 
Corneal sensitivity reduced at  1 month and 3 months but returned back to pre-operative 
values at 6 months 
Table 6. Prevalence of Dry Eye after LASIK surger
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-SMILE 
The advent of lasers in the ophthalmic field to perform corneal refractive surgery lead to the 
concept of lenticule extraction. A precursor of modern techniques was called refractive 
lenticule extraction (ReLex) which consisted in the use of a picosecond laser in order to create 
a flap and an instrastromal lenticule removed manually; however, the lenticule created 
[Krueger et al. 2008, Ito et al. 1996] with the laser required further manual dissection leading 
to irregular surfaces. The apparition of femtosecond laser introduced a new procedure called 
Femtosecond Lenticule Extraction (FLEx) [Sekundo et al. 2008], leading to similar refractive 
results as LASIK [Shah et Shah 2011] but provided a longer recovery time due to laser related 
settings regarding energy delivered on corneal tissue between other things; however, further 
modifications lead to significant improvement in recovery times [Shah et Shah 2011]. 
Following this momentum, Small Incision Lenticule Extraction (SMILE), a refractive surgery 
technique using a femtosecond laser was developed to perform corneal reshaping [Reinstein 
et al. 2014]. This procedure aims to create an intrastromal lenticule (corresponding to the 
amount of power to remove) using the laser and then to extract it using a 2-3 mm tunnel 
incision usually located in the supero-temporal side of the cornea, eliminating the need to 
create a flap. This surgical procedure no longer needs excimer laser ablation nor the creation 
of a flap making this technique less invasive than LASIK. Since no flap is needed for SMILE 
procedure, it is expected that recovery is faster with this technique. Denoyer and al. found 
80% of the 30 SMILE patients did not use any eye drops at 6 months post-surgery versus 57% 
of the 30 LASIK patients [Denoyer et al. 2015]. Furthermore, no patient from the SMILE group 
used any kind of eyedrops whereas 20% of the LASIK group were using tear substitutes 
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frequently. This data was accompanied by a higher osmolarity in the LASIK group. According 
to Li et al. SMILE patients reported less DED symptoms three months after surgery in 
comparison with LASIK patients [Li et al. 2013]. 
- Corneal onlays/inlays  
The main advantage of this procedure over the previously described techniques is double: no 
tissue removal is needed, and it allows for the preservation of the more conventional options 
for correcting presbyopia [Lindstrom et al. 2013]. Corneal onlays/inlays are optical devices 
designed to alter corneal shape, they are inserted in the cornea of the patient. The use of 
highly biocompatible materials combined with surgical techniques at the edge of technology 
(i.e femtosecond laser) raised the positive outcome for the patients [Laroche et al. 1995, 
Waring et Klyce 2011]. Monovision is the most effective and common option to correct 
presbyopia [Fernandez et al. 2013] and it is the best-acknowledged approach regarding 
corneal inlays. Refractive power change is achieved through the alteration of the anterior 
corneal curvature, by the refractive index of the biomaterial, or by the combination of both 
[Evans et al. 2001]. If the lenticule is placed between the epithelium and the stroma it is called 
corneal onlay (epikeratoplasty/epikeratophakia); however, if it is placed within the corneal 
stroma it will be called corneal inlay (refractive keratoplasty). Three main types of corneal 
inlays exist to correct presbyopia and depth of placement in corneal stroma depends on each 
design: refractive inlays (alteration of the refractive index by the mean of bifocal optics), 
reshaping inlays (changes in corneal curvature) and inlays that use small aperture optics in 
order to increase depth of focus [Arlt et al. 2015]. Femtosecond laser is now widely used as it 
provides a more dependable flap than microkeratome [Papadopoulos et Papadopoulos 2014, 
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Binder 2010, Moarefi et al. 2017] and allows for the creation of stromal pockets improving 
accuracy of implantation depth and inlay centration.  
Refractive inlays modify central corneal power to correct near vision, it is achieved through 
modification of the refractive index of the cornea centrally by the means of bifocal optics [Arlt 
et al. 2015, Papadopoulos et Papadopoulos 2014]. It is based on multifocality with a plano 
center surrounded by rings of changing addition to provide intermediate and near vision 
powers [Bouzoukis et al. 2012]. Surgical procedure uses a femtosecond laser to perform a 
lamellar cut at a depth of around 280 µm temporally, no flap is needed. Then, a tunnel 
(stromal pocket) is made in order to reach the pupil area where the inlay is injected and placed 
[Limnopoulou et al. 2013]. Cornea reshaping inlays present no intrinsic refractive power upon 
insertion as they are made of a material, which presents the same refractive index as the 
cornea, usually hydrogel, allowing fluids, nutrients and oxygen permeability, essential to 
maintain corneal homeostasis [Moarefi et al. 2017]. The reshaping of the cornea is achieved 
thanks to its positive-meniscus shape, which increases the central radius of curvature of the 
cornea overlaying the material due to the induced rise of corneal anterior surface profile [Arlt 
et al. 2015]. Since the edges are thinner than the center, it creates a continuous decrease in 
power from the center to the periphery of the implant giving to the overlying remodeled 
cornea a hyperprolate profile providing multifocality [Garza et al. 2013]. A flap is created using 
a femtosecond laser but unlike the previous inlay type, the disruption takes place at an inferior 
depth between 120-200 µm [Moarefi et al. 2017], the inlay positioned and the flap put back 
in place. 
The small aperture optics inlays are a black film-like ring that increases the depth of focus (to 
restore near and intermediate vision) by blocking the peripheral light rays, it is basically a 
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pinhole placed in front of the pupil area [Tomita et al. 2013]. A femtosecond laser is used to 
create a lamellar cut at a depth of around 250 µm and the implant inserted and placed on the 
center of the constricted pupil area. 
Dry eye after corneal inlay implantation is mainly due to the flap creation, which is the same 
technique as for LASIK surgery. Yilmaz et al. [Yilmaz et al. 2011] reported the same outcomes 
for the eye that was implanted with the inlay and the fellow eye that underwent LASIK surgery 
regarding dry eye. We already described the inflammatory mechanisms causes by surgical 
gesture and flap creation (damage to the afferent nerve bundles between other with a spared 
zone corresponding to the hinge) responsible for dry eye signs and symptoms. However, since 
no LASIK is applied to the corneal stroma, less deep nerve damage is expected to occur in 
comparison with LASIK. The stromal pocket technique is less invasive tan the flap technique 
and as such, a reduced incidence of dry eye post-surgery is expected as well as a shorter 
recovery period [Binder 2010, Limnopoulou et al. 2013]. However, the lamellar cut (flap 
creation) is still the more indicated technique as in cases of inlay decentration, the need to 
explantation, or when the inlay implantation is coupled with LASIK surgery, the flap allows for 
an easier access to the biomaterial and for the stromal zone to be treated by LASIK 
[Greenwood et al. 2016]. Further studies are needed to assess the long term outcomes of the 
lamellar cut and tunnel incision performed for the refractive inlay and the small aperture 
optics implants [Dexl et al. 2011] on dry eye signs and symptoms. Corneal inlays represent a 
good option for presbyopia correction and fulfill the requirement of an aging population 
willing to be spectacle independent. The continuous evolution of corneal inlays and their 
methods of insertion reduce the nerve damage to the cornea and the outcome of the surgery 
with faster recovery time and less signs and symptoms of dry eye. 
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Adverse ocular sensation in this age-based population, play a key role in CL wear, during the 
pre-operative assessment of the patient and following surgery; this is why understanding its 
onset and triggering factors will give new insights on patient’s symptomatology as well as 
regarding the efficacy of treatments in DED. As reviewed in earlier, global knowledge 
regarding ocular sensation, damage and its associated pathways have significantly increased; 
however, the thorough mechanisms through which DED rises and further affects ocular 
surface homeostasis are not fully understood due to its high complexity and to the numerous 
mechanisms involved. Further research regarding the neuropathogenesis of impaired ocular 
sensation in DED is warranted in order to deepen the knowledge regarding homeostasis 
mechanisms, ocular response to nerve damage and its role in DED onset and perpetuation in 
a population that faces new challenges due to aging but also to the emergence of new 
refractive techniques. 
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CHAPTER 2 
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2.1 Actual situation 
The scientific significance of epidemiological studies relies on a precise definition and 
classification of the disease, which, until recently, represented the main challenge for DED as 
no consensus was adopted regarding dry eye objective and subjective diagnostic criteria 
[Stapleton et al. 2017]. Furthermore, the absence of gold standard tests to diagnose the 
pathology, which goes hand to hand with an acknowledged heterogeneity between signs and 
symptoms, make the interpretation and comparison of different epidemiological studies more 
difficult to assess. The TFOS II Epidemiology Report reviewed epidemiological studies from 
around the world and found a prevalence ranging between 5-30% in population over 50 years 
old [Stapleton et al. 2017], lower values representing the more severe forms and the higher, 
mild to moderate stages of the disease. According to this literature review, symptomatic DED 
has a higher prevalence in women than men and more common in Asian than Caucasian.  
However, even if DED is considered a symptoms-driven disease [DEWS 2007], epidemiological 
studies focusing only on clinical signs are source of a considerable variation in prevalence 
values. Standardization of diagnostic criteria and clinical tests are the great goal to achieve. 
The actual situation could explain the difficulties researchers are facing when it comes to 
diagnosis criteria; dry eye clinical tests evaluating the same parameter don’t have the same 
sensibility and specificity in diagnosing the disease, tests used often only assess one aspect of 
the pathology, no gold standard or combination of tests have been chosen to evaluate clinical 
features; adding to the previous statements a great extent of DED signs, all of them with 
distinct severity, sensitivity to pain specific to each individual, age-related/ongoing ocular 
surface pathologies and systemic conditions with ocular impact or age-related changes taking 
place in the LFU, make a proper diagnosis based on both signs and symptoms challenging. 
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When coupling signs and symptoms, even with the discrepancies named above and the 
caution to take when looking at the outcomes of different studies, one important information 
stands out as specified by Stapleton et al.; women had 1.3-1.5 x the prevalence of men 
[Stapleton et al. 2017]. The overall prevalence of the disease was very similar (from 8.7-30.1%) 
to the studies only focusing on symptoms, confirming the 2007 hypothesis that DED is a 
symptom driven pathology [Stapleton et al. 2017].  
According to the TFOS Epidemiology Report, prevalence of the disease based on symptoms 
and on clinical signs both show a gradual shift from aged 50 [Stapleton et al. 2017]. It seems 
very likely that important age-related changes take place in the LFU at this period of life (that 
could be due to a combination of aging eye and systemic changes), unbalancing the complex 
homeostasis mechanisms and leading to onset or excacerbation of signs and symptoms of 
dryness. Indeed, when it comes to risk factors for the disease, increased age, again depending 
on diagnostic criteria and variability of the definition of DED, appears to be the most consistent 
factor associated with dry eye [Schaumberg et al. 2009 , Ahn et al. 2014, Um et al. 2014, Lu et 
al. 2008, Moss et al. 2008, Jie et al. 2008, Viso et al. 2009, Hashemi et al. 2014, Vehof et al. 
2014, Schaumberg et al. 2003, Moss et al. 2000 , Lee et al. 2002]. 
CL wear is recognized to play a role in setting up signs and symptoms of dryness [Paulsen et 
al. 2014, Tan et al. 2015]. CLD occurs in almost half of the CL wearing population [Dumbleton 
et al. 2013a]. It is considered, almost at the same level as dryness (24% and 20 % respectively) 
[Sulley et al. 2017] as the main reason for discontinuation. Discontinuation in CL wearers has 
been investigated and recent estimates give a large extent of values ranging from 12% to up 
to 43%, so that real dropout prevalence remains unclear [Weed et al.1993, Pritchard et al. 
1999, Harknett et al. 2001, Jutai et al. 2003, Richdale et al. 2007, Rumpakis 2010, Dumbleton 
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et al. 2013b]. However, a recent study from Sulley et al. gives new insights regarding age-
based CL retention rates showing that people over 45 years of age tend to discontinue more 
CL wear than the younger group (78% versus 63%); material, geometry, replacement schedule 
being additional factors influencing discontinuation [Sulley et al. 2017]. Age-related changes 
taking place in the LFU could potentially further increase dropout rates. Indeed, as it will be 
discussed in this work, CL insertion and its interaction with ocular surface induce changes in 
tear film metrics and ocular surface physiology that could trigger signs and symptoms of 
dryness or even worsen an already unbalanced state. 
Dry eye assessment preceding ocular surgery (corneal refractive surgery, cataract surgery) is 
now a widely accepted and recommended practice among practitioners [Chao et al. 2016] as 
the pre-operative ocular surface state can influence outcomes of the surgical gesture. Both 
surgical procedures are invasive but to different extents and corneal damage (cellular and 
nerve damage) induced by the incision and laser application might never recover to 
preoperative state, giving rise to abnormal ocular surface tear dynamics and eventually to the 
initiation/exacerbation of signs and symptoms of dry eye.  
The widespread use of VDTs for both professional and recreative purposes lead to eye fatigue 
and to reduced blinking frequency both potentially worsening signs and symptoms of patients 
with the disease [Ayaki et al. 2017, Uchino et al. 2013, Uchino et al. 2008]. Indeed, increased 
blinking interval leads to longer exposure time of the corneal and conjunctival epithelia more 
particularly in a region of meniscus induced thinning (corresponding to the black line seen 
with fluorescein sodium staining) where hyperosmolarity is expected to be much higher than 
in the rest of the ocular surface [Bron 2011a, Zubkov et al. 2013, McMonnies 2015]. Combined 
with limited eye movements, which occurs when performing activities requiring attention 
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such as reading a book, watching a movie on a tablet or working on a computer, more localized 
cellular damage is expected to occur inducing/exacerbating signs and symptoms of dryness. 
DED has become a public health issue worldwide as its impact on healthcare systems is 
undeniable [Stapleton et al. 2017, Brown et al. 2009, Clegg et al. 2006, Galor et al. 2012, 
Mizuno et al. 2012, Patel et al. 2011a, Uchino et al. 2014, Waduthantri et al. 2012, Yamada et 
al. 2012, Yu et al. 2011, Fiscella et al. 2008, Wlodarczyk et Fairchild 2009, Bielory et Syed 2013, 
Farrand et al. 2016]. A striking example of the economic burden of DED is emphasized by a 
multicentric study designed to assess the annual cost of DED patients management by 
ophthalmologists in Europe: for 1000 patients with the disease in Europe ranged from USD 
0.27 million in France to USD 1.10 million in United Kingdom [Clegg et al. 2006]. When it comes 
to United States, amounts reached USD 3.84 billion a year for the entire country [Yu et al. 
2011] separated as follow: USD $678, $771, and $1267 for the mild, moderate and severe 
forms of the disease respectively. These patient-related costs also affects global productivity 
as the necessity of treatment and office visits generate an estimated productivity loss of USD 
$12 686, $12 569, $18 168 for the mild, moderate and severe forms of the disease respectively 
[Yu et al. 2012]. Interestingly, Mizuno et al. calculated the direct annual cost for the year 2010 
and found that each DED patient spent USD $323±219 for drugs, USD $165±101 for 
healthcare, and USD $530±384 for punctal plug placement showing the impact of the disease 
on health expenses [Mizuno et al. 2012].  In addition to the economic cost, the social impact 
of the disease gained a foothold and showed reduced quality of life due to the major impact 
of the disease on patient’s visual function with more frequent visits to the physician, higher 
frequency of depression and reduced workplace productivity. 
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2.2 Epidemiology of aging: an economic burden 
Numerous studies have looked into the influence of aging on dry eye signs and symptoms and 
according to estimates from the Physician’s Health Studies, the Women’s Health Study, the 
Beaver dam offspring study, the Blues mountains study between others, age is a significant 
risk factor for the disease as people over 50 years old present a prevalence of dry eye 
increasing every 5 years steps with women being more affected [Schein et al. 1997, Moss et 
al. 2004, Schaumberg et al. 2003, Schaumberg et al. 2009, Schein et al. 1999, Paulsen et al. 
2014, Chia et al. 2003]. The 15% prevalence estimates in the 1997 study from Schein et al. 
[Schein et al. 1997a] does not seem to represent adequately the actual situation as this value 
is now more than 20 years old and that overall population is expected to have increased 
significantly.  
Indeed, the world population is expected to rise from 7.2 billion individuals in 2012 to 8.3-10.9 
billion by 2050 [United Nations. World Population Prospects: The 2012 Revision. June 13, 
2013]. This increase in world population is accompanied by significant aging, as recent 
estimates from the Lancet Series on Ageing expect 2 billion people over 60 years old by 2050 
[The Lancet. Series on Ageing. 2014; November 6]. According to the Report of the Inaugural 
Meeting of the TFOS [Chao et al. 2016] increased prevalence of DED with age is widely 
acknowledged.  
With the increasing aging population and according to estimates of number of people over 60 
years old (2 billion people by the year 2050) [The Lancet Series in Ageing 2014] and an 
approximate prevalence of 25% for the disease [Stapleton et al. 2017], 500 million people will 
suffer from dry eye only in this age-based population. The burden to become for the society 
is thus undeniable. 
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2.3 Hypothesis and objectives 
The aim of this project is to evaluate changes in tear film metrics and ocular signs induced by 
different types of refractive correction (corneal refractive surgery, intraocular lens 
implantation and contact lenses) focusing on the older population, since the prevalence of 
DED increases with age and due to presbyopia, most people over 45 need refractive correction 
for distance, intermediate or near vision, or all three. 
The main goals of the study are as follow: 
-Assess the impact of refractive means to correct presbyopia and their potential impact on 
ocular surface, signs and symptoms of dry eye, through two main research axis: 
1-To assess the impact of CL material and wearing schedule on tear film metrics and ocular 
surface in a presbyopic population. To reach that goal, three research studies were set up: 
- To investigate the clinical performance of a new contact lens (CL) material and 
physiological responses of tear film and ocular surface parameters in a presbyopic 
population over their first day of CL wear. 
- To investigate the clinical performance of two multifocal soft contact lens materials 
and the physiological response of tear film and ocular surface parameters in a 
presbyopic population over a month of contact lens wear. 
- To assess and compare the effect of the corneo-scleral lenses (C-ScL) and scleral lenses 
(ScL) on tear film parameters and central corneal thickness (CCT) in healthy presbyopic 
subjects. 
2- Assess the impact of ocular surgery to correct presbyopia and their potential impact on 
ocular surface, signs and symptoms of dry eye: 
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- To assess the impact of cataract surgery on tear film metrics, ocular surface and MG 
function in a presbyopic population before and after cataract surgery and IOL 
implantation. 
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3.1 General design of the studies 
To implement this manuscript and form the doctoral thesis, a wide range of measurements 
were taken regarding optometric variables in a presbyopic population equipped/implanted 
with different refractive correction options. All of the participants were presbyopic, aged 40 
or older and underwent all examination and surgery, if applicable, in the following research 
centers or clinical facilities: 
- Oftalvist Clinic (Consultation). 
- University of Valencia’s Optometry Research Group (GIO) (Consultation and CL fitting). 
 
To describe the changes in tear film metrics and ocular signs induced by different types of 
refractive correction, one literature review and four clinical studies were planned as follow:  
- Review assessing the impact of all refractive means to correct presbyopia and their 
potential impact on ocular surface, signs and symptoms of dry eye. 
- To investigate the clinical performance of a new contact lens (CL) material and 
physiological responses of tear film and ocular surface parameters in a presbyopic 
population over their first day of CL wear. 
- To investigate the clinical performance of two multifocal soft contact lens materials 
and the physiological response of tear film and ocular surface parameters in a 
presbyopic population over a month of contact lens wear. 
- To assess and compare the effect of the corneo-scleral lenses (C-ScL) and scleral lenses 
(ScL) on tear film parameters and central corneal thickness (CCT) in healthy presbyopic 
subjects. 
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- To assess the impact of cataract surgery on tear film metrics, ocular surface and 
meibomian gland function in a presbyopic population before and after cataract surgery 
and IOL implantation. 
A prospective non-randomized study design was chosen for all aforementioned manuscripts. 
The same optometrist practitioner (Edouard Lafosse) and the same Ophthalmologist 
(Francisco Pastor Pascual), who posteriorly performed the surgery, screened the patient to 
avoid bias in the results. 
This set of prospective, studies were approved by the Institutional Ethics Committee of the 
University of Valencia. Participants were explained his/her rights as a research subject and 
then signed a statement of Informed Consent for the comprehensive ophthalmic examination 
as well as for the surgery and the subsequent collection of data for further analysis. Each of 
the previous study was performed according to the tenets of the Declaration of Helsinki. 
 
Inclusion criteria were:  
- Presbyopic participant 
 
- Aged 40 or older 
- Neophyte CL wearer 
- Refractive defect between +6.00/-10.00 Spherical 
- Corneal astigmatism inferior to 1.00 D 
- Best Corrected Visual Acuity (BCVA) equal or better to 0.0 logMar 
- Willing to comply with the constraints of appointments for the monitoring of 
participants 
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Refractive data will be expressed in diopters. Spherocylindrical refractive errors will be 
converted in vectors in order to be suitable for statistical analysis. [Mico et al. 2014, Thibos et 
Horner 2001]. 
To do so, spherocylindrical refractive errors (Sphere [S], Cylinder [C], and Axis [E] will be 
converted in coordinates of the refractive vector (M, J0, J45) using the following formulas: 
 
𝑀 = 𝑆 + 𝐶/2 
 
𝐽0 = −
𝐶
2
∗ 𝐶𝑜𝑠(2𝐸) 
 
𝐽45 =  −
𝐶
2
∗ sin (2𝐸) 
 
M coordinate represents the spherical equivalent, whereas the others components, 
representing the cylindrical refractive defect, are basically two Jackson Crossed Cylinders with 
their respective axis a 00-900 (J0) and 450-1350 (J45). The components of refractive vector give 
the location of the circle of least diffusion relative to the retina (M) and about the amount of 
astigmatism with the rule (WR)/against the rule (AR) (J0) or skewed (J45). 
3.2 Tests used to evaluate symptomatology 
Nociceptors, representing the great majority of corneal sensory neurons, are stimulated by 
inflammation and cellular damage, which is further worsened by the stimulation of mechano-
nociceptors due to the increase in friction forces between eyelids and ocular surface 
[Belmonte et al. 2004]. Hyperosmolarity and cooling of the ocular surface following tear 
evaporation stimulate cold thermoreceptors inducing dryness sensation and discomfort 
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[Parra et al. 2010, Parra et al. 2014]. A comprehensive assessment of patient symptoms is 
mandatory as unpleasant dryness sensations (i.e. discomfort) are the most defining features 
of DED [DEWS 2007, Nichols et al. 1999]. Furthermore, a great number of patients present 
conflicting signs and symptoms of dry eye [Schein et al. 1997b, Begley et al. 2003, Nichols et 
al. 2004], making the diagnostic much more difficult. Most of the existing questionnaires were 
designed to identify the symptoms associated with the clinical findings and from the 
information collected, develop diagnostic tools according to them [Belmonte et al. 2017]. The 
difficulty to manage the disease is based on the discrepancy between clinical tests [Kallarackal 
et al. 2002, Moore et al. 2008] and patient-reported symptoms [Begley et al. 2003, Nichols et 
al. 2004, Mizuno et al. 2010, Sullivan et al. 2010, Fuentes-Paez et al. 2011]. When performing 
the patient case history in our everyday practice, patients self-expressed symptoms and 
sensations are difficult to quantify and standardize as no repeatable structure to the interview 
is preset [Wolffsohn et al. 2017] and the general term “discomfort” can be understood in many 
other ways making difficult addressing this aspect of the disease [Belmonte et al. 2017]. 
Besides, when translated to other languages, which was the case for the different studies 
forming part of the present thesis, words can take different meanings, which can impair the 
original purpose of the question and influence the answer [Begley et al. 2001, Uchino et al. 
2006, Abetz et al. 2011]. According to Wolffsohn et al., assessing patients symptoms in a 
repeatable fashion is a key factor for its ability to serve various purposes: assessing if the 
patient requires further examination oriented towards clinical signs of the disease, monitor 
the evolution of symptoms over time and subjectively assess the efficacy of the treatment 
[Wolffsohn et al. 2017, Begley et al. 2003, Nichols et al. 2004, Sullivan et al. 2010]. The 
following questionnaires were chosen for the different studies that will be described in the 
present thesis. 
 
 
77 
 
3.2.1 OSDI 
This questionnaire is the most commonly used for DED clinical trials [Wolffsohn et al. 2017]. 
It is a Patient Reported Outcome (PRO) questionnaire following the US Food and Drug 
Administration (FDA) requirements regarding psychometric testing .[Guidance for industry: 
patient-reported outcome measures: use in medical product development to support labeling 
claims: draft guidance, [Guillemin et al. 2012]. Originally developed by the Outcomes Research 
Group at Allergan Inc (Irvine, California) [Walt et al. 1997] the OSDI is a 12-item questionnaire 
designed to assess the frequency of symptoms of ocular irritation consistent with DED and 
their impact on vision-related functions. DED can be graded using a score attributed to each 
question. Its validity has been acknowledged in the diagnosis of DED [Özcura et al. 2007]. The 
questions asked in the questionnaire refer to the “last week period” and present subscales 
allowing for the evaluation of treatment efficacy and impact on quality of life patients with 
different DED etiologies [Chang et al. 2009, Yuksel et al. 2010, Russo et al. 2007, Stevenson et 
al. 2000]. Three different subscales compose the questionnaire: the first one (6 questions), 
focusing on ocular symptoms (blurred vision, poor vision), the second one (3 questions) 
investigating vision-related function and limitations (for several activities such as reading, 
driving at night, watching TV, working on a computer), and the last one (3 questions) aiming 
to assess environmental triggers (wind, humidity levels, air conditioning). The OSDI is scored 
on a scale from 0 to 100, with higher scores representing higher symptomology. Each of the 
12 questions can be scored based on the frequency of the symptoms from 0-4 points where 0 
denotes “none of the time” and 4 indicates “all of the time”. OSDI = [(sum of scores for all 
questions answered) × 100] / [(total number of questions answered) × 4]. Based on the score, 
patients symptoms can be classified as normal (0-12), mild DED (13-22), moderate DED (23-
32) and a score and severe (33-100). Indeed, literature proved the efficiency of this 
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questionnaire for its discriminating abilities between severity levels: normal, mild-moderate 
and severe forms of DED, highlighting the significance differences (P<0.001) in subscales and 
total scores between the aforenamed groups [Simpson et al. 2008, Schiffman et al. 2000, 
Srinivasan et al. 2008]. Furthermore, OSDI questionnaire showed concomitance with other 
validated questionnaires such as: the Symptoms Assessment in Dry Eye (SANDE) [Amparo et 
al. 2015]; the Standard Deviation of Eye Dryness (SPEED) [Asiedu et al. 2017, Finis et al. 2014]; 
the five-item Dry Eye Questionnaire (DEQ-5) [Galor et al. 2015]. 
However, one of the limitations of this questionnaire is its moderate correlation with clinical 
findings [Simpson et al. 2008, Chalmers et al. 2012]. OSDI test is attached in Annex 1. 
3.2.2 DEQ-5 
Five-Item Dry Eye Questionnaire is a shortened version of the DEQ developed by Begley et al. 
[Begley et al. 2002(3)]. It is composed of 5 questions related to the severity of eye discomfort 
visual disturbance, dryness and tearing and how visual instability impacts the participant over 
a one-month recall period [Chalmers et al. 2010, Wolffsohn et al. 2017]. DEQ-5 is scored on a 
scale going from 0-22 with higher scores representing, higher symptomology. According to a 
previous study from Chalmers et al. 2010; [Chalmers et al. 2010] a score between 6 and 11 
represents mild to moderate ocular symptoms, and values > 12 represents severe ocular 
symptoms. According to Galor et al. 2015 [Galor et al. 2015] the results obtained with this 
questionnaire are concurrent with the OSDI even if few manuscripts talk about the DEQ-5 in 
clinical practice or clinical trials. DEQ-5 is attached in Annex 2. 
3.2.3 CLDEQ-8 
CLD occurs in almost half of the CL wearing population [Dumbleton et al. 2013]. It is 
considered, almost at the same level as dryness (24% and 20 % respectively) [Sulley et al. 2017] 
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as the main reason for discontinuation. Therefore, it is logical that PRO questionnaire focused 
on this issue. CLDEQ-8 rises from a longer and older version initially called CLDEQ [Begley et 
al. 2000, Begley et al. 2001] that was designed at the same time as the longer version of the 
DEQ-5 (i.e DEQ). Its validity is based on its ability to correlate, through the 8 questions asked, 
to the overall opinion of CL wearers and to reflect CL wearers’ degree of satisfaction [Chalmers 
et al. 2012]. CLDEQ-8 is attached Annex 3. 
3.3. Techniques used for assessing tear meniscus parameters 
Tear meniscus can be defined as the accumulation of tears between the lid margin and the 
bulbar conjunctiva; it is present on both superior and inferior lids [Santodomingo-Rubido et 
al. 2006]. It is believed that tear meniscus contains up to 90% of the total volume of the TF 
[Holly 1985], which makes it a useful clinical parameter to assess TF volume and its possible 
changes over time. The importance of the TM for the studies forming part of the present thesis 
requires a global knowledge of the background of TM assessment in order to justify the 
devices that were used to measure its parameters. 
 Several parameters can be extracted and analyzed from the simple triangular shape of the 
tear meniscus and give valuable information regarding total volume of the tears. Among them, 
tear meniscus height. TMH is defined as the straight-line distance between the upper and the 
lower edges of the tear meniscus. It is one of the most used TM metrics as a wide range of 
devices allow to measure this parameter from slit lamp to optical coherence tomography. 
However, it is important to underline that a wide range of values has been found in literature 
as it will be further described, depending on the delimitation of the edges of TM: some authors 
considered the height as being the distance between the upper limit of the TM and the upper 
limit of the inferior eyelid which has been defined as “Absolute” TMH (TMH-A) [García‐Resúa, 
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et al. 2009, Mishima et al. 1966, Lamberts et al. 1979] and others as the distance between the 
upper limit of the TM and the brighter reflex of the meniscus [Port et Asaria, 1990, 
Santodomingo-Rubido et al. 2006]. Tables 7, 8, and 9 gather the main publications about this 
topic and underline the importance to know what parameter is being measured in order not 
to jeopardize results. Another TM parameter, TMR, is defined as the curved line joining the 
anterior profile/borderline of the TM. It has been demonstrated that evaluating this 
parameter is clinically accurate in diagnosis of dry eye [Mainstone et al. 1996, Bron et al. 1998, 
Shen et al. 2009, Yokoi et Komuro 2004]. TMD represents the distance between the most 
anterior part of the tear meniscus and the anterior part of the bulbar conjunctiva. TMA is 
defined as the triangular area formed by the anterior corneal boundary, anterior boundary of 
the lower eyelid and anterior borderline of the tear meniscus. [Czajkowski et al. 2012].  TMH, 
TMD, TMR, TMA parameters all refer to the tear meniscus at the center of the lower lid. We 
will see the main devices used to measure these parameters but also the correlation with each 
other and the importance to assess and follow-up these metrics in DED. 
3.3.1 Slit lamp technique with graticule  
It is possible to evaluate TMH vertically at 6-o’clock position (in other words, at the center of 
the lower lid), non-invasively using SL with a calibrated graticule inserted into the eyepiece 
[Santodomingo-Rubido et al. 2006] along with the appropriate magnification (usually 40x), 
giving TMH values between 0.12 mm and 0.35 mm in healthy subjects [Santodomingo-Rubido 
et al.2006, Miller et al. 2004, Lim et Lee 1991]. 
 The following tables summarize mean values for TMH-A and TMH-R with the graticule 
technique and emphasize the importance of specifying which definition of the TMH is used in 
clinical practice. 
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Authors Mean ± SD TMH Parameter 
[Santodomingo et al. 2006] 0.12 ± 0.05 mm TMH-R 
[Tomlinson et al. 2001] 0.35 ± 0.11 mm TMH-A 
[Jordan et Baum 1980] 0.30 ± 0.06 mm TMH-A 
[Miller et al. 2004] 0.22 ± 0.08 mm TMH-A 
[Papas and Vajdic 2000] 0.15 ± 0.04 mm TMH-R 
[Lim et Lee 1991] 0.19 ± 0.05 mm TMH-A 
[Lamberts et al.1979] 0.23 ± 0.09 mm TMH-A 
Mean ± SD TMH 0,22 ± 0,07 mm TMH 
 
Table 7. Mean TMH-R and TMH-A obtained with the SL graticule technique 
3.3.1.1 Slit lamp with image analysis software 
Another technique uses the SL beam height to measure TMH and gives a mean value of 0.32 
mm [Guillon et al. 1997]. The image capture technique uses a video system coupled to the SL 
to take a picture of the tear meniscus (the edges of the meniscus are posteriorly bounded 
manually and the value calculated using a software that converts the number of pixel to a 
physical distance). The picture is then extracted to an image analysis software allowing precise 
measurement of the TMH. More repeatable values (between 0.17 and 0.43 mm in healthy 
eyes) have been found with this technique in comparison to the other SL techniques due to: 
the absence of eye movement when making the measurement and the higher resolution of 
the image  (0,02 ± 0,05 mm p=0,01) (r=0,52, p< 0,0001) and (0,01 ± 0,03 mm, p=0,16)  (r=0,56, 
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p=0,0001) for the graticule and image capture techniques respectively [Johnson et Murphy 
2005]. Table 8 shows the Mean TMH-R and TMH-A values obtained with the image analysis 
technique and Table 9 shows the comparison between graticule and image analysis software 
systems. 
Authors Mean ± SD TMH Parameter 
[Johnson et Murphy 2005] 0.34 ± 0.05 mm TMH-A 
[Doughty et al. 2002] 0.19 ± 0.09 mm TMH-R 
[Glasson et al. 2006] 0.43 ± 0.11 mm TMH-A 
[Kwong and Cho 1998] 0.24 ± 0.07 mm TMH-A 
[Zaman et al. 1998] 0.18 ± 0.11 mm TMH-R 
[Santodomingo et al. 2006] 0.13 ± 0.04 mm TMH-R 
Mean ± SD TMH 0,24 ± 0,07mm TMH 
Table 8. Mean TMH-R and TMH-A obtained with the image analysis technique.
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Parameter TMH (Mean ± SD) 
Image analysis software system 
TMH (Mean ± SD) 
Graticule technique 
TMH-R 0,17 ± 0,07 mm 0,14 ± 0,05 mm 
TMH-A 0,34 ± 0,08 mm 0,26 ± 0,08 mm 
 
Table 9. Comparison between graticule and image analysis software systems. 
Slit lamp technique for assessing TMH presents one limitation, which is the difficult limitation 
of the TM superior edge, which gave rise to TMH-A and TMH-R distinction. However, some 
authors tried to overcome this constraint by the use of fluorescein (TMH-F) defined as the 
distance between the lower lid margin and  and the upper limit of the stained tear meniscus) 
which was proven to reduce tear film stability possibly leading to reflex lacrimation and 
overestimation of TMH values: the fluorescein volume instilled was not controlled and the 
strip potentially could induce reflex lacrimation [Mainstone et al. 1996, Johnson et Murphy 
2005, Lime et Lee 1991, Patel et al. 1985]. 
3.3.2 Other existing devices 
 An optical pachymeter can also allow the assessment of TMH giving similar results (mean 
values between 0.16 and 0.38 mm) [Johnson et Murphy 2005, Port et Asaria 1990, Jones et al. 
2002]. Eventually, TMH can also be evaluated using the Placido disc-based device corneal 
topographer (Oculus GmbH, Wetzlar, Germany). The technique is mainly the same as 
photographing with a SL but presents major advantages like for instance the infrared diodes 
used as a light source that prevent reflex tearing [Baek et al. 2015]. Reflective meniscometry 
is a non-invasive technique allowing to measure TMR; it relies on the projection of a network 
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of white and black stripes (of known dimensions) onto the meniscus at the lower lid margin. 
Using the inferior tear meniscus as a concave mirror it is possible to assess TMR after capturing 
the picture with a digital camera and exporting it to an image analysis software [Bandlitz et al. 
2014]. Reflective meniscometry presents a sensibility of 88,9% and a specificity of 77,8%  in 
measuring TMR [Yokoi et Komuro 2004] which makes it a valuable tool in the diagnosis and 
follow-up of dry eye. Furthermore this technique showed acceptable agreement with the SL 
technique (r=0,51 p = 0,001)[Ibrahim et al. 2010].  
3.3.3 Optical Coherence Tomography  
Details of the AS-OCT imaging technology have been described previously [Izatt et al. 1994, 
Radhakrishnan et al. 2001, Kiernan et al. 2010]. This non-invasive technique provides high-
resolution images (4-10µm) [Kiernan et al. 2010, Maeda 2010] of the tear meniscus. An AS-
OCT (High speed and tri-dimensional) coupled with a slit-lamp is performed in order to assess 
the tear meniscus parameters of the inferior eyelid using the B-scan mode and scanning at 6 
o´clock the upper part of the inferior eyelid vertically to the apex of the cornea. The cross-
section image obtained allow the visualization of the tear prism and can be bounded manually 
in order to assess TMA [Bitton et al. 2007, Czajkowski et al. 2012] defined as the triangular 
area formed by the anterior corneal boundary, anterior boundary of the lower eyelid and 
anterior borderline of the tear meniscus. These measurements can be realized from the 
images taken by the AS-OCT using an image software [http://imagej.nih.gov/ij/]. According to 
Czajkowski et al., anterior segment Spectral OCT presented sensitivity and specificity for dry 
eye diagnosis of 80.56% and 89.33% for TMH,86.11% and 85.33% for TMA, 77.78% and 52.7% 
for TMD respectively. Studies have shown that AS-OCT is a valuable tool for quantification of 
tear meniscus parameters and therefore this technique could be used in diagnosis and follow-
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up of dry eye patients [Ibrahim et al. 2010, Qiu et al. 2011].  
3.3.3.1 Slit lamp SL Scan-1 coupled with OCT (Topcon) (TMA) 
In the present thesis, TMA images were acquired using the SL SCAN-1 (Topcon, Japan), a 
spectral-domain OCT integrated into a slit lamp using an 840 nm super-luminescent diode and 
providing 5000 A-scans/s with an axial resolution of 8-9 µm and a lateral resolution inferior to 
20 µm. Tear meniscus cross-sectional area (TMA) of all participant was obtained manually 
using the B-scan mode and scanning at the 6 o’clock position of the cornea with a cross line 
centered on the inferior lid edge. Settings remained constant throughout the whole 
experiment for all subjects. Participants were asked to blink normally and then hold their blink 
during the acquisition of the scan. 
 Three consecutive scans were performed for each participant. Images were then exported to 
an image analysis software called image J [http://imagej.nih.gov/ij/] that allows, after manual 
delimitation of the edges of the central tear meniscus, to calculate TMA in mm2. It is 
undoubtful that the best objectivity would be achieved with a program recognizing the 
borders [Tittler et al. 2011] as manual delimitation of TMA is dependent on the examiners’ 
marking. However, Canan et al. [Canan et al. 2014] showed that TMA measurements with FD-
OCT are reproducible and reliable. 
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Figure 3.1. An illustration of the slit-lamp SL SCAN-1 (Topcon, Japan) 
3.4 Pachymetry: OCT (CCT) Visante Zeiss 
Several devices and imaging techniques have been used over the years in an attempt to 
measure corneal thickness [Garcia-Resua et al. 2012]. Optical coherence tomography is a non-
invasive high-resolution imaging technology that relies on the analysis of the interference 
between a signal coming from a structure under analysis and a reference signal [Podoleanu 
2012]. It allows for the obtention of cross-sectionnal, two-dimensional images. VisanteTM OCT 
[Carl Zeiss, Meditec, Dublin, CA, USA] is a TD-OCT which uses an optical source [infra-red light 
(1310nm)] to scan the anterior segment of the eye to construct a 2-dimensional image and an 
interferometer (Michelson interferometer) where a reference mirror and an optical splitter 
are used to produce a reference beam. The interference of light resulting from the difference 
between the reference optical source and the beam signal returned is processed to image the 
anterior segment of the eye, hence the AS-OCT.  
 
Figure 3.2. CCT obtained with VisanteTM OCT [Carl Zeiss, Meditec, Dublin, CA, USA] 
The axial resolution of the VisanteTM is 18 µm and the transverse resolution is 60 µm. Various 
studies have looked into the repeatability of the device regarding pachymetric values [Otchere 
et Sorbara 2017, Mencucci et al. 2012, Mohamed et al. 2007] and OCT VisanteTM showed good 
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repeatability and satisfactory agreement when compared with the former gold standard 
(ultra-sound pachymetry) and Scheimpflug imaging device both for normal [Sadoughi, et al. 
2015] and diseased corneas [De Sanctis et al. 2007]. The global corneal “pachymetry map” 
protocol of the Visante OCT was used to capture 8 radial scans centered on the corneal vertex 
reflection [Radhakrishnan et al. 2001]. Three consecutive scans were carried out for each eye 
by the same examiner in order to calculate mean CCT. 
3.5 Tear Osmolarity (I-Pen/TearLab) 
Osmolarity can be defined as concentration of dissolved, active particles in a solution. These 
active particles, in tears, are called electrolytes [Taskapiliet al. 2015] and are mainly 
represented by cations sodium and potassium, anions chloride and bicarbonate: major 
contributors to osmolarity [Murube 2006, Stahl et al. 2012]. Tear hyperosmolarity is, along 
with loss of tear film stability, a key stone of the pathophysiology of DED [DEWS 2007/2017]. 
Objective measurement and monitoring of osmolarity data are as such a valuable source of 
information in the diagnostic of the disease. Mathematical models have estimated osmolarity 
values at the site of tear break up to be as high as 1900mOsm/L demonstrating the importance 
to monitor TF osmolarity values [Peng et al. 2014b]. Furthermore, an increased variability in 
osmolarity values has been evidenced in patients with DED [Keech et al. 2013]. Osmolarity at 
the TM normally is well defined and ranges between 270-400mOsm/L [Sullivan et al. 2010] 
and, according to mathematical models [Gaffney et al. 2010], is recognized to be very inferior 
to the mean values found at the ocular surface.  Furthermore, in healthy subjects, osmolarity 
values taken from the lower meniscus are very stable and present a low variability [Lemp et 
al. 2011)]. Mean values of 302 ± 9.7 mOsm/L [Tomlinson et al. 2006] with an inter-eye 
variation of 6.9 ±5.9 mOsm/L [Sullivan et al. 2015] were reported at the TM [Bron et al. 2017] 
in healthy subjects. 
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Several existing devices are available on the market to measure osmolarity either by sampling 
of directly in situ. [Tomlinson et al. 2010]. The two following technologies will be briefly 
detailed, as they were not used in the present work; however, it is important to describe them 
as the devices used in the study rely on recent advances in technology and facilitate clinical 
use. 
Vapor pressure technique [Terry et Hill 1978] relies on the principle that, at the same pressure 
and temperature, the vapor pressure of a solution is lower than that of the pure solvent. The 
more particles are present in a solution, the longer it will take to evaporate. The difference 
with water’s time of evaporation gives osmolarity. It requires up to 5 µL of tears [Tiffany et al. 
1994]. Given that the total amount of tears is 7-8 µL; even if the device performs the 
measurement fastly, DED patients are expected to have less tear available which could 
possibly enable the measurement. This technique has been relegated to a second option 
[Lemp 1995] and its clinical use requires practice in order not to trigger any reflex tearing that 
could jeopardize the measurement. 
 Freezing point depression is the second technique, it presents the advantage to require only 
a reduced amount of tears (0.2µL), which is suitable for DED patients; however, this device is 
space-consuming and is more indicated for research purposes [Gilbard et al. 1978]. Water 
freezes at 0° Celsius, but water mixed with different solutes (like in the tears) will freeze at 
lower temperatures hence the name “depression”. The lower the freezing temperature, the 
higher the osmolarity values. This device can be used in DED but is subject to errors [Nelson 
et Wright 1986, Sullivan 2005] due to evaporation occurring directly from the sample; besides 
this device is space consuming and would hardly fit in an optometry practice. 
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The last technique, electrical impedance, is based on the recent advances in technology and 
allows taking measurements at the point-of-care, presenting the great advantage to be much 
more suitable than the previously described techniques for clinical practice. Electrical 
impedance relies on the electrical charges carried by the ions contained in a solution, for 
instance, the tear fluid. The higher the concentration of ions in a solution, the higher the 
osmolarity values. 
3.5.1 TearLab Osmolarity System 
Tear film osmolarity can be measured using a laboratory-on-a-chip system [TearLabTM Corp, 
San Diego, CA] in order to analyze the electrical impedance of a 50 nL tear sample from the 
infero-lateral tear meniscus. This device was commercialized in 2012 [US FDA. k083184, 
TearLab Osmolarity System. April 23, 2009] and has been the subject of numerous studies 
regarding its utility in the diagnosis, grading of severity and follow-up in DED [Farris et al. 1986, 
Versura et al. 2010, Tomlinson et al. 2010, Potvin et al. 2015]. 
 
Figure 3.3. An illustration of the TearLab osmolarity System (TearLabTM Corp, San Diego, CA) 
The pen of the device is gently lowered towards the external third of the inferior lid until the 
tip of the pen touched the inferior tear meniscus and could collect the sample. An electronic 
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check card is used every morning in order to ensure accuracy of the measurements. In order 
to diagnose mild to moderate dry eye subjects, a thresold of 308 mOsm/L is now widely 
accepted in clinical practice [Lemp et al. 2011] and was used in the following studies as a cut-
off value for DED. Readings between 308 and 325 mOsm/L are representative of mild-to-
moderate dry eye, and values above 325mOsm/L indicate the severe state of the disease 
[Foulks et al. 2009].      
3.5.2 I-Pen Osmolarity System 
The other device used in the present work to assess tear osmolarity is the i-Pen Osmolarity 
System (I-Med Pharma Inc; 2016) commercially available since 2017 [Government of Canada. 
Medical Devices Active Licence Listing #94538. I-PEN, Life Care Ltd. Available from 
https://health-products. canada.ca/mdall-limh/index-eng.jsp. Accessed May 15, 2017]. This 
device also relies on electrical impedance to assess osmolarity of the ocular tissue on the 
inferior palpebral conjunctival membrane [i-Pen Osmolarity System User Manual. I-Med 
Pharma Inc, 2016]. The pen of the device is gently lowered towards the third middle of the 
everted inferior lid until the tip of the pen touched the inferior conjunctival epithelium and 
performs the measurement. The i-Pen device presents a cut-off value for DED at 300 mOsm/L 
[i-Pen Osmolarity System User Manual. I-Med Pharma Inc, 2016]. 
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Figure 3.4. An illustration of the I-Pen Osmolarity System (I-Med Pharma Inc; 2016) 
Various studies have looked into this device’s ability to reproduce a range of normal values in 
a healthy samples [Nolfi et Caffery 2017, Rocha et al. 2017] in vitro data suggest that this 
device does not provide sufficient accuracy and precision in assessing osmolarity levels 
belonging to physiological ranges. Since it is a new device, it would be interesting to test it and 
evaluate its strengths and weaknesses. 
3.5.3 TBUT / vital staining of the cornea and conjunctiva 
Tear break up time is defined as the interval between a blink and the first occurrence of dry 
spots on the cornea [Norn 2009]. As TF impaired stability is a hallmark of DED, evaluating this 
parameter is valuable tool for diagnosis and follow-up of patients [Wolffsohn et al. 2017]. The 
present thesis focused on the assessment of TF stability using a staining dye which goal is to 
enhance visibility of TF [Wolffsohn et al. 2017], thus it will be named by the acronym FBUT 
standing for fluorescein BUT. TFOS Diagnostic and Methodology Report emphasizes that FBUT 
can be contemplated only when non-invasive techniques are not available, in other words, 
this is not the first intention test. On the other hand, it is still the most used clinical test for 
the disease in clinical practice [Cardona et al. 2011, Graham et al. 2010, Turner et al. 2005], 
and from that point of view, using this technique reflects the real conditions a practitioner is 
facing on a daily basis. Existing literature underlines the necessity of using controlled amounts 
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of fluorescein as this vital dye reduces TF stability [Mengher et al. 1985, Mooi et al. 2017] and 
could jeopardize the measurements. 
Mooi et al. advise to use a fluorescein strip (a dry sterile applicator) previously soaked with 
saline solution (and immediately shaken so as to eliminate the excess of liquid) and apply the 
edge of the strip onto the outer canthus in order to avoid ocular surface damage [Mooi et al. 
2017]. To optimize the visualization of fluorescein, we followed the recommendations from 
Peterson et al. [Peterson et al. 2006], that is, to wait between 1-3 minutes after instillation of 
the dye. Besides, the choice of an appropriate yellow filter, apart from the blue filter, is of 
great importance in the enhancement of fluorescence [Wolffsohn et al. 2017], in our case, a 
Wratten 12 short-wavelength barrier filter was used. Patient is asked to blink three times and 
then to hold blinking until instructed [Johnson et Murphy 2007]. Vitali et al. found a sensitivity 
and specificity of 72.2% and 61.6% respectively for a cut-off value < 10 s [Vitali et al. 1994]. 
Even if this parameter is assessed subjectively, a standardized procedure as described above, 
performed by the same examiner should ensure minimal variability and give reproducible 
results [Mooi et al. 2017]. A stopwatch was used to measure the interval between the last 
complete blink and the first appearance of a dry spot on ocular surface. The median of 3 
consecutive measurements of the FBUT was calculated and presented as the final value for 
this parameter. Due to its invasiveness, this test was always performed after tear osmolarity 
measurement. 
Vital staining of the cornea and conjunctiva was performed according to Efron’s grading scale 
using fluorescein. EFRON grading scale for CL complications is attached Annex 4. Staining of 
ocular surface in a punctate pattern is not a specific feature of DED as many ocular conditions 
can induce those [Wolffsohn et al. 2017]; however, the distribution and location of the dye 
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uptake gives valuable information regarding its etiology [Bron et al. 2015]. Staining occurs 
whenever TJs are disrupted or glycocalyx is defective [Bron et al.2015] which basically 
represents local rupture of trans-cellular (mucins) and para-cellular (TJs) epithelial barrier.  
This happens in physiological conditions, as epithelial cell turnover implies desquamation and 
shedding, which allows fluorescein uptake in the paracelular space. Thus, it is easily 
understandable to discard fluorescein uptake due to this renewing process. In DED, the 
pattern of staining is characteristic and distributed over the inter-palpebral area horizontally 
[Bron et al. 2017] and usually described as the “3 hours-9 hours syndrome”. The TFOS II 
Diagnostic Methodology Report advise to use a solution of 2% fluorescein and 1% lissamine 
green increasing the likelihood of cellular damage observation as lissamine green dye 
produces staining only if the cell membrane is damaged irrespective of the presence of mucin 
[Bron et al. 2017]. In the present study, only fluorescein was used for corneal and conjunctival 
staining using a proper yellow filter (Wratten short-wavelength barrier filter) properly shaking 
the excess of saline solution (on a 1 mm strip and using a dry sterile applicator) on the 
fluorescein strip and having a single investigator applicating the strip onto the inferior 
conjuntiva  steps that should ensures minimal variability and give reproducible results and 
good visibility of any, if present, conjunctival and/or corneal damage [Mooi et al. 2017]. 
3.6 Biometer (IOL Master 700): CCT 
Various biometers are now available on the market [Holzer et al. 2009, Buckhurst et al. 2009, 
Hoffer et al. 2010, Goebels et al. 2015] and optical non-contact devices are now considered 
the gold standard for anterior segment measurements, supplanting the aging immersion 
ultrasound biometry in accuracy [Montés-Micó et al. 2011] and reproducibility [Findl et al. 
2001, Goel et al. 2004], device that required contact with the patient’s eye possibly source of 
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discomfort, and could lead to corneal complications [Haigis et al. 2000] and jeopardize further 
testing like in our case, TF metrics. 
 Accurate biometric measurements are essential in many areas of clinical practice such as 
ocular parameters follow-up for progressing ametropias, pre-operative assessment of 
patients undergoing cataract surgery (as visual outcomes rely on the precision of the 
measurements) and for the assessment of potential candidates for refractive surgery. The IOL 
Master 700 is one of the numerous optical laser systems for ocular biometry measurements 
available on the market. It uses a swept-source optical coherence tomography (SS-OCT) 
technology [Grulkowski et al. 2013] to obtain optical cross-sections (B-scans) necessary to 
provide biometric data of the eye. It enables measurements up to 44 mm in scan depth with 
22µm resolution in tissue [Kunert et al. 2016]. Unlike its previous version (i.e IOL Master 500), 
this new device provides, in addition to : Axial length, anterior chamber depth, horizontal 
white to white corneal diameter, and keratometry, the central corneal thickness (CCT) and 
crystalline lens thickness (LT) [Kunert et al. 2016]. 
 
 
 
 
Figure 3.5. An illustration of the Biometer IOL Master 700 (Carl Zeiss Meditec, Jena, Germany) 
To achieve measurements of CCT, the device uses an infrared light source varying from 
1050nm to 1095 nm [Grulkowski et al. 2013]. This device showed good repeatability and 
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consistency of CCT measurement and provided the higher ICC with the lowest difference 
between each measurement when compared to similar devices [Kiraly et al. 2017]. 
3.7 Aberrometry (Atlas 9000) 
TF stability is a keystone for the maintenance of the optical quality of the eye [Rieger 1992] as 
drying of the TF has a major impact on the quality of the optical system of the eye, increasing 
wavefront aberrations [Montés-Micó et al. 2004]. TF rupture at the break-up site induces 
variations in its thickness and above all in its curvature and resulting power, giving rise to High 
Order Aberrations (HoAs) [Montés-Mico et al. 2010]. Several studies have looked into the 
impact of DED on HoAs after blinking and found that changes in optical aberrations after break 
up contribute to reduce retinal image quality affecting visual function [Koh et al. 2008, 
Denoyer et al. 2012, Habay et al. 2014].  Among the HOAs, two individual ones stand out in 
DED patients: spherical- and coma-like aberrations are greater by a factor of about 2.5 
compared with healthy subjects [Montés-Micó et al. 2010, Montés-Micó et al. 2005, Montés-
Micó et al. 2004, Koh et al. 2008]. 
 
 
 
 
 
 
Figure 3.6. An illustration of the Atlas 9000 [software v3.0.0.39; Carl Zeiss Meditec, Jena, Germany] 
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The corneal front surface wavefront aberrations, derived from the Placido-based corneal 
topographer Atlas 9000 [software v3.0.0.39; Carl Zeiss Meditec, Jena, Germany] over a 6 mm 
central zone, was assessed with a non-dilated pupil for a pupil size of 4.5 mm and repeated 
three times between 3-6 seconds after blink in order to minimize the effect of lens movements 
and tear film stability on the measurements [Montes-Mico et al. 2004a, Montés-Micó et al. 
2004b]. 
 The choice not to control pupil diameter was deliberate, as studies of the thesis evaluating 
this parameter intended to assess the effect of the multifocal CL material in normal conditions 
of illumination, under the condition patients are usually assessed.  Since the device used to 
quantify aberrometry is a Placido disk-based topographer, it uses the first Purkinje image, 
which is formed on the PLTF, to calculate topographic and aberrometric values. Image capture 
was timed for the same time post blink for each subject, as it has been found that TF stability 
is achieved approximately 6 seconds after blink, and overall aberrations tend to rise about 10 
seconds after blink [Montés-Mico et al. 2004a]. 
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CHAPTER 4 
RESPONSE OF THE AGING EYE TO FIRST DAY OF 
MODERN CONTACT LENS WEAR 
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4.1 Introduction   
 
CL fitting aims to provide good on-eye material stability, adequate vision for the required 
tasks, and comfort, all three ideally maintained throughout the period of wear. These are the 
main goals a practitioner intends to reach when fitting a new customer. This cannot be truer 
with young presbyopes, a growing population approaching a decisive turning point regarding 
their visual abilities, the progressive loss of focus coming hand to hand with a higher 
prevalence of age-related changes possibly leading to signs and symptoms of dry eye. This 
age-based population is highly demanding regarding the preservation of their quality of vision, 
willing to be spectacle independent maintaining high visual demands; and the more the visual 
loss advances, the more complex it is to provide statisfactory quality of vision at all distances 
[Pérez-Prados et al. 2016, Madrid-Costa et al. 2012]. CLs creating simultaneous images provide 
a good compromise for this age-based population expectations as these optical designs allow 
to achieve a corrected vision at all distances, avoiding monovision and its associated loss of 
stereopsis or the use of additional reading glasses [Pérez-Prados et al. 2016, Madrid-Costa et 
al. 2012]. The low use of CL designs to correct presbyopia was explained at the time by Morgan 
et al. by a lack of clinical knowledge from the practicioner and supported by a false idea that 
visual compromises inherent to their design are too great to achieve a good vision. 
Interestingly, a recent survey from Rueff et Bailey [Rueff et Bailey 2017] demonstrates the 
importance of considering the presbyopic population for CL fitting as it is acknowledged that 
presbyopic CL modalities are still under-prescribed worldwide [Morgan et al. 2011, Woods et 
al. 2007]. Furthermore, the advent of new technologies, materials and designs allowed 
enhanced CL comfort and quality of vision and were the presumed basis of the CL fitting 
increases during these last few years [Efron et al. 2015, Jones et al. 2016]. However, CL 
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discomfort is still identified as the primary reason for CL discontinuation [Glasson et al. 2006, 
Pritchard et al. 1999, Dumbleton et al. 2013a, Richdale et al. 2007]. CL material (silicone 
hydrogel [Sulley et al. 2017], parameters (lower sphere power [Pritchard et al. 1999] and 
wearing schedule (daily disposable [Sulley et al. 2017] have been reported as the main aspects 
associated with CL dropouts [Sulley et al. 2017].  
According to a recent survey [Sulley et al. 2017], increased age is the main factor impacting 
retention rate, with multifocal CL fittings presenting the lowest continuation of use (57%) in 
comparison with other CL designs for the same age range population; poor achieved vision 
was identified as a key factor in multifocal CL wearers that stopped wearing CLs. Besides, Patel 
et al. suggest that the presbyopic population might be more susceptible to dryness-related 
comfort problems [Patel et al. 2000], mainly due to decreased TF stability, eventually leading 
to CL discomfort and dropout.  
The purpose of this study was to assess the performance of a new daily disposable CL material 
on the ocular surface of a presbyopic population. To the best of our knowledge, this is the first 
study reporting the clinical outcomes of a water gradient daily CL material in a presbyopic 
population over their first day of CL wear. To achieve that goal, TF and ocular surface 
parameters were investigated at time intervals during a day of CL wear.    
4.2 Methods 
Forty subjects, neophyte CL wearers, were recruited. This prospective, non-randomized study 
was approved by the Institutional Ethics Committee of the University of Valencia. Informed 
consent was obtained for all subjects enrolled in the study. The clinical study adhered to the 
tenets of the Declaration of Helsinki.      
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Each of the subjects underwent a comprehensive ophthalmic examination as previously 
described in the methodology chapter, which included (in the following sequence): visual 
acuity, monocular and binocular refraction, anterior segment slit lamp biomicroscopy, 
osmolarity, measurement of the inferior TMA, topographic examination and TBUT assessment 
using fluorescein.   
The room temperature was controlled and maintained between 20 and 25 degrees Celsius; 
the room humidity was maintained between 35 to 40%. The same investigator carried out all 
measurements and subsequent data analysis. Inclusion criteria were spherical equivalent 
refractive error between +6.00 to -10.00D, astigmatism ≤0.75D, monocular corrected distance 
visual acuity of 0.0 logMAR or better and normal binocularity. Patients who experienced any 
anterior segment pathology, previous corneal surgery, corneal abnormalities, self-reported 
DED or any general health condition were excluded from the study. Each subject underwent 
a comprehensive SL exam looking for any signs of inflammation of the anterior segment; 
cornea was assessed with different magnifications, using parallelepipedic and optical sections. 
CL fit quality was assessed according to Wolffsohn et al. critical fitting characteristics:  
centration, coverage, horizontal lag, movement on blink in up-gaze and push-up recovery 
speed [Wolffsohn et al.2009]. Tear osmolarity measurement was performed using the TearLab 
osmolarity system by collecting a minimal tear simple from the inferior lid tear meniscus (at 
the outer canthus). 
Inferior TMA 
Details of the AS-OCT imaging technology have been described previously [Izatt et al. 1994, 
Radhakrishnan et al. 2001]. The SL SCAN-1 is a spectral-domain OCT integrated into a slit lamp 
which details have been specified in the methodology. This device allows images of the inferior 
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tear meniscus to be obtained using the B-scan mode by scanning at the 6 o’clock ocular 
position with a cross line centered on the inferior lid edge. Measurements of the inferior TMA, 
defined as the triangular area formed by the anterior corneal boundary, anterior boundary of 
the lower eyelid and anterior borderline of the tear meniscus, were performed manually using 
image analysis software imageJ (http://imagej.nih.gov/ij/). In order to perform the 
measurement of this tear meniscus parameter, images acquired with the OCT were exported 
to an image analysis software. After determination of the number of pixels contained from 
one side of the image to another (each scan performed was 2 mm wide), and knowing the 
actual value of one pixel (by imaging an object of a known size with the same OCT settings), it 
was possible to calculate distances between the three points of the triangle formed by the 
tear meniscus and by extension to assess it surface. The previous explainations are illustrated 
in Figure 4.1. 
 
 
 
Figure 4.1. Images obtained with SL SCAN-1 (Topcon, Japan) Manual delimitation of TM edges using 
ImageJ Software (naked eye) 
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Aberrations Analysis     
The corneal front surface wavefront aberrations derived from the Placido-based corneal 
topographer Atlas 9000 over a 6 mm central zone was assessed with a non-dilated pupil and 
repeated three times between 4-6 seconds after a blink [Montés-Micó et al. 2004a, Montés-
Micó et al. 2004b]. Image capture was timed for the same time post blink for each subject, as 
it has been found that TF stability is achieved approximately 6 seconds after a blink, and 
overall aberrations tend to rise for about 10 seconds after a blink [Montés-Micó et al. 2004a]. 
Evaluating this parameter across a  8 hours period allowed information to be obtained about 
PLTF behavior on the CL material surface. 
TBUT and Corneal-Conjunctival Staining Score     
TBUT was measured subjectively with a slit lamp (equipped with a blue illumination filter and 
a yellow observation filter) by inserting into the lower fornix a fluorescein strip moistened 
with one drop of a nonpreserved saline solution. The strip was shaken in order to get rid of 
the saline solution in excess that could potentially jeopardize the measurement [Wolffsohn et 
al. 2017]. Patient was asked to blink three times and look forward during the procedure. The 
average of three consecutive TBUT measurements was then calculated. Corneal staining was 
evaluated after TBUT under blue illumination, between 1 and 3 minutes after fluorescein 
instillation. Corneal and conjunctival subjective assessment followed the grading scheme from 
Efron’s scale (grades from 0-4 in 0.5 unit steps) observed with 16x slit lamp magnification.      
Eligible patients (based on inclusion and exclusion criteria) were fitted binocularly with 
multifocal CLs (delefilcon A, Dailies Total1® Multifocal) in randomised sequence. CL material 
characteristics, according to manufacturer’s data is displayed table 10. All baseline measures 
were repeated at 20 minutes and 8 hours after CL insertion.   
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Unites States Adopted Names 
Council (USAN) 
Delefilcon A 
Company Alcon 
Polymer type Silicone Hydrogel 
FDA group I 
Equilibrium water content (%) Core 33% 
Periphery above 80% 
Dk/t ([cm2 s-1][mL O2/(mL × 
mmHg)] × 10−11) 
159 @ -3.00D at a central 
thickness of 0.09 mm 
Base Curve (mm) 14.1 
Diameter (mm) 8.5 
 
Table 10. Delefilcon A characteristics (Manufacturer’s data) 
Statistical Analysis     
Statistical analysis was performed using the Statistical Package for Social Science software 
[Version17.0, SPSS, Inc., Chicago, IL, USA]. Only right eye data was analyzed to avoid bias due 
to the similarities between the eyes of an individual. Friedman’s nonparametric statistical test 
was used to detect differences over time of TMA, osmolarity and aberrations as they were not 
normally distributed (Kolmogorov-Smirnov). The Sign test was used to compare related 
intergroups for ordinal parameters (conjunctival and corneal staining), whereas a related 
samples average t test was used in the intergroup parameters with normal distribution (TBUT). 
Differences were considered statistically significant at p ≤ 0.05.             
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4.3 Results    
The average age of the participants was 50.0±4.4 years, ranging between 41 and 60 years old. 
Mean spherical equivalent refractive error was +1.11±0.35 D and ranged from -4.25 to +2.50 
D. From the 40 eyes included, 18 were myopic (mean spherical equivalent error -2.80±0.72D) 
and 22 hypermetropic (+0.90±0.24D). Mean values and standard deviations of the parameters 
assessed at each visit over the day are presented in Table 11. 
  
   Baseline (t0) At 20 minutes (t1) At 8 hours (t2) P value 
Aberrations (µm)  0.38 ± 0.21 0.61 ± 0.04 0.64 ± 0.41 (t0)/ (t1) P< 0.01 
(t0)/(t2)  P< 0.01 
(t1)/(t2)  P=0.71 
Osmolarity 
(mOsm/L)  
306.9 ± 2.3 312.4 ± 2.4 310.4 ± 2.3 (t0)/ (t1) P=0.02 
(t0)/(t2)  P=0.09 
(t1)/(t2)  P=0.71 
TMA (mm2)  0.020 ± 0.003 0.019 ± 0.002 0.017 ± 0.003 P=0.061 
TBUT (s)  10.4 ± 0.4 - 9.0 ± 0.3 P <0.01 
 
Table 11. Comparison of the objective measurements of the non-previous CL wearers at the initial visit (t0), 20 
minutes (t1) and 8 hours (t2) after CL insertion (mean ± SD). TMA: tear meniscus area; TBUT: tear break-up time. 
 
Osmolarity showed significant changes between baseline (306.9±2.3 mOsm/L) and 20 minutes 
(312.4±2.4 mOsm/L) (P=0.02) (Figure 1). No statistically significant changes were found 
between baseline (306.9±2.3 mOsm/L) and 8 hours (310.4±2.3 mOsm/L) (P=0.09). TMA values 
diminished across the day (from 0.020±0.003 mm2 to 0.017±0.03 mm2) (P=0.061) but was not 
statistically significant.   
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Figure 4.2. Box-plot of osmolarity at baseline, 20 minutes and 8 hours of Cl wear. Medians are represented for 
each plot; quartiles are shown as boxes, ranges as whiskers and outliers as dots. 
               
Figure 4.3. Box-plot of TMA values at baseline, 20 minutes and 8 hours of Cl wear. Medians are represented for 
each plot; quartiles are shown as boxes, renges as whiskers and outliers as dots. 
Figure 4.3 displays aberrometric RMS data before CL adaptation at 20 minutes and 8 hours 
after CL insertion. Ocular surface higher order RMS aberrations showed a statistically 
significant increase between baseline (0.38±0.21 µm) and 20 minutes (0.61±0.44 µm) 
(P≤0.001) and between baseline and 8 hours (0.64±0.41 µm) (P≤0.001). 
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Figure 4.4. Box-plot of osmolarity at baseline, 20 minutes and 8 hours of Cl wear. Medians are 
represented for each plot; quartiles are shown as boxes, ranges as whiskers and outliers as dots. 
No statistically significant changes were found between 20 minutes (0.61±0.44 µm) and 8 
hours (0.64±0.41 µm) (P=0.711). TBUT worsened by the end of the day from 10.4±0.4 seconds 
at baseline to 9.0±0.3 seconds after 8 hours of CL wear (P<0.05) (Figure 4). No statistically 
significant differences were found between the measurements at baseline, and after 8 hours 
of CL wear regarding fluorescein corneal (P=0.727) and conjunctival staining (P=0.092).   
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Figure 4.5. Box-plot of FBUT at baseline, 20 minutes and 8 hours of Cl wear. Medians are represented 
for each plot; quartiles are shown as boxes, ranges as whiskers and outliers as dots. 
4.4 Discussion    
A healthy tear film is a key factor in order to maintain a functional and efficient ocular surface. 
Ocular dryness and discomfort represent the main complaints in CL wearers [Pritchard et al. 
1999, Dumbleton et al. 2013, Richdale et al. 2007, Young et al. 2002]; CL discomfort (CLD) 
(24%) and dryness (20%) being the primary reasons for discontinuation [Pritchard et al. 1999, 
Dumbleton et al. 2013, Sulley et al. 2017]. According to Dumbleton et al., “discomfort” is the 
most frequently cited reason for CL dropout [Dumbleton et al. 2013], but its precise meaning 
to the individuals is more complex to assess. Indeed, the terms dry eye and CL discomfort 
closely interlace, since a patient that presents signs and symptoms of dry eye has more 
propensity to have CL discomfort when fitted with CLs [Begley et al. 2001].      
 Tear hyperosmolarity is a key mechanism of ocular surface inflammation leading to dry eye 
clinical features [Suzuki et al. 2010, Sullivan et al. 2010]. Environment, CL materials and 
parameters, and TF factors such as stability have been described as triggers for the rise of 
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osmolarity [Nichols et Sinnott 2006, González-Méijome et al. 2009, Gilbard et al. 1986]. TF 
stability is altered by CL wear regardless of the lens type as CLs induce changes in TF structure, 
creating a PLTF and a postlens TF, that is, new interfaces within the ocular environment 
[Glasson et al. 2006]. PLTF is mainly responsible for the hydration and wettability of the CL 
front surface, facilitating the interaction with palpebral conjunctiva, by reducing friction forces 
and hence providing a smooth optical surface [Koh et al. 2016, Nichols et King-Smith 2003]. 
PLTF instability can be found in hydrogel high water content and thin CLs, leading to a rise of 
osmolarity, since it has been suggested that this type of lens can dehydrate easily partly due 
to its elevated water content [González-Méijome et al. 2009, Ramamoorthy et al. 2010].    
Previous studies demonstrated that refractive index (RI) of a CL material and its water content 
are closely related, showing the interest of evaluating RI to assess lens water content [Brennan 
1983]. Delefilcon A provides a water gradient and a surface water content corresponding to a 
high-water content hydrogel material, and as such, it may be expected to induce a rise in 
osmolarity values when fitted, due to partial dehydration of the outermost part of the CL 
material. This hypothesis seems robust since in Schafer et al. study, an index change was found 
to occur on the CL surface after 15 minutes of lens wear, shifting from a high-water content 
RI to a level compatible with a low water content material RI [Schafer et al. 2015]. However 
[Szczesna-Iskander et al. 2014] found that this water gradient material provided a better end 
of the day TFSQ than a high-water content hydrogel material. This finding implies that the rate 
of superficial dehydration of this material is lower than other CLs [Szczesna-Iskander et al. 
2014].     
Previous studies of existing, largely young, CL wearers reported significant rises in tear 
osmolarity in CL wearers during the time of use [Farris 1985, Iskeleli et al. 2002, Sarac et al. 
 
 
110 
 
2012]. Iskeleli et al. found that monthly hydrogel soft CLs induced a raise in osmolarity values 
between 1-2 hours after insertion [Iskeleli et al. 2002]. Sarac et al. evaluated osmolarity with 
daily wear silicone-hydrogel CLs over the course of a day and found a rise in tear osmolarity 
after 4 hours of CL wear, followed by an insignificant reduction in osmolarity values at the end 
of the day [Sarac et al. 2012]. These results are in agreement with the present study. Indeed, 
statistically significant differences have been found between baseline and 20 minutes showing 
that an increase in osmolarity values occurs even sooner than evaluated before; while over 
the course of the day a reduction in tear osmolarity values could be observed, although not 
statistically significant, but consistent with the findings of Sarac and al [Sarac et al. 2012].     
According to Nichols et al. the on-eye CL sits in and not on the TF [Nichols et King-Smith 2003]; 
CLs are many times thicker than the TF so its insertion is expected to induce perturbation to 
the ocular surface as noted earlier [Mann et Tighe 2013]. Furthermore, CL interaction with the 
eyelid and cornea can modify tear composition and electrolytes levels, as shown by Tighe 
[Tighe 2013]. The hypothesis explored in the present study was that CL initially disturbs the 
newly formed PLTF (by inducing reflex tearing), leading to decreased TF stability and increased 
evaporation, resulting in elevated tear osmolarity values at 20 minutes. Besides, it is 
speculated that increases in osmolarity at 20 minutes might also be partly due to both an 
ocular surface response to CL insertion, and an individual tear interaction with the CL material.     
 At the end of the day (i.e after 8 hours of CL wear), osmolarity values were lower than those 
obtained at 20 minutes, but did not reach the baseline level. Furthermore, both values 
obtained at 20 minutes and after 8 hours of CL wear were higher than the cut-off value of 
308mOsm/L, which, according to Foulks, can be considered as a mild form of dry eye [Foulks 
et al. 2009].      
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It is important to emphasize that no significant changes were found regarding corneal or 
conjunctival staining by the end of the day, which means that even if osmolarity was above 
cut-off values, it was not clinically significant with short term wear since there was no 
significant cellular damage. Osmolarity values did not change over the time of wear, which 
may imply that CL surface properties remain rather stable during the 8 hours of CL wear and 
provide enough oxygen transmission and lubrication to the ocular surface in order not to 
induce any additional staining. However, if the osmolarity changes occur in a similar pattern 
over longer-term wear, corneal integrity could well be compromised.       
It is known that tear hyperosmolarity induces epithelial cell hyperosomolarity [Baudouin et al. 
2016, Baudouin et al. 2013, Li et al. 2004, Luo et al. 2007], leading to intracelular activation 
involving MAP Kinase and NFĸB pathways and therefore liberation of pro-inflammatory 
cytokines, which eventually induce epithelial cell apoptosis [Downie et Keller 2015, Li et al. 
2004, Luo et al. 2007]. Further investigation is needed in order to assess the rise in osmolarity 
values from baseline and the duration of this elevation that could trigger an inflammatory 
response from the ocular surface, leading to cellular apoptosis and the corresponding positive 
vital dye staining.     
Tear meniscus can be defined as the accumulation of tears between the lid margin and the 
bulbar conjunctiva; it is present on both superior and inferior eyelids [Holly 1985, Garcia-
Lázaro et al. 2012]. It is believed that tear meniscus contains 75%-90% of the total volume of 
the TF [Holly 1985], which makes it a useful clinical parameter to assess TF volume and its 
possible changes over time. AS-OCT is a useful device for in vivo non-invasive quantification 
of tear meniscus parameters, with [Garcia-Lázaro et al. 2012, Del Águila-Carrasco et al. 2015] 
or without CLs [Wang et al. 2006, Chen et al. 2009]. Czajkowski et al. showed that AS-OCT 
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presents sensitivity and specificity for dry eye diagnosis (prior to the standardisation of TFOS 
DEWS II) of 86.1% and 85.3% for TMA and a strong positive correlation to tear meniscus height 
(r=0.763, p<0.0001), making this device a valuable tool for diagnosis and follow-up of patients 
with dry eye disease [Czajkowski et al. 2012].    
 In the present study, TMA values did not show significant changes across the day. It suggests 
that short-term CL wear may have limited impact on tear volume in a non-dry eye presbyopic 
population, which is in agreement with Wang et al. work on the influence of CL wear on upper 
and lower meniscus in a normal young adult population [Wang et al. 2009]. Chen et al. 
evaluated CL wearers with self-reported dryness, asymptomatic wearers and asymptomatic 
non lens wearers [Chen et al. 2009]. No significant statistical changes were found between 
baseline and after 30 minutes for the asymptomatic wearers, which is in agreement with the 
results obtained in this study. According to our results, it seems very likely that CL insertion 
induces reflex lacrimation responsible for an immediate increase of tear volume and 
decreased TF stability, but it tends to return back to normal values by 20 minutes after CL lens 
insertion. PLTF quality mainly relies on surface wettability and the water content of CL 
materials [Tonge et al. 2001, Jones et al. 2002b]. 
 In this study, no difference was found at the end of the day in comparison to baseline, even 
if TMA diminished over the day, which suggests that PLTF surface quality remained stable over 
time. Higher-order aberrations are believed to contribute up to seven percent of retinal image 
quality [Porter et al. 2001, Guirao et al. 2002]. The main difference between a perfect 
wavefront and the one displayed by the human eye mainly is due to higher order aberrations, 
more precisely third order coma-like and fourth-order spherical aberrations [Charman 2005, 
Thibos et al. 2002a, Thibos et al. 2002b]. It is known that the effect of coma and spherical 
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aberrations is pupil dependent, the greater the pupil size, the greater the aberrations and the 
depreciation of the final retinal image [Patel et al. 2002].      
In this study, the CL geometric characteristics were a front and back surface aspheric center-
near multifocal design, which is expected to induce a certain amount of spherical aberration 
[Peyre et al. 2005]. Moreover, decentration of a CL on the eye due to eye movement or to the 
lag in the replacement of the CL after blink are expected to induce coma-like aberrations 
proportional to the amount of decentration from the visual axis [Patel et al. 2002, Kollbaum 
et al. 2011, Gatinel 2003]. For these reasons it was decided to only assess ocular surface high 
order RMS of coma-like and spherical aberration in this study. Data were converted into RMS 
values for spherical aberrations and coma combined [Patel et al. 2002, Gatinel 2003] in order 
to follow-up changes of the total RMS over time and to assess the influence of the CL insertion 
over this parameter.      
A statistical significant increase in ocular surface higher order RMS was found between 
baseline and 20 minutes, i.e from the CL insertion. In the majority of participants, the set of 
ocular surface higher order RMS increased 20 minutes after CL insertion, but remained stable 
over the day; no significant difference was found between 20 minutes and 8 hours of CL wear. 
This could be explained by the behaviour of the lens on the eye, remaining stable throughout 
the day, and the time the lens took to centre after a blink, which was approximately the same 
at 20 minutes and 8 hours, thus obtaining similar aberrations values for all participants.      
Tear quality, stability and dynamics play a key role in optical performance of CLs [Montés-Micó 
et al. 2004a, Erdélyi 2006, Zhu et al. 2007]. Indeed, local variation of PLTF thickness influences 
the amount of ocular aberrations being measured [Rae et Price 2009]. DED, according to its 
severity, is also known to induce a significant rise in aberrations, so the fact that corneal high 
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order RMS remained rather stable during the day may imply that the pre-lens TFSQ and 
dynamics were minimally impacted over the course of the day. TBUT is one of the clinical 
methods used to assess compromised tear film stability [Pflugfelder et al. 1998]. In the present 
study, a significant decrease in TBUT was found between baseline and 8 hours of wear. This 
decrease in TF stability was an expected outcome, since TF structure is altered by CL (increased 
evaporation and perturbation in TF spreading) [Glasson et al. 2006, Pritchard et al. 1999, 
Dumbleton et al. 2013, Richdale et al. 2007]. Since measurement was carried out just after CL 
removal, it was expected that complete recovery of the TF would not yet have been achieved 
at that moment. So, even if a statistical decrease in TBUT was evidenced, it is unlikely to have 
any clinical significance. Fluorescein dye is not the first option to assess TF stability (since its 
efficiency relies on a controlled amount of fluorescein instilled and on the practitioner’s 
experience to detect the first dry spot on corneal surface), as objective, non-invasive methods 
are now available [Wolffsohn et al. 2017]. The topographer used in the current study was the 
Atlas 9000, which although it utilises a Placido disc, does not include in the software an 
automatic delimitation of the BUT. Instead the TFOS DEWS II standardized methodology for 
use of fluorescein to assess subjectively tear film stability was adopted [Wolffsohn et al. 2017] 
using a single investigator applicating the strip onto the inferior conjunctiva to ensure minimal 
variability and give reproducible results. The subjective assessment of TBUT and vital staining, 
as discussed before, could be limitations of the study along with the time between visits that 
was not masked to the investigator and could have influenced the results. Duration of wear 
might be another limitation of the current study as previous works reported a longer average 
time of wear with up to 25% of the patients wearing their lenses up to 16 hours [Riley et al. 
2006, Long et McNally 2006]. The duration evaluated in this study is more in agreement with 
a recreational wear including hobbies or social activities [Riley et al 2005, Wolffsohn et al. 
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2015], which gives valuable information, but does not represent a typical day for usual CL 
wearers.      
 
4.5 Conclusions 
This study reports the clinical performance of a water gradient daily disposable soft CL on the 
ocular surface and the TF in a neophyte presbyopic population over their first 8 hours of wear. 
CL insertion induces an initial decrease in TF stability observed by osmolarity values rising after 
20 minutes of wear, but it did not impact tear meniscus metrics and seemed to be transitory, 
as a decrease, without reaching baseline values, occurred by the end of the wearing period. 
Ocular surface aberrations remained largely stable from CL insertion, demonstrating an even 
repartition of TF over the CL material surface.    
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CHAPTER 5 
 CLINICAL PERFORMANCE OF TWO SILICONE 
HYDROGEL MULTIFOCAL MATERIALS ACROSS A 
MONTH OF WEAR IN A PRESBYOPIC POPULATION 
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5.1 Introduction 
Optical devices to correct presbyopia such as multifocal designs in soft CL materials have 
boomed over the last decades mainly due to increased demand of visual solutions for this age-
based population [Pérez‐Prados et al. 2016]. These designs provide at least two refractive 
zones with different powers in order to create simultaneous images: distance and near powers 
are positioned within the pupillary area at the same time. The wearer is expected to receive 
superimposed multiple images on the retina and their neural processing select the clearest 
one for a given task. Several modalities of wear are now available in soft CLs, daily and monthly 
disposable being the most popular [Morgan et al. 2011]. Practitioners tend to favor daily 
disposable wear as no cleaning or storing is necessary and above all, it avoids the use of 
chemicals. New CL materials constantly appear on the market aiming to provide more and 
more ease of wear and biocompatibility with the ocular surface in order to improve signs and 
symptoms of dryness and discomfort. 
However, CL material interaction with TF and ocular surface is wearer-dependent and could 
be further influenced by the age-related changes taking place in the LFU, the geometry of the 
lens and modalities of wear. CL interaction with tear variables (lipid layer integrity, tear film 
stability and tear volume among others) is a key factor on which relies the success of the fit 
and the end-of-day comfort. The 2013 report of the TFOS International Workshop on Contact 
Lens Discomfort [TFOS CLDW] defined CLD as “a condition characterized by episodic or 
persistent adverse ocular sensations related to lens wear, either with or without visual 
disturbance, resulting from reduced compatibility between the contact lens and the ocular 
environment, which can lead to decreased wearing time and discontinuation of contact lens 
wear” [Nichols et al. 2013].  As specified in the introduction of this thesis, discomfort is one of 
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the main factors of CL discontinuation [Dumbleton et al. 2013, Richdale et al. 2007]. Thus, 
identifying the factors influencing comfort and understanding the underlying mechanisms is a 
crucial step towards improving CL material characteristics. 
The purpose of this study was to assess the effect of lens wearing modality on the ocular 
surface physiology across a month in a presbyopic population. To the best of our knowledge, 
this is the first study to look into the effect of lens wearing modality on the ocular surface 
physiology in presbyopic subjects. To achieve that goal, TF, ocular surface parameters and 
symptoms were investigated along a typical month of CL wear. 
 
5.2 Methods 
A total of forty eyes of 40 subjects, no previous CL wearers, aged between 41 and 60 years 
old, were included in this study. Only right eye data was analyzed to avoid bias due to the 
similarities between the eyes of an individual [Mcalinden et al. 2011]. This prospective, cross-
over study was approved by the Institutional Ethics Committee of the University of Valencia. 
Participants were explained his/her rights as a research subject and agreed to take part by 
signing a statement of informed consent. The study was performed according to the tenets of 
the Declaration of Helsinki. As part of the study screening, each of the participants underwent 
a baseline comprehensive ophthalmic examination, which included, in the order as follow:  
OSDI, CLDEQ-8, visual acuity, refraction, slit lamp biomicroscopy, topographic examination 
using the topographer Atlas 9000, ocular fundus examination, horizontal visible iris diameter 
measurement using a ruler to nearest 0.5 mm and CCT measurements using OCT and a swept-
source biometer, osmolarity measurement and FBUT and TMA using SL integrated OCT SL 
SCAN-1. Patients who experienced any anterior segment pathology, previous corneal surgery, 
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corneal abnormalities, chronic self-reported DED or ocular fundus diseases, conjunctival 
staining present ≥2, corneal staining present ≥2 were excluded from the study. Participants 
were randomly assigned to be initially fitted with either Dailies Total One Multifocal (center-
near aspheric; Alcon, Texas, U.S.A.) or Air Optix Aqua multifocal (center-near aspheric; Alcon, 
Texas, U.S.A.). CL characteristics are summarized in table 12. Before dispensing the lenses, all 
participants were taught appropriate lens insertion, removal, and cleaning techniques for the 
EW lenses (which are basically daily wear monthly replacement schedule CLs), with 
preservative-free multipurpose solution (Optifree Replenish (Alcon). Previously described 
parameters were measured at: baseline (t0), 20 min margin (t1) and 8 hours margin after 
insertion (t2), in morning hours (t3) and in the afternoon (t4) of the 30th day except for 
OSDI/CLDEQ-8 that were assessed at the end of the wearing period for each CL material. CL 
wear was discontinued for four days between each period of one month of wear in order for 
the eyes to fully recover (wash-out period). 
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Table 12. Contact lenses characteristics according to manufacturer’s data
Unites States Adopted 
Names Council (USAN) 
Delefilcon A Lotrafilcon B 
Company Alcon Alcon 
Polymer type Silicone Hydrogel Silicone Hydrogel 
FDA group I I 
Equilibrium water content 
(%) 
Core 33% 
Periphery above 80% 
33% 
Dk/t ([cm2 s-1][mL O2/(mL × 
mmHg)] × 10−11) 
159 @ -3.00D at a central thickness of 
0.09 mm 
138 @ -3.00D at a central thickness of 
0.08 mm 
Base Curve (mm) / 
Diameter (mm) 
14.1/8.5 14.2/8.6 
Wearing Schedule Daily Disposable Daily Wear Monthly Replacement 
Schedule 
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- Symptomatology questionnaires (OSDI and CLDEQ-8) were administered as described 
in general methodology. 
- Slit Lamp Examination was performed for each subject of the oculus uterque (OU) 
looking for any signs of inflammation of the anterior segment; the cornea was assessed 
with different magnifications, using parallelepipedic and optical sections. CL fit quality 
was assessed according to Wolffsohn et al. critical fitting characteristics:  centration, 
coverage, horizontal lag, movement on blink in up-gaze and push-up recovery speed 
[Wolffsohn et al. 2009]. Tear osmolarity measurement was performed using the 
TearLab osmolarity system by collecting a minimal tear simple from the inferior lid tear 
meniscus (at the outer canthus). 
- Tear osmolarity was performed as explained in the general methodology before FBUT 
and vital stainings. 
- Inferior Tear Meniscus Area: Images obtained with SL-Scan 1 were then exported to an 
image analysis software called imageJ [http://imagej.nih.gov/ij/] that allows, after 
manual delimitation of the edges of the central tear meniscus, the calculation of TMA 
in mm2 as illustrates Image 2. 
 
Figure 5.1. TMA measurement performed on the first day of CL wear (delefilcon A) 
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- Aberrations Analysis was performed as detailed in Chapter 3. 
- CCT: Optical Coherence Tomography was used for assessing corneal-CL Pachymetry 
AS-OCT Visante. The IOL Master 700 uses swept source OCT (SS-OCT) to measure 
corneal-CL pachymetry. Corneal thickness is known to increase over night [(Mertz 
1980] reaching a peak upon waking [Mandell et Fatt 1965]. According to this, baseline 
(t0) and morning measurements (t1/t3) were performed at least two hours after 
awakening so as to allow the cornea to return to its basal thickness. 
- Tear Film Breakup Time and Corneal-Conjunctival Staining Score (Fluorescein Sodium) 
was performed as detailed in Chapter 3. 
Statistical Analysis 
Statistical analysis was performed using the Statistical Package for Social Science software 
(Version17.0, SPSS, Inc., Chicago, IL, USA). Friedman’s non-parametric statistical test was used 
to detect differences over time for TMA, osmolarity, CCT and aberrations as they were not 
normally distributed (Kolmogorov-Smirnov p < 0.05). Wilcoxon test was used in order to 
compare related intergroups for ordinal parameters, whereas Mann-Whitney test was used 
to compare parameters not normally distributed between the two CL materials. Correlations 
between the questionnaires responses were assessed by the Spearman coefficient of 
correlation. Differences were considered statistically significant at p ≤ 0.05.  
5.3 Results 
Forty right eyes from 40 presbyopic subjects (50.0 ± 4.4 years) completed the study. Mean 
spherical equivalent refractive error was +1.1 ± 0.4 D. 
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OSDI scores obtained at (t0) an (t4) for the daily and extended wear (EW) lenses were 8.5, 
13.2 and 24.4 points respectively and showed significant differences only regarding the EW 
lens (p=0.042; Figure 1.a).  
 
Figure 5.2.a. Box-plot of OSDI scores the month of CL wear for each lens. Medians are shown for 
each plot, quartiles are shown as boxes, ranges as whiskers and outliers as dots. 
CLDEQ-8 scores obtained at (t0) and (t4) for the daily and extended wear (EW) material were 
6.2 ± 3.8 points, 10.6 ± 8.5 points and 18.1 ± 9.8 points respectively and showed significant 
differences lotrafilcon B giving the higher scores (P=0.012)(Figure1.b). 
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Figure 5.2b. Box-plot of CLDEQ-8 scores at the end of CL wear for each lens. Medians are shown for 
each plot; quartiles are shown as boxes, ranges as whiskers and outliers as dots 
Spearman correlation coefficient results revealed a strong correlation between the OSDI and 
CLDEQ-8 scores at baseline visit (R = 0.76; P < 0.0001), at one month for delefilcon A (R = 0.65; 
P < 0.002), but it was not significant regarding the lotrafilcon b material (R= 0.3; P < 0.203). 
For both lenses, TMA decreased with time (p<0.001) and (p<0.002) respectively (Figure 2). The 
post-hoc analysis revealed only significant differences for the daily lens between the 
measurements taken at baseline (t0)/(t2), (t0)/(t3), (t0)/(t4), as well as between (t1)/(t2) and 
(t1)/(t4) (p<0.05). For the EW lens, significant differences were found between (t0)/(t1) 
(p=0.016), (t0)/(t3) (p=0.009), (t0)/(t4) (p=0.001) and (t1)/(t4) (p=0.017).   
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Figure 5.3.a. Box-plot of tear meniscus area at baseline, 20 minutes, 8 hours, one month morning 
and afternoon of CL wear for Delefilcon A. Medians are shown for each plot, quartiles are shown as 
boxes, ranges as whiskers and outliers as dots. 
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Figure 5.3.b. Box-plot of tear meniscus area at baseline, 20 minutes, 8 hours, one month morning 
and afternoon of CL wear for Lotrafilcon B. Medians are shown for each plot, quartiles are shown as 
boxes, ranges as whiskers and outliers as dots. 
 
No statistical significant differences in osmolarity were found across the day and at the end of 
the month for each lens (Figure 3). When comparing both lenses, significant differences exist 
at (t1) (p=0.006) and at (t2) (p=0.002) values being greater for Delefilcon A. 
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Figure 5.4.a. Box-plot of osmolarity at baseline, 20 minutes, 8 hours, one month morning and 
afternoon of CL wear for Delefilcon A. Medians are shown for each plot, quartiles are shown as 
boxes, ranges as whiskers and outliers as dots 
 
Figure 5.4.b. Box-plot of osmolarity at baseline, 20 minutes, 8 hours, one month morning and 
afternoon of CL wear for Lotrafilcon B. Medians are shown for each plot, quartiles are shown as 
boxes, ranges as whiskers and outliers as dots 
 
4. Figure 4 shows the boxplot obtained for the total higher order root means square changes 
for both lenses with time. For the daily lens, mean values for (t0), (t1), (t2), (t3) and (t4) were 
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0.39, 0.63, 0.63, 0.68, 0.69 µm respectively. Regarding EW lens, mean values for (t0), (t1), (t2), 
(t3) and (t4) were 0.39, 0.61, 0.57, 0.63, 0.66 µm respectively. For both lenses, higher order 
aberrations were significant differences with time whereas Wilcoxon test found significant 
differences between (t0)/(t1), (t0)/(t2), (t0)/(t3) and (t0)/(t4) (p<0.001) for each lens 
respectively. No differences were found between lenses across the month of lens wear. 
 
Figure 5.5.a. Box-plot of high order root means square at baseline, 20 minutes, 8 hours, one-month 
morning and afternoon of CL wear for Delefilcon A. Medians are shown for each plot, quartiles are 
shown as boxes, ranges as whiskers and outliers as dots 
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Figure 5.5.b. Box-plot of high order root means square at baseline, 20 minutes, 8 hours, one-month 
morning and afternoon of CL wear for Lotrafilcon B. Medians are shown for each plot, quartiles are 
shown as boxes, ranges as whiskers and outliers as dots 
Significant differences in corneal thickness were found from lens insertion for both lenses as 
expected while the post-hoc analysis revealed statistically significant differences for all paired 
comparisons (p<0.001) for the daily lens excepted between (t1) and (t3) (p=0.2; Table2). 
 
 
 DAILIES 
(Mean value± 
SD µm) 
Visante OCT 
Baseline (t0) 20 minutes (t1) 8 hours (t2) 1 month 
morning (t3) 
1 month 
afternoon (t4) 
526±28 660±43 653±41 657±41 655±41 
                                   IOL Master 
532±30 675±46 666±44 673±45 666±44 
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AIR OPTIX 
(Mean value ± 
SD µm) 
                                                               Visante OCT 
Baseline (t0) 20 minutes (t1) 8 hours (t2) 1 month 
morning (t3) 
1 month 
afternoon (t4) 
526±28 625±34 622±34 626±34 623±35 
                                  IOL Master 
532±30 638±38 630±34 637±39 630±37 
 
Table 13. Pachymetric measurements obtained with both devices. 
Regarding EW lens, significant differences were found for all paired comparisons excepted for 
(t1)/(t3), (t1)/(t4), (t2)/(t4) pairs (p>0.05). When comparing both lenses, significant 
differences were found between all paired comparisons (p<0.001). The IOL Master 700 gave 
higher mean values for (t0), (t1),(t2), (t3) and (t4) of 532, 674, 666, 673, 666 µm and 532, 638, 
630, 637, 630 µm for daily and EW lenses respectively. All paired comparisons showed 
significant differences (p<0.001) excepted when comparing (t1)/ (t3) and (t2)/(t4) values for 
both lenses (p>0.05). When comparing both lenses, significant differences were found 
between all paired comparisons (p<0.001). 
 
5.4 Discussion 
CLD, contributes almost at the same level as dryness (24% and 20% respectively) as the 
primary reasons for CL discontinuation [Nichols et al. 2013, Sulley et al. 2017]. Chao et al. 
identified various factors including ageing, female sex, and the medication used to treat 
systemic conditions as increased risk factors for DED, these factors being encountered as well 
in the “inherent patient factors” classification of CLD (Chao et al. 2016, Moss et al. 2008). 
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During CL wear, the interaction of the material with the TF separates it into PLTF and  PoLTF. 
This affects its stability by modifying the lipid layer spread hence influencing TF evaporation, 
these series of events being directly linked to CLD [Markoulli et Kolanu 2017, Craig et al. 2013]. 
Friction plays as well a key role in CLD, as repeated interactions of CL material with conjunctiva 
during blink and eye movement (when the lid border moves over CL rim and along the anterior 
surface) has been shown to induce changes over the limbal and conjunctival area, possibly 
leading to positive vital staining of both corneal and conjunctival tissues as well as symptoms 
of ocular dryness [Efron et al. 2013]. 
The results of the OSDI questionnaire showed an average increase of 4.7 points across the 
month for the daily lens. However, as this increase was not statistically significant, this could 
be attributed to a noise in measurement and not a real effect of the CL material. Furthermore, 
the mean value of OSDI score (13.1 points) was just above the cut-off value (i.e 13.0 points) 
for dryness as defined by Wolffsohn et al. [Wolffsohn et al. 2017] which supports the 
hypothesis that comfort remained rather stable across the month of wear for this lens 
material. Regarding the EW lens, a significant increase in OSDI score occurred across the 
month of wear: from 8.5 to 24.4 points, which would correspond, according to the cut-off 
values previously described, to moderate ocular surface disease. CLDEQ-8 scores were 6.2 ±  
3.8 points at baseline,  10.6 ± 8.5 points and 18.1 ± 9.8 points at one month for delefilcon A 
and lotrafilcon B respectively, and significantly different (P=0.01). Delefilcon A scores were 
below the cut-off value for CLD (i.e ⩾12) [Chalmers et al. 2016], which was not the case with 
lotrafilcon B material, showing that the former indeed induced discomfort across the month 
of wear. Patients were randomly fitted with one of the two CL materials so as no bias was 
induced during the study.  
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According to Sulley et al. [2017b], overall performance of a CL material can be anticipated 
based on material physical characteristics such as modulus, oxygen permeability and 
thickness. Indeed, it is known that higher moduli silicone hydrogel CL materials are related to 
a higher rate of mechanical events, as greater stiffness is expected to impact CL edges and its 
interaction (mainly friction) with both bulbar and palpebral conjunctiva [Ozcan et al. 2010].  
According to manufacturers’ data, delefilcon A presents a very low surface modulus of 0.025 
MPa (core of 0.76 MPa) whereas lotrafilcon B material has an overall modulus of 1.2 MPa 
making it more rigid. This could induce increased discomfort across the period of study 
compared to the daily CL material (as lens design affects lens comfort) and this partly explains 
the higher symptomatology scores obtained for the EW CL material. This will be discussed 
later with vital stainings. 
TMA 
Tear meniscus is believed to contain up to 90% of the TF [Holly 1985], which makes it a key 
parameter to assess the impact of CL wear on tear volume. AS- OCT is a valuable device to 
assess TF parameters changes over time non-invasively [Wang et al. 2006, Del Águila-Carrasco 
et al. 2015] due to the use of a light source outside the visible spectrum reducing 
photostimulation and thus possible induced reflex tearing [Shinzawa et al. 2017]. Besides, a 
high sensitivity and specificity for TMA has been found in diagnosing dry eye disease, 86.1% 
and 85.3% respectively [Czajkowski et al. 2012], make this device a valuable tool for diagnosis 
and follow-up of DED patients [Akiyama et al. 2017]. The goal of evaluating TMA in the present 
study was to assess in which extent CL wear alters this parameter. Baseline values were 0.023 
±  0.015 mm2  which are in agreement with Wang et al. work (22,732 ± 11,974 μm2 for healthy 
subjects) [Wang et al. 2006]. For both the daily and EW lenses, TMA decreased gradually from 
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baseline to the last visit, changes being significant only after 8 hours or longer. No significant 
difference occurred between 8 hours and 1 month of wear, which indicates that TMA 
remained rather stable over this period and both lenses performed similarly regarding this 
parameter. Previous works have studied tear meniscus volumes variation across the day in 
healthy and dry eye subjects finding stable diurnal values for both populations with however 
reduced values in the dry eye group [Shen et al. 2008] and in CL wearers [Del Águila-Carrasco 
et al. 2015]. Shen et al. [Shen et al. 2009] measured upper and lower TMA comparing two 
different soft CL materials with the naked-eye (i.e no CL). As with this study, 20 minutes from 
CL insertion, they found no significant differences in TMA values in comparison with the naked 
eye scenario. These results are partly in agreement with the current study; it is believed that 
this time interval is sufficient to stabilize reflex tearing that occurs in response to insertion. 
This was the case for the daily lens as no significant changes occur during the first day (t1 and 
t2) nor during the 4 weeks of wear (t3 and t4). Regarding both lens materials, a significant 
reduction in TMA values occurred from the first to the 30th day of wear (from 0.019 mm2/0.020 
mm2 on the first day of wear to 0.017mm2/0.016 mm2 on day 30 for the daily and EW lens 
materials respectively). Since every participant of the study did not present any signs and 
symptoms of DED, it seems reasonable to surmise that the reduction in TMA values found in 
the present study might be due to: the destabilization of TF by CL material regardless of lens 
type as well as to the large day to day variability of this parameter. Indeed, CL wear directly 
impacts tear meniscus characteristics [Downie et Craig. 2017], and it is known that tear 
meniscus volume is significantly reduced from the time of lens application to end-of-day 
removal [Chen et al. 2009, Chen et al. 2010] by an order of approximately one-third [Craig et 
al. 2013]. In the present study, even if TMA values significantly decreased across the month of 
wear, these changes were clearly inferior to the values found by [Craig et al. 2013], which 
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allow us to hypothesize that both CL materials minimally impacted this parameter during the 
study. Since some factors, being controlled during the measurements sessions such as time of 
day, time after blink, temperature, humidity, air speed and illumination can influence TMA 
values [DEWS 2007, Johnson et Murphy 2007, Bandlitz et al. 2014b], the outliers found during 
the experiments could be due to remaining influencing factors such as measurement locus 
along the lid margin (it is indeed really difficult that the row of three measurements be exactly 
on the same locus) and biasing parameters such as conjunctivochalasis, disorders of lid margin 
congruity and apposition between lid margin and ocular surface [Ibrahim et al. 2010, Pult et 
Pult 2015]. No conjunctivochalasis or apposition issues were noted in the subjects enrolled in 
the study. However, lid margin congruity disorders (found in 4 participants), corresponds to 
MG atrophy and it is obvious that if this abnormality is located at 6 o’clock vertically to the 
corneal apex, the measurement could be easily jeopardized the TMA measurement since it is 
expected a superior amount of fluid to accumulate in the depression made by the atrophy and 
thus give greater values of TMA. 
Osmolarity 
Tear osmolarity is considered by some as the best single metric to diagnose, classify and 
monitor DED [Tomlinson et al. 2006, Lemp et al. 2011]. According to Potvin et al. 2015, [Potvin 
et al. 2015] hyperosomolarity of the ocular surface induces the activation of inflammation 
pathways leading to epithelial cell apoptosis and positive vital staining of the ocular surface, 
these series of events possibly challenging CL comfort. According to Keech et al. [Keech et al. 
2013], a healthy population is expected to exhibit little day-to-day and visit-to-visit variation 
of osmolarity values. However, raised osmolarity in CL wearers is associated with CL increased 
symptomatology [Stahl et al. 2009]. In order to diagnose mild to moderate dry eye subjects, a 
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thresold of 308 mOsm/L is now widely accepted in clinical practice [Lemp et al. 2011]. 
Readings from the measuring device are expected to fall within a +/- 5 mOsm/L interval in 
healthy subjects according to the TearLab® device standard deviation [Wilson et Canavan 
2013]. Previous studies have related CL use to low or moderate variations in tear osmolarity 
[Chao et al. 2016, Wolffsohn et al. 2017, Miller et al. 2004]. In the present study, only first-
time CL users were included with no diagnosed DED and mean baseline value of osmolarity 
(i.e 307 mOsm/L) was below the cut-off value set up for the present experiment. Delefilcon A 
only showed a significant difference between (t1) (312mOsm/L) and (t4) (306mOsm/L), which 
however stays within the standard deviation of the device and just above the cut-off value for 
DED. Anyhow, this slight punctual raise in osmolarity is not clinically significant since it came 
back to baseline levels across the month of wear and did not lead to any significant changes 
in vital stainings. The EW material showed constant values of osmolarity between each visit 
as well, which allow us to hypothesize that both materials provide high compatibility and 
minimum disturbance with the ocular surface of first time presbyopic CL wearers.  
Aberrations 
Optical aberrations of the eye play a key role in the final retinal image quality [Liang et Williams 
1997]. Assessing optical performance of modern multifocal CL materials is of great relevance 
as numerous presbyopic wearers complain of halos and contrast sensitivity reduction being 
the result of the sum of aberrations from both optical systems (i.e CL and eye) taken together 
[Lopez-Gil et al. 2002]. Once defocus and astigmatism are corrected by the CL, differences 
between a perfect wavefront and the human eye relies on HOAs mainly third order coma-like 
and fourth-order spherical aberrations [Patel et al. 2002, Peyre et al. 2005]. Both CL materials 
used in the present study provide the same geometry, i.e front aspheric center-near multifocal 
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design. This design, is expected to generate SA induced by the gradient power change from 
center to periphery of the optical zone which is originally designed by the manufacturers to 
increase the depth of focus in presbyopes. The induction of coma-like aberration is in direct 
relationship with the amount of decentration of CL material from the pupil center [Patel et al. 
2002, Gatti et Lipener 2008]. Indeed, blinking and in a lesser extent, eye movement, displace 
the optical center of the lens from the visual axis. The association of raised SA (within the CL 
material) and coma gives an overall decrease of optical quality that was assessed in the 
present study as an RMS combination of both aberrations in order to follow-up changes of the 
total high order RMS and the influence of CL insertion on this parameter across a month of 
wear. In the present study, total RMS, regardless of CL material, significantly increases from 
CL insertion (REF). This was an expected outcome given both CL designs. At 20 mn after CL 
insertion, the set of high order RMS rose from 0.39 µm (i.e no CL/(t0)) to 0.60 µm (t1) for the 
daily lens and remained rather stable across the month of wear. Lotrafilcon B showed a similar 
behavior, total RMS rising from baseline/(t0) (0.39 µm) to 0.61 µm at (t1) and remained 
statistically unchanged during the study period except for the end of the day values ((t2)/(t4)) 
where a significant difference has been found (0.57 µm versus 0.66 µm respectively). One 
interesting point to raise here is that, when a CL is inserted on eye, the separation of TF into 
two layers makes it more prone (overall the pre-lens TF (PLTF)) to disruption and evaporation. 
Indeed, the normal pre-corneal tear film is expected to be around 3 µm thick whereas PLTF is 
expected to be 1 µm thinner [Chen et al. 2010, Nichols et King-Smith 2003]. Tear film 
quality/quantity, stability and dynamics play a key role in optical performance over the course 
of CL wear [Downie et Craig 2017] hence PLTF surface quality is an excellent indicator of the 
TF ability to prevent CL surface dehydration. 
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 Surface wettability and water content of the CL material are the main parameters that can 
impact PLTF quality [Tonge et al. 2001, Jones et al. 2002b] as local variations of PLTF thickness 
directly impacts the amount of aberrations being measured [Montés-Micó et al. 2004a, Erdélyi 
et al. 2006]. In the present study, the CL materials are different and, even if both are silicone-
hydrogel lenses, their water content and core structure do differ. On the basis of this 
observation, significant differences were expected to be found across a month of wear 
regarding PLTF quality. However, no disparities were found when comparing lenses, except 
for the end of the day values ((t2)/(t4)) which suggests that PLTF might have showed local end 
of the day variations regarding lotrafilcon B. Pre-lens TFSQ and dynamics were minimally 
impacted across a month of CL wear. However, it would have been interesting evaluating this 
parameter over a longer period of wear as previous works reported that up to 25% of the 
patients wearing their lenses up to 16 hours [Riley et al. 2005]. The duration evaluated in this 
study gives valuable information, but does not represent a typical day for usual CL wearers 
[Riley et al. 2005, Wolffsohn et al. 2015].      
Pachymetry 
New high Dk soft CL silicone-hydrogel materials minimally impact corneal swelling [Covey et 
al. 2001, Keay et al. 2000, Stapleton et al. 2001, Dumbleton et al. 2001, Nilsson 2001, Papas 
et al. 1997] and hypoxic effects of those silico-hydrogel materials are considered to be 
negligible. Both CL materials have been worn for a limited period of one month and no or 
minimal corneal changes were expected to occur. Furthermore, as CL edges (back surface) are 
very difficult to delimitate using the Visante device due to the reduced resolution of the back 
surface of the CL (index changes from CL material to TF and anterior corneal surface) and given 
that the IOL master does not allow for a manual delimitation of the central CL edges, it was 
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decided to consider the complex Cornea-CL as a whole and baseline CCT as a constant in order 
to evaluate and compare variation of lens thickness across a month of CL wear. The main goal 
here was to assess the evolution of CL material thickness over time and to explain the possible 
causes of it. According to previous studies [Hong et al. 2012, Huang et al. 2010, Li et al. 2008, 
Rao et al. 2011, Mohamed et al. 2007], baseline CCT values acquired with OCT in healthy eyes 
ranges between 520 – 545 µm, comparable to the values obtained in this study, i.e, 526 ± 28 
µm. Values obtained with both devices are summarized Table 2. 
Regarding the daily lens using the IOL Master device, mean CCT varied from an average 675 
µm at (t1) to 666 µm (t2) and from 673 µm (t3) to 666 µm (t4). This corresponds to a 1.33% 
and 1.04% decrease respectively in cornea-Daily CL central thickness and differences between 
each morning as well as between each afternoon were not statistically relevant. This allow us 
to hypothesize that CL material do dehydrate during wearing time and that the dehydration 
rate remain rather stable from one daily lens to another across the month of wear. The Visante 
OCT gave similar results and lead to similar conclusions; mean CCT varied from an average 660 
µm (t1) to 653 µm (t2) and from 657 µm (t3) to 655 µm (t4). This corresponds to a 1.1% and 
0.3 % decrease respectively in CL central thickness of the daily lens and the difference between 
each morning as well as between each afternoon were not statistically relevant. IOL Master 
device for the EW lens showed a decrease in overall thickness across the month: mean 
Lotrafilcon B-CCT varied from an average 638 µm (t1) to 630 µm (t2) and from 637 µm (t3) to 
630 µm (t4). This variation was for the Visante from an average 625 µm (t1) to 622 µm (t2) 
and from 626 µm (t3) to 623 µm (t4). 
 This corresponds to a 1.3% and 1.1 % decrease for the IOL Master and 0.5% for the Visante in 
CL central thickness of cornea-monthly CL and the difference between each morning as well 
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as between each afternoon were not statistically relevant for both devices. An interesting fact 
is the slight superior in-vivo dehydration rate of the Delefilcon A lens that was found in the 
current study. Delefilcon A is a layered material composed of a silicone core (water content 
33%) and a silicone free (or hydrogel) outermost part with a water content superior to 80%. 
Lotrafilcon B is a polymer that requires surface treatments to hide the silicone from the 
surface of the lens to keep it wettable. According to the model developed by Fornasiero et al. 
2006 [Fornasiero et al. 2006], in vivo hydrogel CL dehydration takes place during blink cycle. 
A fresh PLTF is deposited on the CL upon each blink [Miller et al. 2004, Wong et Fatt 1996] 
which allows for the hydration of the CL. However, water evaporation mainly due to the 
environment induces decrease in PLTF thickness to the point that it finally ruptures, and if that 
break occurs during the blink interval, the exposed CL surface loses water. Water content of 
the anterior surface of the CL decreases inducing water flow from the PoLTF giving rise to lens 
dehydration. This is partly what is thought to happen in the delefilcon A scenario as the 
dehydration process could be divided into two different stages: a continuous and progressive 
dehydration across the day as explained earlier since the outermost part of the CL (in contact 
with environment on one side and PoLTF on the other side) can be considered as a hydrogel 
material on a behavioural point of view, but also an immediate surface water loss upon 
material insertion as reported by Schaffer et al. [Schaffer et al. 2015]. Indeed, previous studies 
evidenced a rapid surface dehydration of this material upon insertion, the surface refractive 
index swiftly shifting towards the silicone core water content index [Schaffer et al. 2015, 
Szczesna-Iskander et al. 2014].  
However, these events must be taken with caution as in the present study, the dehydration 
process, although present, was really limited and did not present any statistical significance. 
Furthermore, as discussed before, TFSQ remained stable across the day and month of wear 
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showing that CL anterior surface maintained the same slighty reduced water content from 
lens insertion to the end of the day. Lotrafilcon B showed an inferior overall dehydration rate 
during the month of study which leads to one of the possible limitations of the present study. 
Indeed, dehydration estimates for this CL material were obtained without taking into account 
the possible depositions on the CL material [González-Méijome et al. 2013] that could possibly 
influence central CL thickness measurements and surface wettability. However, existing 
literature and clinical experience of the examiner showed a certain trend: lotrafilcon B has one 
of the lowest affinity for tear lipids [Carney et al. 2008] and protein adsorption such as 
lysozyme among silicone-hydrogel materials [Chow et al. 2009, Zhao et al. 2009]. Lens care 
system used in this study was Optifree Replenish and it could be hypothesized that the non 
significant decrease in dehydration across the month could partly be attributed to the lens 
care-induced increased capacity of retaining water [González-Méijome et al. 2013]. More 
studies are needed to better understand the influence of lens care systems on overall behavior 
of the CL materials on-eye. Values of dehydration obtained in the present study, regardless of 
the lens type, were inferior to the values reported by Morgan and Efron 2003 or by Gonzalez-
Meijome et al. [Morgan et Efron 2003, González-Méijome et al. 2013]. One explanation for 
these differences is wearing time as in their studies CL were worn for a 10 hours period and 
more evaporation is expected to occur during this time span.  
TFBUT and vital staining  
Due to the lack of non-invasive methods to assess TF stability, it was decided to evaluate this 
parameter using a fluorescein dye according to Mooi and al. standards in order to minimize 
the impact of fluorescein on clinical measurements [Mooi et al. 2017]. In the current study, 
mean values of baseline TFBUT were 10.4± 2.3 seconds above the cut-off values for dry eye 
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[Mooi et al. 2017] significant differences were found between baseline, 8 hours and the end 
of the month for the daily CL material with a gradual decrease of FBUT values across the month 
of wear. This was the case for the EW lens even if no difference was found when comparing 
values at 8 hours and at the end of the month. No difference between each CL material has 
been evidenced which seems be due to the very ressembling parameters and on-eye 
behaviour of both CL materials. 
 Corneal and conjunctival staining decreased from baseline across the month of wear for both 
lenses. However, from the 40 patients included in the study, 18 reported end of the day 
discomfort (t2 and t4) with mild symptoms when wearing the EW lens resulting in positive 
staining described by the investigators as a “Circumlimbal staining sometime continuous, 
sometime discontinuous corresponding to CL edges located at 1-3 mm from the limbus ”. It 
seems reasonable to hypothesize that interaction of the conjunctival epithelia with CL edges 
design and modulus directly impacts superficial cells giving rise to positive staining as it has 
been suggested by Sapkota et al.2016 and Radford et al. 2009 [Sapkota et al. 2016, Radford et 
al. 2009]. Chao et al. [Chao et al. 2017] found an association between EW CLs wear and an 
increase in tear CKs and conjunctival staining in comparison with daily disposable wearers. 
This could be induced by the use of multipurpose solutions with EW CLs which are associated 
with an increase in CKs levels [Kalsow et al. 2013] and the possible accumulation of debris 
across the month of wear, which could increase friction forces at the edges of the lens giving 
rise to this pattern. However, it is unlikely to have occured in our study since circular staining 
was already visible after 8 hours of wear and it is thought to be due to CL material edges 
interaction with the conjunctival epithelia.  
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5.5 Conclusions 
Attempts to target unmet needs for a growing presbyopic population especially regarding CL 
fitting strategies require previous identification of the changes taking place in the LFU, how 
they affect the ocular surface and in which extent the insertion of a CL would affect this set of 
structures or worsen an already unbalanced ocular environment. Both CL materials fitted in 
this study provided satisfactory and similar objective on-eye behaviour and remained rather 
stable along the experiment period. However, subjective symptoms showed a greater increase 
from baseline regarding the extended wear lens. Comfort seems to be impacted by CL material 
modulus, parameters of both CLs being otherwise very ressembling. 
  
 
 
145 
 
 
 
CHAPTER 6 
 COMPARISON OF THE INFLUENCE OF CORNEO-
SCLERAL AND SCLERAL LENSES ON OCULAR SURFACE 
AND TEAR FILM METRICS IN A PRESBYOPIC 
POPULATION  
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6.1 Introduction 
ScLs are rigid gas permeable devices that are supported entirely by the conjunctival tissue 
overlying the sclera and vault the cornea and limbus [Schornack et al. 2015]. Their major 
advantage lies in the vaulting of the cornea (and the subsequent apical clearance) that avoids 
direct mechanical stress to this ocular tissue. The development of new lens materials, 
computer-generated lens devices as well as new insights into the anterior scleral shape and 
corneo-scleral junction have contributed to improve designs and oxygen transmissibility 
allowing better ocular health, longer wearing time and ease of lens fit [Pearson 2007, Ezekiel 
1983,  Bavinger et al. 2015, Van der Worp 2015]. ScLs are typically prescribed for corneal 
ectasia (primary corneal ectasia like keratoconus) [Barnett et Mannis 2011] and ocular surface 
diseases when a patient’s corneas shows intolerance to other forms of vision correction (rigid 
gas permeable and soft lenses materials) and does not provide adequate visual acuity to the 
patient [Schornack 2015]. ScLs have shown good results in patients with graft versus host 
disease, DED and exposure keratopathy among others [Schornack 2015], but also for high 
ametropias [Visser 1997] and for cosmetic purposes such as in atrophia bulbi [Van der Worp 
2015, Tan et al. 1995].  
As well as the prevalence of DED increasing with age, systemic disorders (and the medication 
associated with them) are recognized as risk factors that might jeopardize ocular surface 
homestasis and induce dry eye signs and symptoms [Chao et al. 2016]. Fitting CLs in a 
presbyopic population is as such expected to be more challenging in comparison with a 
younger sample. However, presbyopics patients could benefit from wearing ScLs; multifocal 
designs such as centre near or centre distance vision exist and these present a great advantage 
over conventional rigid gas permeable lenses devices (lens stability on eye due to reduced 
movement) and in a lesser extent over multifocal soft CLs (optical quality and resulting higher 
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contrast sensitivity) [Van der Worp 2015]. ScLs allow for a better centration of the lens and an 
easier adaptation to simultaneous images due to the stability of the image provided by the 
scleral design. Furthermore, ScLs have demonstrated interesting qualities in maintaining 
homeostasis beneath the lens [Bavinger et al. 2015, Van der Worp 2015, Barnett et Mannis 
2011].  
However, even if a larger CL diameter would provide more stability regarding multifocal 
designs, to the best of our knowledge academic literature is missing in the matter of how CL 
diameter changes affect ocular surface physiology as well as tear quality/quantity of 
presbyopic patients. Thus, it may be interesting to research into the differences between a full 
ScLs and a smaller diameter lens that partly rests on the sclera [corneo-scleral lenses (C-ScL)]. 
Theses CLs offer more consistent visual performance, due to the larger optic zone and 
increased stability, than corneal CLs.   
Thus, the aim of this study was to assess and compare the effect of the C-ScL and ScLs on TF 
parameters and corneal thickness in healthy presbyopic subjects. 
6.2 Methods 
This prospective study was conducted in the Valencia’s University laboratory facility, Valencia, 
Spain. The project was approved by the Ethical Committee of our institution. Patient’s consent 
forms were obtained for all participants. The clinical study adhered to the tenets of the 
Declaration of Helsinki. As part of the study screening, each of the participants underwent a 
comprehensive ophthalmic examination, which included, in the order as follow: visual acuity, 
refraction, slit lamp biomicroscopy, topographic examination using the topographer Atlas 
9000, ocular fundus examination, horizontal visible iris diameter measurement using a ruler 
to nearest 0.5 mm and  CCT measurement using OCT. Patients who experienced any anterior 
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segment pathology, previous corneal surgery, corneal abnormalities, chronic DED or ocular 
fundus abnormalities were excluded from the study. The subjects wore two contact lenses, 
randomly assigned, with neutral power and different diameters [12.7 mm (C-ScL), 18 mm (ScL) 
Figure 6.1] and being the samefor the other parameters: material (HS100) and central 
thickness (0.29mm) (Tiedra Farmacéutica SL, Alcorcón, Spain). 
 
Figure 6.1. C-ScL diameter: (12.7 mm), ScL (diameter 18 mm) 
 At baseline, 20 min margin (t1) and 8 hours margin after insertion (t2), the area of the tear 
meniscus was evaluated with OCT (SL SCAN-1, Topcon) as well as CCT and tear osmolarity. CL 
wear has been discontinued for four days between each measurement in order for the eyes 
to fully recover. 
Details of the AS-OCT imaging technology have been described previously (Izatt et al. 1994; 
Radhakrishnan et al. 2001). An anterior segment OCT [coupled with a slit-lamp was performed 
in order to assess the tear meniscus parameters of the inferior eyelid using the B-scan mode 
and scanning at 6 o´clock the inferior eyelid right below the centre of the pupil. TMA 
[Czajkowski et al. 2012], the triangular area delimited by the anterior corneal boundary, 
anterior boundary of the lower eyelid and anterior borderline of the tear meniscus was 
calculated using an image analysis software imageJ (http://imagej.nih.gov/ij/). The same 
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examiner carried out all of the three measurements for each patient as well as manual 
demarcation of the boundaries of the TM.  
The global corneal “pachymetry map” protocol of the Visante OCT was used to capture 8 radial 
scans centered on the corneal vertex reflection. Each scan line was 10 mm long, with a 
transverse resolution of 60 μm and a vertical resolution of 18 μm. Three consecutive scans 
were carried out for each eye by the same examiner.  
Tear film osmolarity was measured using a laboratory-on-a-chip system which analyzes the 
electrical impedance of a 50 nanoLiter (nL) tear sample taken from the inferior lateral 
meniscus of both eyes of the patient. Osmolarity values below 308mOsm/L are considered as 
normal [Lemp et al. 2011]; readings between 308 and 325 mOsm/L are representative of mild-
to-moderate dry eye, and values above 325mOsm/L indicate the severe state of the disease 
[Foulks et al. 2009]. 
Statistical analysis 
Measurements were evaluated using SPSS v.22 (IBM Corp., New York). Normality was 
evaluated by the Shapiro-Wilk test. To analyze the results as a function of the lens wearing 
time a repeated measures analysis of variance (rANOVA) was performed to reveal significant 
differences among time periods; Greenhouse-Geisser correction was applied when the 
rANOVA sphericity assumption checked using the Mauchly's test was breached [Box 1965]. 
Bonferroni correction was applied to post-hoc tests for comparisons between time periods. 
When normality of data groups could not be assumed, a non-parametric Friedman test was 
performed. Then, if needed, a Wilcoxon signed-rank or a Sign test, depending on the 
symmetry of the differences distribution, was performed as a post-hoc test. To analyze the 
results as a function of the diameter of the lens, a Student’s t test for related samples was 
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used when normality can be assumed, while a Wilcoxon signed-rank or a Sign test was used 
when normality could not be assumed. The statistical significance limit was set at p<0.05.  
6.3 Results 
Thirty eyes from thirty presbyopic subjects (average age from thirty presbyopic subjects 
(average age 54 ± 4 years, range: 46-63 years) completed the study. 
Analysis as a function of the lens wearing time 
Boxplots obtained for the tear meniscus area for the both designs are shown in Figure 6.2. For 
the C-ScL, median values for basal, 20 min, and 8 hours were 0.0213, 0.0216, and 0.0152 mm2, 
respectively. For the ScL, median values obtained for basal, 20 min, and 8 hours were 0.0213, 
0.0205, and 0.0137 mm2, respectively. For both lenses, Friedman test revealed statistically 
significant differences with time (p<0.001), while the post-hoc analysis revealed only 
significant differences between the measurements taken at 8 hours and the other two earlier 
time periods (p<0.001). 
 
Figure 6.2. Boxplots over time obtained for the tear meniscus area for the corneo-scleral lens (white) 
and the scleral lens (grey) 
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Boxplots for the central corneal thickness for the both designs are shown in Figure 6.3. For the 
C-ScL, median values for basal, 20 min, and 8 hours were 549, 555, and 563 µm, respectively. 
For the ScL, median values obtained for basal, 20 min, and 8 hours were 549, 556, 577 µm, 
respectively. For both lenses, Friedman test was statistically significant between visits 
(p<0.001), while the post-hoc revealed statistically significant differences for all paired 
comparisons (p<0.001). 
 
Figure 6.3. Boxplots over time obtained for the central corneal thickness for the corneo-scleral lens 
(white) and the scleral lens (grey). 
Figure 6.4 shows the boxplots obtained for the osmolarity changes for both lens designs with 
time. For the C-ScL, mean values for basal, 20 min, and 8 hours were 296, 298, and 305 
mOsm/L, respectively. For the ScL, mean values for basal, 20 min, and 8 hours were 296, 299, 
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and 306 mOsm/L, respectively. For both lenses, the rANOVA procedure revealed statistically 
significant differences between visits (p<0.001), while the post-hoc revealed statistically 
significant differences between all paired time periods (p≤0.002). 
 
Figure 6.4 Boxplots over time obtained for the osmolarity for the corneo-scleral lens (white) and the 
scleral lens (grey). 
Analysis as a function of the lens diameter  
 The tear meniscus area revealed statistical differences for both lenses at 20 min 
(p<0.001), and also at 8 hours (p=0.003), being greater for the C-ScL. The central corneal 
thickness revealed statistical differences for both lenses at 20 min (p=0.002), and also at 8 
hours (p=0.001), being lower for the C-ScL. Osmolarity did not reveal statistical differences at 
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20 min (p=0.29), while it was statistically different at 8 hours (p=0.03), being lower for the C-
ScL. 
 
6.4 Discussion 
The aim of this study was to assess and compare the effect of the C-ScL and ScLs on TF 
parameters and corneal thickness in healthy presbyopic subjects. In this study, statistical 
significant decreased occurred in TMA regarding both CLs being more marked for ScL. CL wear 
induces decreases of tear meniscus values across the day [Chen et al. 2009; Chen et al. 2011), 
Wang et al. 2009, Le et al. 2009]. Moreover, CL wear is known to negatively impact the TF, 
separating it into two parts; pre and post lens TF, making it thinner and more susceptible to 
evaporation [Guillon et Maissa 2008, Tomlinson et Cerdastaff 1982] and disruption [Muntz et 
al. 2015]: C-ScL showed a 29% decrease in TMA across the day whereas the diminution was 
up to 36% regarding the ScL. When a ScL is fitted on an eye, little to no movement is expected 
which is not the case with a C-ScL, the latter providing greater mobility and tear exchange 
under the lens. This is a very important point to take into account when comparing both 
designs. Indeed, movement and tear exchange (C-ScL) versus an almost sealed post-lens TF 
(ScL), coupled with increased instability of the tears induced by the insertion of the material 
and its interaction with TF, could explain the significant differences in TMA found at the end 
of the day.  
Failure to deliver proper amounts of oxygen to the cornea during CL wear might induce 
corneal oedema, observed as increased CCT, as one of the numerous complications [Klyce 
1981, Michaud et al. 2012] that can occur secondary to CL induced hypoxia. It is acknowledged 
that the great majority of ScCLs available on the market, once placed on eye and thus forming 
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a tear reservoir beneath the lens, do not meet either the Holden and Mertz (central cornea) 
or Harvitt and Bonanno’s (limbal area) criteria for oxygen permeability [Harvitt et Bonano 
1999, Bland 2012, Dalton et Sorbara 2011, Tan et al. 1995]. However, clinical manifestation of 
corneal oedema is seldom seen in clinical practice [Klyce 1981, Michaud et al. 2012].   
 ScLs, once settled on the sclera, have a tear reservoir beneath the lens which is believed to 
be almost sealed [Tan et al. 1995, Fatt 1997, Weissman et Ye. 2006, Bergmanson et al. 2015, 
Cotter et Rosenthal 1998]. Hence  the perpendicular outflow of oxygen through the material 
and its further mixing with the tear reservoir is more important than transversal tear exchange 
that could occur between tear reservoir and peripheral tears [Bergmanson et al. 2015] 
Michaud et al. calculated that a lens would need parameters of  central thickness of 250 μm,  
Dk 100 and  central clearance of no more than 100 μm to give Dk/t of 26.5, above the cut-off 
value of Holden and Mertz  [Michaud et al. 2012, Fatt 1997, Weissman et Ye 2006]  and the 
more recent findings of Morgan et al [Morgan et al. 2010] for daily wear. Previous studies 
have investigated the correlation between tear clearance, central lens thickness and corneal 
hypoxia [Morgan et al. 2010, Jaynes et al. 2015].  
In our study, an average 2.6% (C-ScL) and 5.1% (ScL) CCT increase occurred across the day of 
lens wear. CCT changes can be directly related to patient specific corneal physiology as it is 
acknowledged that corneal response to hypoxic stress is specific to each individual and is 
subject to a great variability [Benjamin et Hill 1988]. However, the 2.6% increase found in this 
study is in agreement with Mountford et al. and corresponds to 1µm per hour CCT increase, 
result obtained in the former study with a 120 Dk material [Mountford et al. 1994]. It allows 
us to hypothesize that since the lenses were of the same material and transmissibility, the 
combination of movement induced tear exchange beneath the lens on one hand and a 
 
 
156 
 
sufficiently low tear clearance on the other hand, explain lower values of CCT increase across 
the day by bringing (laterally) more oxygen to the area under the lens and by efficiently mixing 
(transversally) the transported oxygen to the underlying tear pool to nourish properly corneal 
tissue.  
Tear film osmolarity assessment is proven to be an effective diagnostic tool for dry eye disease 
[Chen et al. 2009, Chen et al. 2011, Wang et al. 2009, Tsubota et Yamada 1992, Gaffney et al. 
2010; Gilbard et Farris 1979, Baudouin et al. 2017]. Tear osmolarity increases have been 
associated with CL wear in some studies [Muntz et al. 2015, Iskeleli et al. 2002, Stahl et al. 
2009], whereas other studies evidenced no changes [Sarac et al 2012, Benjamin et al. 1983]. 
According to Efron and colleagues, it is thought increase tear evaporation inducing electrolyte 
concentration changes could explain tear osmolarity build up associated with CL wear 
[Tomlinson et Cedarstaff 1982, Romero-Rangel et al. 2000]. 
Over the past decade, there has been a growing interest in using ScL for the treatment of DED 
by protecting the ocular surface [Rosenthal et Cotter 2003, Rosenthal et Crotteau 2005, 
Rosenthal et al. 2000, Schornack et al. 2014, Weyns et al. 2013, Takahide et al. 2007, Pullum 
et Buckley 2007, Alipour et al. 2012, Papakostas et al. 2015] due to advances in CL  materials 
and oxygen permeability [Bland 2012, Bergmanson et al. 2015, Weyns et al. 2013, Takahide et 
al. 2007, Pullum et Buckley 2007, Alipour et al. 2012, Papakostas et al. 2015]. Weber et al 
found a significant decrease of osmolarity in severe dry eye patients adapted with ScLs for 6 
months; the vaulting of the cornea and conjunctiva is believed to prevent evaporation and the 
tear reservoir maintains direct contact between tears and corneal tissue in addition to playing 
the role of interface protecting the cornea from possible abrasion from eyelid conjunctiva 
irregularities or trichiasis [Benjamin et Hill 1988, Weber et al. 2016]. In our study, only healthy 
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presbyopic patients were recruited without any anterior segment signs or symptoms of DED; 
baseline osmolarity was below the cut-off value for the disease and this remained the case 
even with the significant increase in osmolarity over the 8 hours of wear. Further studies are 
needed to better assess the influence of lens diameter over this parameter over a longer 
period of wear. Furthermore, as suggested by Carrecedo et al., it would have been interesting 
comparing osmolarity measurements just before and after removal of the ScL as it is expected 
that the release of the tears held under the scleral lens vault might increase tear meniscus 
volume and thus modify the final value of osmolarity, giving further information about the 
retained volume of tears beneath the lens [Carracedo et al.2016].  
6.5 Conclusion 
Ageing population is more prone to develop DED as increased aged is associated with higher 
prevalence of systemic and ocular disorders that may disturb anterior segment homeostasis. 
ScLs present a double advantage for this population as ScL can be a good optical platform for 
correcting presbyopia through multifocality as well as protecting the ocular surface by vaulting 
the cornea. Further studies are needed to better identify the benefits of the ScL could bring 
to an older population with anterior segment pathologies and to better understand ScL 
potential role in restoring/maintaining ocular surface homeostasis over longer periods of 
time. 
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CHAPTER 7 
THE IMPACT OF CATARACT SURGERY ON TEAR FILM 
METRICS, OCULAR SURFACE AND MEIBOMIAN GLAND 
FUNCTION  
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7.1 Introduction 
The increase in world population is accompanied by significant aging, as recent estimates from 
the Lancet Series on Ageing expect 2 billion people over 60 years old by 2050 [The Lancet. 
Series on Ageing. 2014; November 6]. Because the incidence of cataract increases with age, 
the growing elderly population is expected to lead to a significant increase in cataract 
prevalence [Gupta et Ram. 2017]. For instance, from the 26 million Americans affected by 
cataract [Wittenborn et Rein. 2014], one out of four is aged between 65 and 69 years old,  this 
proportion increasing  to almost seven people out of 10 for people aged 80+ years [Friedman 
et al. 2012]. Social and economic burden of this age-related condition is undeniable in 
developed countries [Abraham et al. 2006, Resnikoff et al. 2004] as recent estimates from 
2015 evaluate direct costs of cataract in the United States to approach $ 12 billion [Mariotti 
2012]. Besides, cataract surgery remains an important healthcare expense in Europe 
[Prokofyeva et al. 2012]. The prevalence of cataract in Europe increases with age from 5% for 
aged based population between 52-62 years old [Moshetova et al. 2009], to 30% for 60–69 
years old and up to 64% for the population over 70 years [Das et al. 1990]. Cataract surgery is 
the most commonly performed ophthalmic procedure worldwide with more than 23 million 
operations in 2014 [Freeman 2014]. According to the WHO, this number is very likely to reach 
32 million by the year 2020 as the population over 65 years old is expected to double between 
2000 and 2020 [Brian et Taylor 2001].  
Phacoemulsification is the main technique used for cataract surgery accounting for 90% of the 
procedures in developed countries [Leaming 2004]. The goal of the surgery is double: to 
restore quality of the optical media and change the refractive power of the eye with the 
possibility to correct presbyopia with the use of foldable IOLs [Skiadaresi et al. 2012]. 
Phacoemulsification technique remained almost unchanged through the years as introduced 
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by Charles Kelman in the 1970s including: manual minimal corneal incision, capsulorrhexis and 
phacoemulsification using ultrasound energy [Nagy et al. 2009] making this surgery an 
efficient and safe procedure. However, the introduction of femtomsecond laser for cataract 
surgery in 2009 [Nagy et al. 2009] is considered a breakthrough in ophthalmic surgery: its 
combination with a computer controlled delivery systems allow for precise incisions with 
limited collateral damage to surrounding tissues [He et al. 2011, Seitz et al. 2003, Sugar 2002]. 
The main drawback of this advanced technology relies on its high cost. A recent review 
comparing both techniques underlies the fact that femtomsecond laser improves 
reproducibility and precision of corneal incision [Dick et Schultz 2017] possibly reducing 
corneal nerve damage and a major potential adverse effect of the surgery: DED. Dry eye after 
cataract surgery or worsening of signs and symptoms of dryness are not uncommon as this 
procedure is invasive and the limbal incision necessary to gain access to the posterior chamber 
where the clouded lens is located, induces damages to the corneal nerves and cells. However, 
pre-existing MGD, the most common cause of evaporative dry eye [Foulks et Bron 2003, Bron 
et Tiffany 2004] could be an important factor influencing surgery outcomes as suggested by 
Han et al. [Han et al. 2014]. Indeed, it is recognized that increasing age goes hand to hand with 
an increased loss of meibomian glands acini. From the 236 patients aged 4-98 years old 
evaluated by Arita et al. using meibography , gland dropout was found to be significant for 
participants over 20 years old [Arita et al. 2008]; in contrast, Villani et al. [Villani et al. 2013] 
found the decrease in the number of acini to be most noticeable at 50 and 60 years of age. 
These results are consistent with previous studies from Norn and Den et al. reporting 
increased changes in meibomian glands after 40 years of age [Norn 1987, Den et al. 2006]. 
These works suggest that age-related acinar atrophy leads to an initial loss of acini followed 
by further obstruction of meibomian glands, the former leading to obstructive MGD [Bron et 
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al. 2017]. Three main forms of MGD have been identified, hyposecretevive, hypersecretive 
and obstructive, the latter being the most common type [Foulks et Bron 2003, Knop et al. 
2011].  The obstructive subtype is the main factor responsible for a reduced amount of 
meibum delivered on the ocular surface eventually giving rise to EDE, or “MGD-dependent 
EDE” [Bron et al.2017] considered as the most frequent form of DED [Nichols et al. 2011, Lemp 
et al. 2012, Schaumberg et al. 2011].  Han et al. found that patients without preexisting MGD 
developed it after uncomplicated cataract surgery showing, on one hand, the potential impact 
of the surgery on meibomian gland function [Han et al. 2014] and on the other, the interest 
to evaluate changes and the short-term impact of the surgery on meibomian gland function 
in an aging population more prone to MGD. 
The goal of the present study was to evaluate the short-term influence of cataract surgery on 
tear film metrics and meibomian glands function in an aging population. 
7.2 Methods 
This prospective study was performed according to the tenets of Helsinki. The protocol was 
approved by the ethical committee of the University of Valencia and Oftalvist clinic in Valencia. 
All subjects were given written information about the study before they signed a written 
statement of consent to participate. Eleven patients with cataract (mean [±SD] age 62.10 
[±10.7] years (range 40 – 75 years, median 63.5 years) were included in the present study. 
Cataract surgery 
Cataract surgery was performed using the FEMTO LDV Z8 [Ziemer Ophthalmology 
(Deutschland) GmbH]. The cutting device of the Femto LDV is integrated into a hand piece and 
positioned onto the eye during the docking procedure directly by the hands of the surgeon. 
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Femto LDV lasers have a suction ring and a central transparent part that are merged into one 
piece in association with a spectral-domain OCT. The former device is used to image anterior 
segment, centre the cornea and mark corneal incisions location and capsulorrhexis pattern 
which must remain within the pupillary border (generally 5.0 mm) [Donaldson et al. 2013]. 
Laser energy is absorbed by the tissue resulting in plasma formation and disruption induced 
by the cavitation bubbles. Ultra-short duration of the pulses (10−15 seconds) [Kullman et 
Pineda 2010] allows for a limited strength of the shock waves induced by the photodisruption 
and the creation of spots of 3 µm diameter and with an accuracy of 5 µm in depth. 
Capsulorrhexis was performed first by the surgeon (F.P.P) followed by lens fragmentation and 
corneal incisions (paracentesis and primary incision) the phacoemulsification through a 2.2 
mm clear corneal temporal incision under topical anesthesia. The IOL implant was the PodEye 
Monofocal (Physiol, Advanced Optical Solutions, Liège, Belgium). At the end of surgery, the 
corneal incision was sealed with stromal hydration. There were no intraoperative or 
postoperative complications. Postoperatively, topical moxifloxacin 0.5% (Alcon Laboratories, 
Inc. Fort Worth, Texas 76134 USA) and dexamethasone 0.1% (NOVARTIS  PHARMA SA) were 
instilled 4 times daily for 4 weeks.. 
Clinical examination included the following exams: 
Patients were seen on two occasions: seven days before cataract surgery, and 7 days after the 
surgical procedure. At each visit, the following tests were performed. Symptomatology was 
evaluated according to the TFOS DEWS II Diagnostic methodology report [Wolffsohn et al. 
2017] using the OSDI due to the strong acceptance among professionals [Wolffsohn et al. 
2017] and the DEQ-5 for its quick instruction and high discriminative capacity [Chalmers et al. 
2010]. 
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The I-Pen device was used to assess the osmolarity of the ocular tissue on the inferior 
palpebral conjunctival membrane [i-Pen Osmolarity System User Manual. I-Med Pharma Inc, 
2016]. The pen of the device is gently lowered towards the third middle of the everted inferior 
lid until the tip of the pen touched the inferior conjunctival epithelium and performs the 
measurement. As previously described in the general methodology, a cut-off score of 300 
mOsm/L for DED was chosen for the study. 
As non-invasive methods were not available, FBUT was evaluated by using blue illumination 
and a yellow filter (Wratten #12), and placing a single fluorescein strip (previously shaken) at 
the outer canthus of the inferior eyelid [Mooi et al. 2017]. After a time laps between 1 and 3 
min [Peterson et al. 2006], the time from the last blink to the first appearance of a randomly 
distributed dry spot on the cornea was recorded in seconds using a stop watch. The mean time 
for 3 consecutive attempts was recorded. After measuring TBUT, corneal and conjunctival 
staining were assessed by evaluating the extent of the staining of conjunctiva and cornea 
(central, superior, temporal, inferior, and nasal) was graded from 0 (none) to 4 (severe), 
according to the Efron’s grading scale for ocular surface staining [Bronet al. 2003]. Lower TMH 
was evaluated using a Slit-Lamp (SL-Scan, Topcon, Japan). Biomicroscope observation system 
was aligned with the illumination system, tangential to the inferior tear meniscus. Patients 
were asked to look straightforward. TMH was measured as the distance between the darker 
edge of the lower eyelid and the tear strip. Beam width and height were settled on the 
patients closed eye in order not to induce reflex lacrimation, in other words the height of the 
beam was always sufficiently low so as not to enter the pupil area, an event that would 
jeopardize TMH measurements. At a magnification of 32x, TMH measurement was performed 
by coupling the width to the absolute height of the tear meniscus [Guillon et al. 1997] (TMH-
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A as described by Santodomingo-Rubido et al. 2006) in order to form a square. The test bar 
was then placed on its support and TMH measured using a ruler to the nearest 0.05 mm.  
Expressibility of the meibum was scored by the application of digital pressure to the central 
third of the upper tarsus. The ease of meibum secretion was graded as follow: 0 (clear meibum 
easily expressed); 1 (cloudy meibum expressed with mild pressure); 2 (cloudy meibum 
expressed with more than moderate pressure); and 3 (meibum not expressed, even with 
heavy pressure) [Shimazaki et al. 1995]; higher scores represented a more obstructive status. 
Meiboscore ranges as follow: from 0 to 3 for each eyelid giving an overall score ranging from 
0 to 6 [Arita et al. 2017]. The cutoff value of the meiboscore as a criterion for the diagnosis of 
MGD was found to be ≥3 [Arita et al. 2009]. 
The meibography system was composed of a SL (SL-D701, Topcon, Japan) equipped with an 
infra-red transmitting filter (BG-5; Topcon, Japan) coupled  with a digital camera (DC-4; 
Topcon, Japan) allowing  still images or videos to be captured of the morphology of meibomian 
glands. The upper and lower eyelids were everted and images were obtained in which intact 
glandular tissue appears pale against a dark background. Areas where glandular tissue could 
not be visualized were considered areas of meibomian gland dropout. 
Meibography scores, which quantify obstruction of meibomian glands, were obtained using 
the following grades for each eyelid: 0 (no loss of meibomian glands); 1 (meibomian gland loss 
involving less than one third of the total meibomian gland area); 2 (area lost between one 
third and two thirds of the total meibomian gland area); and 3 (area lost more than two thirds 
of the total meibomian gland area). The total meibography score was the sum of the scores of 
the upper and lower lids and was recorded as 0 to 6 [Arita et al. 2009, Arita et al. 2013]. 
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Figure 7.1. Infrared meibography of superior eyelid at baseline 
 
Figure 7.2. Infrared meibography of superior eyelid 7 days after the surgery 
 
 
Figure 7.3. Infrared meibography of inferior eyelid at baseline 
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Figure 7.4. Infrared meibography of inferior eyelid 7 days after the surgery 
Statistical analysis 
All statistical analyses were performed using SPSS V.21.0 (SPSS, Chicago, Illinois, USA). 
Descriptive statistics were used to summarise patient demographic and clinical information. 
Shapiro-Wilks test was used to assess distribution of the variables included in the present 
study. Wilcoxon’s test was used for the data which was not normally distributed whereas 
paired sample t-test was used for the data normally distributed. Pearson's and Spearman's 
correlations were used to evaluate the strengths of association between questionnaires. 
7.3 Results 
Eleven eyes from 11 patients participated in the study. The mean Five-item DEQ score was 
9.82 (SD 1.9 range 1 to 18) before the surgery of which 63% (n=7) had a baseline score greater 
than 6 (indicative of mild or greater DED symptoms). Post-surgery, mean DEQ score was 14 
(SD 1.9 range 3 to 20) of which 82% (n=9) had a score greater than 6. A significant increase in 
DEQ-5 score was found after surgery (Wilcoxon test p= 0.017). 
 
 
169 
 
 
Figure 7.5. Boxplot over time of Five-Item Dry Eye Questionnaire 
Mean OSDI score at baseline was 36 (SD 4.8 range 4 to 62) of which 91% were above the cut-
off score for DED. Post-surgery, mean OSDI score was 42.4 (SD 5 range 8 to 67) of which 91% 
were above the cut-off score for DED. A significant increase in OSDI score was found after 
surgery (Paired sample t-test p=0.03). 
 
Figure 7.6. Boxplot over time of OSDI score 
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The correlation between these two questionnaires was moderate (Pearson’s r= 0.60, 
Spearman’s ρ= 0.57 p=0.05). Mean TBUT values were 8.6 s (SD 0.5 range 6 to 11 s) before 
surgery and 8.4s (SD 0.6 range 6 to 11 s). No significant differences were found between pre- 
and post-surgery values (p= 0.608). Mean staining scores were 0.3 (SD 0.5 range o to 1) and 
1.3 (SD 0.5 range 1 to 2) pre- and post-surgery respectively. Vital staining significantly 
increased through the surgery (p=0.004). Mean TMH values were 0.26 mm (SD 0.03 range 0.10 
to 0.40 mm) and 0.27mm (SD 0.03 range 0.15 to 0.40mm) pre- and post-surgery respectively. 
No differences could be evidenced between the appointments. Mean osmolarity values were 
299.2 mOsm/L (SD 4.6 range 282 to 333 mOsm/L) and 294 mOsm/L (SD 2.3 range 275 to 303 
mOsm/L) pre- and post-surgery respectively. Osmolarity values did not show significant 
changes during the study (p= 0.66).  Mean MGs expressibility scores were 1.0 (SD 0.3 range 0 
to 2) and 1.7 (SD 0.3 range 0 to 3) pre-and post-surgery respectively. From the 11 patients 
included in this study, 6 presented a pre-surgery meiboscore ≥3 which classified them as 
having MGD. MG expression was significantly more difficult to perform after the surgery (p= 
0.011). Regarding IR imaging of MGs, mean grades were 2.5 (SD 0.4 range 1 to 4) for pre- and 
post-surgery respectively. No statistical differences were detected between appointments for 
this parameter. 
7.4 Discussion 
Numerous factors can induce signs and symptoms of DED following cataract surgery despite 
uncomplicated procedure. Ocular discomfort following cataract surgery has been attributed 
to exacerbation of preexisting DED or to its onset [Li et al. 2007, Ram et al. 1998, Oh et al. 
2012, Cho et Kim 2009, Chung et al. 2013] mainly due to surgery-related events: corneal nerve 
section that is recognized to reduce corneal sensitivity and thus the efficiency of the feedback 
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loop of the LFU; toxic changes at the ocular surface induced by preservatives found in topical 
eyedrops used consistently before, during and following the procedure and repeatedly 
insulting corneal and conjunctival tissue [Salomão et al. 2009, Walker 2004]; a drastic 
reduction in blinking rate during the surgery coupled with repeated irrigations of the ocular 
surface are thought to snatch goblet cells and further impact TF stability [Salomão et al. 2009, 
Walker 2004, Cho et Kim 2009, Nakamori et al. 1997], a long time of exposure of the ocular 
surface to the light of the microscope leading to thermal damage [Salomão et al. 2009, Walker 
2004, Cho et Kim 2009]. Ocular surface structures are fundamental for the proper functioning 
of the LFU and as such, their insult is expected to generate signs and symptoms of DED 
[Baudouin et al. 2013]. Thus, numerous patients candidate for cataract surgery and presenting 
MGD often present a fairly wide range of symptoms [Arita et al. 2008]. Previous studies 
focusing on the impact of surgery on dry eye signs and symptoms, found an aggravation of the 
evaluated parameters after the surgical procedure [Ram et al. 2002, Cho et Kim. 2009]. Oh et 
al. found that even if TF function gradually improved after the surgery, increased ocular 
symptomatology could last more than three months after the procedure before returning to 
levels approaching the pre-operative state [Oh et al. 2012]. In the present study, a significant 
increase in OSDI scores was found 7 days after the procedure, which is in agreement with 
previous studies [Ram et al. 2002, Cho et Kim. 2009, Oh et al. 2012]. The 5-Item dry eye 
questionnaire also showed an increased score after the surgery but only a moderate 
correlation was found between both questionnaires.  
This moderate correlation could be due to two main factors: the low number of participants 
to the study and the fact that on the contrary to what was previously done regarding OSDI 
testing in patients undergoing cataract surgery [Park et al. 2016], items 4 and 5 were not 
removed from the questionnaire. These questions evaluate the blurred vision and it is indeed 
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difficult to seclude vision-related symptomatology changes due to cataract removal from the 
dry eye induced symptoms related to surgery itself, which could undoubtedly lead to some 
degree of bias. However, this “r” value obtained in the present study is consistent with 
literature, as similar moderate correlation has been found when comparing both 
questionnaires [Galor et al. 2015]. Further research is needed in order to develop a definite 
cataract and corneal surgery questionnaire evaluating dry eye symptoms with a specific focus 
on surgery associated changes in vision (separating the ones expected from the surgery and 
the unwanted dry eye induced changes). 
Regarding the influence of cataract surgery on TF stability, existing literature gives inconsistent 
results. Li et al. [Li et al. 2007, Liu et al. 2002] both found a significant decrease in TBUT values 
along with other TF parameters such as Schirmer test 1 and lower TMH. In the study from Li 
et al., TBUT, evaluated at one week, one month and three months showed a significant 
decrease only after 3 months, which is consistent with the present study. However, Liu et al. 
found a significant decrease in TBUT values from day 1 post-surgery that came back to pre-
operative value after one month.  
In the current study, no significant differences were found before and after the surgery, these 
results are in agreement with Ram et al. study [Ram et al. 2002]. Discrepancies between 
studies might come from differences in the study design, methodology (all of the previous 
studies did not evaluate MG function and structure before and after the surgery) as well as 
sample used, as prevalence of MGD increases with age. In this study, it is thought that a small 
corneal incision of 2.2 mm caused a very limited focal reduction in corneal sensitivity, retaining 
intact the majority of corneal nerve architecture, which undeniably resulted in token short-
term changes in tear secretion and tear film stability. Indeed, a previous study indicates that 
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recovery times are directly related to incision size [Oh et al. 2012]. Besides, patients were seen 
seven days after the surgical procedure, and initial post-surgery TF instability as evidenced by 
Li et al. and Liu et al. occurred only a few hours after the surgery [Li et al. 2007, Liu et al. 2002]. 
However, long-term follow-up of this parameter, as performed by Li et al. would give valuable 
information on TF stability over time as significant decrease in stability have been highlighted 
at three months post-surgery [Li et al. 2007]. We hypothesize that surgery-related functional 
changes taking place in MGs could positively impact TF stability, with a lag time for setting it 
up post-surgery which might depend on MG degree of dropout at baseline. Further studies 
are needed in order to better understand which factors can influence TF stability values over 
time following cataract surgery as the TFOS Workshop on MGD [Schaumberg et al. 2011], 
emphasize that TBUT is considered “as a secondary or surrogate measure of MGD and 
therefore is a less specific indicator of disease status” . 
The important role played by the long-term use of preservative-containing eyedrops on TF 
stability, epithelium barrier disruption, goblet cell loss and ocular surface cells apoptosis is 
well recognized [Baudouin et al. 2010]. BAK is the most commonly used preservative in 
ophtalmic drug formulations and its role is double. First, for its preservative intrinsic qualities, 
but also because the epithelium barrier disruption induced by quaternary ammoniums 
enhances the penetration of drugs into the anterior chamber.  The precise mechanisms 
through which its use induces inflammatory processes leading to pro-inflammatory CKs 
expression and ocular surface damage are yet to be elucidated; however, its toxic effects are 
known to be dose- and time-dependent [Baudouin et al. 2010]. Dry eye models in rats [Lin et 
al. 2010] suggest that the use of BAK for 7 days is sufficient to induce inflammatory cascades 
at the ocular surface leading to the liberation of pro inflammatory CKs such as TNF-α which 
effects have already been described in the introduction of this manuscript. The following 
 
 
174 
 
ocular surface cells apoptosis gave a pattern very similar to the one that can be found in dry 
eye patients suggesting that this preservative potentially could aggravate or induce signs and 
symptoms of dry eye on its own. In the present study, patients used Vigamox and Diclofenac-
Lepori eyedrops, which are preservative-free and with very limited adverse effects [Miller 
2008]. The other drops used just after the surgery were Maxidex, known to contain BAK. 
However, its use was too limited in time and dose to have induced further corneal staining 
that would have maintained until the seventh day following the surgery. Thus, the significant 
increase in vital staining found in the present study cannot beattributed to the use of 
eyedrops. A recent study focused on the in-vitro effect of light exposure on conjunctival cells 
and shown that even a quarter of the amount of microscopic light used during the surgery was 
sufficient to induce cellular damage that could slow down the wound healing process [Ipek et 
al. 2018] possibly leading to short-term increased positive vital staining. Further studies are 
needed to better understand the role played by microscopic light illumination in post-surgery 
signs and symptoms of dryness.  
According to the TFOS Diagnostic Methodology report, tear osmolarity is the tear parameter 
that provides the strongest correlation to DED severity among all other tests [Sullivan et al. 
2010, Wolffsohn et al. 2017]. Besides, it is considered the best tear film metric to diagnose 
and classify the disease [Tomlinson et al. 2006, Lemp et al. 2011, Potvin et al. 2015]. Few 
studies focused on the impact of cataract surgery on osmolarity values [Khanal et al. 2008, 
González-Mesa et al. 2016]. Khanal et al. found an early post-operative (at 3 days) significant 
increase in comparison with pre-operative values, and even if osmolarity remained higher 
than baseline at 10 days, the difference was not sufficient to be significant [Khanal et al. 2008]. 
The device used in this study was based on freezing point depression to determine osmolarity 
values and nowadays, higher specificity “lab-on-a-chip” devices using electrical impedance 
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exist to perform the measurement [Tomlinson et al. 2010].  The device used in the present 
study is the i-Pen, one of the both “lab-on-a-chip” devices available on the market along with 
the TearLab. The former has demonstrated its usefulness through numerous studies for 
diagnosis, grading of severity, and follow-up of DED patients [Farris et al. 1986, Versura et al. 
2010, Tomlinson et al. 2010, Potvin et al. 2015]. However, the i-Pen system, appeared recently 
on the market and little is known about its ability to properly diagnose and grade patients with 
the disease. Few studies have looked into this device’s ability to reproduce a range of 
physiological values [Nolfi et Caffery 2017, Rocha et al. 2017] and both in vitro and in vivo data 
suggest that this device does not provide sufficient accuracy and precision in assessing 
osmolarity levels belonging to physiological ranges [Nolfi et Caffery 2017, Rocha et al. 2017]. 
The present study did not find any statistical change in osmolarity values before and after the 
surgery, which is in agreement with González-Mesa et al., and even if a different “lab-on-a-
chip” device was used, it lead to similar conclusions [González-Mesa et al. 2016]. It seems that 
ocular surface discomfort increase, as evidenced by both questionnaires in this study, cannot 
be attributed to osmolarity changes. The i-Pen device was designed to sample the inferior 
eyelid conjunctival epithelium, which could very possibly be at the origin of differences 
between devices.  However, Rocha et al. already looked into the reasons for differences 
between devices displayed values: if the i-Pen really measures tissue impedance (which is 
expected to give much higher values than a solution like the tears [Pethig 1987]), little is 
known about what happens in clinical practice when some of the tear accidentally bridges the 
tip of the pen, which occurred almost every time during the present study [Rocha et al. 2018].  
Osmolarity values obtained should be far out of the normal human osmolarity range [Rocha 
et al. 2008] as this device was calibrated to measure a tissue with electrical resistance greater 
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than the tear film. Further research is needed to better understand the measurements taken 
by this device. 
Data regarding changes induced by cataract surgery in TM measured using SL and Schirmer 
test gave discordant results [Ram et al. 2002, Kim et al. 2009, Oh et al. 2012, Sanchez et al. 
2010, Cho et Kim. 2009; Lim et al. 2007]. We measured subjectively TMH using SL and 
graticule, which has shown acceptable repeatability and high reproducibility between visits 
[Santodomingo-Rubido et al. 2006, Imamura et al. 2017]. As underlined by García-Resúa 
[García-Resúa et al. 2009], measuring TMH with SL requires a learning-curve as identifying 
TMH superior edge might not be as easy as it seems. However, the practitioner (i.e. E.L) is an 
experienced optometrist and has been practicing this technique for several years. Measuring 
this parameter did not show significant changes between visits. Even if newer, more precise 
and reproducible techniques exist, a previous work by Han et al. [Han et al. 2014] evaluating 
TMH using OCT before and after cataract surgery was not able to show any significant 
influence of cataract surgery on this parameter [Han et al. 2014]. The hypothesis explored by 
the authors to which we adhere is that ocular symptoms following cataract surgery cannot be 
attributed to a decrease in aqueous tear production alone as increased symptomatology is 
still present more than 3 months post-surgery and literature reports that corneal sensitivity 
could take between one and 3 months to go back to pre-operative levels . 
Among the age-related changes taking place in MGs, recent studies identified, in addition to 
already acknowledged alterations (i.e gland atrophy and decreased acinar cell proliferation) 
[Jester et al. 2015] a significant decrease in the expression and localization of a receptor, a 
major regulator of lipogenesis called proliferator-activated receptor gamma (PPARγ) [Nien 
2011, Nien et al. 2009]. This receptor plays a key role in meibocytes differentiation and thus 
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in lipid synthesis, so the decrease in PPARγ expression is directly linked to age-related MGD 
leading to gland dropout and changed lipid composition and protein to lipid ratio [Jester et al. 
2015]. Indeed, studies based on animal models suggest that, in normal conditions, lipids 
synthesized by the MGs are subject to a maturation process as they migrates along the ductule 
to reach the main duct and then the meatus of the MG during which, they progressively lose 
their associated proteins before leaving the lumen [Suhalim et al. 2014]. Sulajhim et al. found 
that this protein to lipid ratio remains almost unchanged in prolonged dessicating stress 
conditions indicating the impact of this environmental change on MG function. Interestingly, 
Ong et al., Palaniappan et al. and Millar et al., found that the incorporation of protein to 
normal MG secretion possibly increases lipid rigidity and viscosity making it more fragile and 
prone to rupture by reduction of surface tension when incorporated to the TF [Ong et al. 1991, 
Palaniappanet al. 2013, Millar et al. 2009]. The protein very likely to be responsible for MG 
obstruction is keratin and its derivatives as they are the major proteins found in meibomian 
secretions [Tsai et al. 2006, Ong et al. 1991]. This theory seems to be robust as some authors 
confirmed that keratin found in MGs secretions originates from the shedding of the epithelial 
cells upholstering the ducts [Ong et al. 1991, Knop et Knop. 2009] but also MG acini [Liu et al. 
2010]. Therefore, mechanisms of accumulation of cellular debris and lipids create an 
obstruction further leading to duct dilation and gland atrophy [Blackie et al. 2010, Korb et 
Henriquez 1980]. 
 As suggested by Jester et al., the overall mechanism of age-related obstruction would be as 
follow; an initial environmental trigger increases epithelial duct and acinar cells turnover that 
leads to accumulation of desquamated cells and proteins in the ducts affecting lipid properties 
and possibly inducing mechanical obstruction [Jester et al. 2015]. However, it is necessary to 
take into account the interesting theory that could combine to, and further promote 
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keratinization at the main ducts: the recent TFOS DEWS II pathophysiology report [Bron et al. 
2017] mentions the possibility that the incomplete apposition of the lid margins with every 
blink [Pult et al. 2015], possibly further aggravated by the surgery, would make Marx’s line a 
permanent hyperosmolarity site allowing the diffusion, up to the terminal MG ducts, of low 
molecular weight proteins such as pro-inflammatory CKs among which IL-1β and INFγ, CKs 
that provide the ability to induce the expression of precursors of cornifying proteins that could 
possibly, with time, induce further hyperkeratinization, a keystone of the pathophysiology of 
the disease. Besides, let us not forget that pre-existing DED permanently drops at the ocular 
surface and thus over MCJ site, the same pro-inflammatory CKs (among others) that could 
accelerate the keratinization process and excacerbate obstruction and lipid delivery 
reduction. 
As defined by Korb and Blackie, MG expressibility is used to depict “the ease with which 
secretion can be physically expelled from the gland” [Korb et Blackie 2008] and scientific 
literature demonstrated the importance of the efficacy of such glands in preventing dry eye 
signs and symptoms [Bron et al. 2017]. In the present study, a significant reduction in glands 
expressibility was found after cataract surgery. Interestingly, ocular surface and adjacent 
structures such as eyelids and the glands they enclose are subject to the same general 
inflammatory response following surgery as the liberation of pro-inflammatory signaling 
molecules is ubiquitous and could very easily amplify age-related changes leading to 
keratinization and epithelial cells turnover. Interestingly, MG expressibility worsening through 
the surgery should be considered as an enhancement of an already on-going process that 
could be related to aging, to DED alone, or the combination of both. Furthermore, the amount 
to which feedback loop damage, secondary to corneal nerves harm, impacts MG function is 
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difficult to assess as the effect of nerves on MGs is still unclear and requires further 
investigation [Cox et Nichols 2014].  
From the 11 patients included in this study, 55% (n=6) were initially diagnosed with MGD. 
Even if the number of patients is reduced, MGD prevalence in this group was almost the same 
as the ones reported in previous epidemiological reports, i.e 61.9% according to Uchino et al. 
study [Uchino et al. 2006] based on gland dropout, expressibility and nature of meibum 
secretion; and 60.8% in the Shihpai Eye Study [Lin et al. 2003]. However, vigilance is required 
when looking at these numbers as ethnicity varies between studies and, as shown in the 
Salisbury Eye Evaluation, even if parameters evaluated largely differ, prevalence in Caucasian 
population was found to be much lower than the group evaluated in the present study [Schein 
et al. 1997]. 
 
7.5 Conclusions 
We hypothesize that cataract surgery further promotes short-term MG obstruction, as only 
functional changes (reduction in MG expressibility) could be evidenced and IR meibography 
did not show any significant structural change. As proposed by Han et al., it is more likely that 
structural changes impacting MGs, which were not found in the present study, are more the 
result of a chronic dysfunction than a part of the short-term cataract surgery outcomes [Han 
et al. 2014]. The present study could not elucidate the exact mechanisms by which functional 
short-term changes occur in MGs following the surgery; however, it is very likely that even 
without significative signs of MG structure damage, cataract surgery seems to impact MG 
function. Previous litterature suggest that surgery-induced inflammation, bacterial infection 
from breached ocular surface, preservative-containing postoperative medications or 
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combination of the former, are thought to play a role, even if in different extents [Sutu et al. 
2016, Li et al. 2009, Akyol-Salman et al. 2012]. Besides, it would be interesting to follow-up 
changes taking place in both upper and lower MCJ and Marx’s line, as widening and anterior 
displacement of Marx’s line is a good indicator of meibomian glands orifices status. 
This study has some drawbacks. First, it was conducted in a relatively small number of subjects 
and did not have a control group that had not undergone cataract surgery. Second, the lid 
hygiene status was not studied and Marx’s line and MCJ not evaluated which could have given 
valuable information on the impact of the surgery on these parameters; indeed, a previous 
study showed significant changes in lid margin vasculature and irreversible MCJ displacement 
through the surgery [Han et al. 2016]. Third, meibum expressibility was not objectively 
measured using a device that delivers standardized pressure on the lid [Korb et Blackie 2008]. 
Promizing therapies are emerging in order to treat MGD, such as Intense Pulsed Light (IPL) 
systems used to treat the disease (REFs). Further investigation is needed to assess the impact 
of this therapy in MGD patients on surgery outcomes 
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CHAPTER 8 
GENERAL CONCLUSIONS  
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The clinical studies presented in this doctoral tesis with patients corrected for presbyopia with 
different refractive modalities allow us to draw the following conclusions: 
 
1. The eye, as well as the entire human body, is subject to the process of aging, the most 
remarkable manifestations of which are presbyopia and opacification of the lens, in 
other words, cataract. Almost every anterior segment structure undergoes age-related 
functional and morphological changes, from the lacrymal glands (main lacrymal gland, 
meibomian glands, and goblet cells) to eyelids and conjunctiva. These changes reduce 
both quantities and quality of tear secretion, prevent an optimal repartition of the tear 
film on the ocular surface potentially leading to/ worsening signs and symptoms of 
dryness.  
DED prevalence increases with age, because of the aforementionned aging processes, 
and compensating for presbyopia or getting rid of crystalline opacities require a 
comprehensive previous assessment of the Lacrymal Functionnal Unit and more 
generally of the anterior segment. The great majority of refractive options available, 
apart from eyeglasses, are considered as invasive and could easily perturb the ocular 
surface homeostasis. Multiple approaches can be considered when correcting 
presbyopia and cataract, the common goal being to restore vision and give sustainable 
comfort to the patient.  
Presbyopia correction can be achieved through eyeglasses (monofocal, bifocal, trifocal 
and multifocal lenses) and the former approaches are not expected to induce or 
worsen signs and symptoms of dryness. Presbyopia correction through CLs is another 
option that includes: rigid gas permeable contact lenses (from corneal RGPs to semi-
 
 
184 
 
scleral and scleral designs with different geometries such as monofocal, bifocal, soft 
contact lenses). However, CLs, once upon eye, sits in the tear film (TF), disturbing its 
normal structure and interact with the ocular surface possibly worsening an already 
unbalanced environment. Refractive surgery is another option available (cataract 
surgery with implantation of different geometry intra ocular lenses (IOL) (monofocal, 
bifocal, trifocal), corneal refractive surgery) but its invasiveness, even if great steps 
forwards have been made, disturbs as well the ocular surface and can worsen or induce 
signs and symptoms of dryness. 
2. Clinical performance of a water gradient daily disposable soft CL on the ocular surface 
and the TF in a neophyte presbyopic population over their first 8 hours of wear induced 
an initial decrease in TF stability from CL insertion observed by osmolarity values rising 
after 20 minutes of wear; however, it did not impact tear meniscus metrics and 
seemed to be transitory, as a decrease, without reaching baseline values, occurred by 
the end of the wearing period. Ocular surface aberrations remained largely stable from 
CL insertion, demonstrating an even repartition of TF over the CL material surface.   
3. Attempts to target unmet needs for a growing presbyopic population especially 
regarding CL fitting strategies require previous identification of the changes taking 
place in the lacrimal functional unit, how they affect the ocular surface and in which 
extent the insertion of a CL would affect this set of structures or worsen an already 
unbalanced ocular environment. Both daily disposable and extended wear soft CL 
material fitted provided satisfactory and similar objective on-eye behavior and 
remained largely stable along the experiment period. However, subjective symptoms 
showed a greater increase from baseline regarding the extended wear lens in 
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comparison with the daily lens. Comfort seems to be impacted by CL material modulus, 
parameters of both CLs being otherwise very similar. 
4. Ageing population is more prone to develop DED as increased aged is associated with 
higher prevalence of systemic and ocular disorders that may disturb anterior segment 
homeostasis. ScLs present a double advantage for this age-based population as ScL can 
be a good optical platform for correcting presbyopia through multifocality as well as 
protecting the ocular surface by vaulting the cornea and limbo. Further studies are 
needed to better identify the benefits of the ScL could bring to an older population 
with anterior segment pathologies and to better understand ScL potential role in 
restoring/maintaining ocular surface homeostasis over longer periods of time. 
5. The results of this pilot study suggest that cataract surgery further promotes short-
term MG obstruction, as only functional changes (reduction in MG expressibility) could 
be evidenced and IR meibography could not evidence any significant structural 
modification. As mentionned in other studies, it is more likely that structural changes 
impacting MGs, which were not found in the present study, are more the result of a 
chronic dysfunction than a part of the short-term cataract surgery outcomes. The 
results obtained did not allow the exact mechanisms to be elucidated by which 
functional short-term changes occur in MGs following the surgery; however, it is very 
likely that even without significative signs of MG structure damage, cataract surgery 
impacts MG function. MG expressibility worsening through the surgery is thought to 
be an enhancement of an already on-going process that could be related to aging, to 
DED alone, or the combination of both. 
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CHAPTER 9 
FUTURE LINES OF INVESTIGATION 
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From the data analyzed in the clinical studies forming part of this doctoral thesis, we arrived 
at various conclusions concerning the different types of refractive corrections in a presbyopic 
population and their impact on dry eye signs and symptoms. These conclusions raise a number 
of questions that deserve further investigation. Here are the main topics requiring further 
research: 
 Questionnaires 
Evaluating symptomatology in a comprehensive way is a very difficult goal to achieve. Indeed, 
as reviewed in this manuscript and through the different clinical studies performed, ocular 
sensation is very subjective and given symptoms can be described in many different ways by 
the patient. Even if considerable efforts have been made to design and validate questionnaires 
aiming to assess general and contact lens associated symptomatology, we realized that 
information is still lacking regarding specific DED induced symptomatology like for instance 
the specific impact of corneal refractive and cataract surgeries. Indeed, this scientific vacuum 
has been highlighted in Chapter 7 where generic questions related to vision quality were not 
appropriate in the case of media opacities as for instance: cataract surgery with IOL 
implantation would definitely improve those symptoms (thus reduce the overall score of the 
questionnaire) no matter if  DED was already present before the surgery; which means that 
those questions, in their actual formulation, fail to properly quantify/segregate cataract 
associated symptomatology/ DED associated decrease in quality of vision and should be 
removed (or re-formulated towards pre-surgery DED symptomatology and surgery-induced 
possible symptomatology).  Both corneal refractive and cataract surgeries are rapidly 
expanding, and the impact of these techniques on DED signs and symptoms needs to be 
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precisely assessed. Hence the necessity to design new screening tools such as ocular surgery-
oriented questionnaires to compare pre- and post-surgery outcomes. 
 CL materials biocompatibility 
Considerable efforts have been made in the last few years to describe corneo-scleral and 
scleral profiles principally due to recent technologic advances in anterior segment-OCT 
imaging. This device helped to design scleral lenses with customized periphery in order to fit 
as best as possible the chiral nature of the sclera, thus increasing comfort and stability of 
vision. However, little is known regarding the long-time effect of these new designs and the 
benefits that could arise for patients in terms of, comfort, quality of vision, 
maintaining/restoring ocular surface homeostasis but also the gain of office-time for the 
practitioner with a set of trial scleral lenses which would accelerate the fitting process. 
 Inflammatory cascades in response to osmolarity changes 
Inflammatory processes taking place at the ocular surface are highly complex and involve 
many inflammatory mechanisms and immune cells. Great advances have been made to 
identify and describe inflammatory markers responsible for the spread of the inflammation 
signal triggered by the multifactorial etiology of the disease. This lead to the development of 
new anti-inflammatory strategies that intend to block key interactions between immune cells 
and thus prevent the propagation of the inflammation signal. Even if some of these new 
therapies are still in development, they gave promising results in clinical trials and showed the 
importance to study cellular interactions in DED associated immune responses. Future lines 
of investigation in this domain should focus on how to modify/counteract the intracellular 
activation cascade induced by raised osmolarity, or cellular damage, like for instance the Toll-
receptors. These latter are able to: recognize auto-Antigen, internalize them and present part 
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of them to APCs. Blocking that interaction by a system of competitive ligand (mimicking the 
human body) as for the IL-1 RA which union to IL-1 receptor (IL-1 R) induces no effect, 
preventing effectory IL-1 to bind to this receptor and promote inflammation signal. 
Besides, further research is needed regarding the impact of a raised osmolarity on ocular 
surface: the duration of an increased osmolarity and the amount of this increase from baseline 
values that will induce cellular damage.  
Evaluate if, before cellular damage takes place, there is warning signs like for instance a 
change in cellular function or metabolism that could be used as an early marker of ocular 
surface loss of homeostasis.  
Assess type cells sensitivity to osmolarity (bulbar conjunctival cells versus corneal cells versus 
palpebral conjunctiva cells) in order to establish a sequence, if applicable, of cellular damage 
that could be a pharmaceutical target for dry eye eyedrops in order to palliate the decrease 
in some cell type function that would strengthen TF composition and stability on ocular 
surface. 
 Tear meniscus parameters 
Assessing tear meniscus parameters (TMH, TMA, TMV) non-invasively using OCT has been 
proven to be of great value in the diagnosis and monitoring of DED patients. However, these 
parameters are generally evaluated in the center of the eyelid, typically called “six o’clock 
position” below the pupil center, and in both nasal and temporal locations in a reproducible 
way [Pult et Riede-Pult 2015]. Previous studies proposed a mathematical model to extrapolate 
from TMA values at the center of the inferior eyelid including in the formula a compensation 
factor for the eyelid’s curvature [Del Águila-Carrasco et al. 2015, Palakuru et al. 2007, Bandlitz 
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et al. 2016]. However, this formula, even if giving interesting data regarding the overall TMV, 
does not take into account biasing lid and conjunctiva disorders such as LIPCOF, 
conjunctivochalasis disorders of the lid margin congruity and apposition between the lid and 
ocular surface [Ibrahim et al. 2010, Pult et Riede-Pult 2015, Wolffsohn et al. 2017]. 
Understanding the influence of these disorders on tear meniscus parameters from canthus to 
canthus would give valuable information regarding total TMV for diagnosis and follow-up of 
DED patients. To do so, further research is needed in order to find a way to visualize/ map 
continuously from canthus to canthus the entire shape of the inferior tear meniscus. The 
investigation should focus on built-in softwares that can mark the area of the inferior meniscus 
already scanned and, with an additional image analysis software unite every scan in order to 
form a tridimensional image that would give an information on every tear meniscus parameter 
and how it is modified by lid margin disorders and DED. 
 Refractive surgery   
Further investigation should focus on the impact of corneal refractive surgery to correct 
presbyopia (the different techniques described in the introduction) as new techniques 
constantly appear. Evaluate the impact of the surgery approach and the technique used in 
inducing/ worsening signs and symptoms of DED would give new sight on the pathophysiology 
of the disease. Again, this goes in pair with the design of new questionnaires dedicated to 
segregate visual symptoms due to refractive defects from those induced by DED, and be able 
to evaluate the impact of the surgery on those symptoms. Besides, the advent of new 
promising therapies to improve surgery outcomes such as IPL devices deserve further research 
as some studies already showed the positive impact of this technology on MG function and 
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expressibility, this could be used as a preventive/ prophylactic treatment for every patient 
over 40 years old in order to preserve/enhance MG function. 
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Appendix 
Annex 1: Ocular Surface Disease Index questionnaire (OSDI) 
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Annex 2: Five-Item Dry Eye questionnaire (DEQ-5) 
 
 
Annex 3: Eight-Item Contact Lens Questionnaire (CLDEQ-8)
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Annex 3: EFRON grading scale for CL complications 
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